var title_f7_56_8064="Contents: Laboratory medicine";
var content_f7_56_8064=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?23/51/24382\">",
"       Adult Primary Care and Internal Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Laboratory medicine",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Laboratory medicine",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Adrenal tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/35/7736\">",
"           Assays of the renin-angiotensin-aldosterone system in adrenal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/46/44777\">",
"           Diagnosis of adrenal insufficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/25/21913\">",
"           Establishing the diagnosis of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/19/40246\">",
"           Measurement of ACTH, CRH, and other hypothalamic and pituitary peptides",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/8/132\">",
"           Measurement of cortisol in serum and saliva",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/22/41319\">",
"           Measurement of urinary excretion of endogenous and exogenous glucocorticoids",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Autoantibody tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/43/2743\">",
"           Anti-U1 RNP antibodies in mixed connective tissue disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/10/1192\">",
"           Antibodies to double-stranded (ds)DNA, Sm, and U1 RNP",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/4/27718\">",
"           Antiribosomal P protein antibodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/28/9674\">",
"           Clinical spectrum of antineutrophil cytoplasmic antibodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/23/3447\">",
"           Definition and diagnosis of mixed connective tissue disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/29/27096\">",
"           Diagnosis of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/54/28520\">",
"           Measurement and clinical significance of antinuclear antibodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/44/42695\">",
"           Miscellaneous antinuclear antibodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/41/42648\">",
"           Origin and utility of measurement of rheumatoid factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/34/29224\">",
"           Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/23/8568\">",
"           The anti-Ro/SSA and anti-La/SSB antigen-antibody systems",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fluid and electrolyte tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/44/31432\">",
"           Approach to the adult with metabolic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/13/5338\">",
"           Approach to the patient with hypertension and hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/35/39479\">",
"           Clinical manifestations and evaluation of metabolic alkalosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/7/2167\">",
"           Diagnosis and treatment of hypophosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/28/20934\">",
"           Diagnostic approach to hypercalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/13/34005\">",
"           Diagnostic approach to hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/63/11254\">",
"           Evaluation and treatment of hypomagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/9/9366\">",
"           Evaluation of the patient with hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/20/21832\">",
"           Evaluation of the patient with hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/13/13527\">",
"           Overview of the causes and treatment of hyperphosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/29/470\">",
"           Regulation of magnesium balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/8/23685\">",
"           Relation between total and ionized serum calcium concentration",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/43/36533\">",
"           Serum anion gap in conditions other than metabolic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/29/41430\">",
"           Serum osmolal gap",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/41/27288\">",
"           Simple and mixed acid-base disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/1/21526\">",
"           The ������anion gap/������HCO3 ratio in patients with a high anion gap metabolic acidosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hematology tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/3/5178\">",
"           Approach to the adult patient with a bleeding diathesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/46/29418\">",
"           Approach to the adult patient with anemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/19/15674\">",
"           Approach to the adult patient with thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/3/18489\">",
"           Approach to the diagnosis of hemolytic anemia in the adult",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/10/24745\">",
"           Approach to the patient with eosinophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/52/29511\">",
"           Approach to the patient with neutrophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/6/24681\">",
"           Approach to the patient with thrombocytosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/54/35690\">",
"           Automated hematology instrumentation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/22/5482\">",
"           Bone marrow aspiration and biopsy: Indications and technique",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/39/26234\">",
"           Causes and diagnosis of anemia due to iron deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/6/20586\">",
"           Clinical and laboratory aspects of platelet transfusion therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/60/4041\">",
"           Clinical course and management of monoclonal gammopathy of undetermined significance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/51/19256\">",
"           Clinical features and diagnosis of autoimmune hemolytic anemia: Warm agglutinins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/56/33672\">",
"           Clinical features and treatment of autoimmune hemolytic anemia: Cold agglutinins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/13/30938\">",
"           Clinical manifestations and diagnosis of immune thrombocytopenia (ITP) in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/36/4682\">",
"           Clinical use of coagulation tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/0/5130\">",
"           Diagnosis and treatment of vitamin B12 and folate deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/59/15290\">",
"           Diagnosis of monoclonal gammopathy of undetermined significance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/54/42856\">",
"           Diagnosis of sickle cell syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/12/24777\">",
"           Diagnostic approach to the patient with polycythemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/32/9738\">",
"           Diagnostic approach to the patient with suspected polycythemia vera",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/23/13689\">",
"           Evaluation of bone marrow aspirate smears",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/26/38313\">",
"           Evaluation of the peripheral blood smear",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/45/35543\">",
"           Mean corpuscular volume",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/47/18170\">",
"           Overview of neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/19/35129\">",
"           Pathophysiology and diagnosis of iron overload syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/59/23482\">",
"           Platelet function testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/26/24999\">",
"           Prenatal testing for the hemoglobinopathies and thalassemias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/58/10154\">",
"           Recognition of monoclonal proteins",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Liver function tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/18/34090\">",
"           Approach to the patient with abnormal liver biochemical and function tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/28/36294\">",
"           Clinical aspects of serum bilirubin determination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/50/42790\">",
"           Diagnostic approach to the patient with jaundice or asymptomatic hyperbilirubinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/57/19353\">",
"           Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5���������-nucleotidase, gamma-glutamyl transpeptidase)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/63/21494\">",
"           Liver biochemical tests that detect injury to hepatocytes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/20/5446\">",
"           Patterns of plasma aspartate and alanine aminotransferase levels with and without liver disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/29/24022\">",
"           Tests of the liver's biosynthetic capacity (eg, albumin, coagulation factors, prothrombin time)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/22/22889\">",
"           Tests of the liver's capacity to transport organic anions and metabolize drugs",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/42/38569\">",
"           Acute phase reactants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/15/40185\">",
"           Cervical cytology: Interpretation of results",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/11/28857\">",
"           General principles in the use of immune globulin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/49/17175\">",
"           Intravenous immune globulin in hematologic disorders",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pancreas function tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/27/10679\">",
"           Approach to the patient with elevated serum amylase or lipase",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/21/38232\">",
"           Clinical features and diagnosis of malabsorption",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary function tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/33/15894\">",
"           Arterial blood gases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/14/7400\">",
"           Diffusing capacity for carbon monoxide",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/53/4952\">",
"           Overview of pulmonary function testing in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/8/33925\">",
"           Oxygenation and mechanisms of hypoxemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/32/9736\">",
"           Pulse oximetry",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/59/9141\">",
"           Reference values for pulmonary function testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/41/27288\">",
"           Simple and mixed acid-base disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/35/13877\">",
"           Venous blood gases and other alternatives to arterial blood gases",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Renal function tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/45/36570\">",
"           Assessment of kidney function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/37/13914\">",
"           Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/23/35190\">",
"           Calculation of the creatinine clearance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/57/41875\">",
"           Drugs that elevate the serum creatinine concentration",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/54/12138\">",
"           Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury (acute renal failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/17/8472\">",
"           Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/1/34839\">",
"           Investigational biomarkers and the evaluation of acute tubular necrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/15/17655\">",
"           Orthostatic (postural) proteinuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/39/34418\">",
"           The significance of urinary eosinophils",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/34/22058\">",
"           Urinalysis in the diagnosis of kidney disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tests for infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/14/11494\">",
"           Blood cultures for the detection of bacteremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/15/35059\">",
"           Microbiology specimen collection and transport",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/11/17591\">",
"           Sputum cultures for the evaluation of bacterial pneumonia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/41/24214\">",
"           Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tests of immune system",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/38/24167\">",
"           Human leukocyte antigens (HLA): A roadmap",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/58/43945\">",
"           Laboratory evaluation of the immune system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/25/10647\">",
"           Overview and clinical assessment of the complement system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/51/12090\">",
"           Pathogenesis of spondyloarthritis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Thyroid function tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/7/26744\">",
"           Diagnosis of and screening for hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/57/26520\">",
"           Diagnosis of hyperthyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/40/42632\">",
"           Drug interactions with thyroid hormones",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/53/856\">",
"           Euthyroid hyperthyroxinemia and hypothyroxinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/33/3608\">",
"           Laboratory assessment of thyroid function",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Transfusion medicine",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/22/2407\">",
"           Compatibility testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/18/4393\">",
"           Granulocyte transfusions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/41/40601\">",
"           Laboratory testing of donated blood",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/53/27480\">",
"           The incompatible crossmatch",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/37/21081\">",
"           Use of red blood cells for transfusion",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-F0C427ABF9-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f7_56_8064=[""].join("\n");
var outline_f7_56_8064=null;
var title_f7_56_8065="Contents: Viral infections (except HIV)";
var content_f7_56_8065=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?15/21/15710\">",
"       Infectious Diseases",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Viral infections (except HIV)",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Viral infections (except HIV)",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Adenoviruses",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/52/26441\">",
"           Adenovirus pathogenesis and vector applications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/40/37513\">",
"           Diagnosis and treatment of adenovirus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/21/39257\">",
"           Epidemiology and clinical manifestations of adenovirus infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Antiviral drugs",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/60/10183\">",
"           Acyclovir: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/47/37620\">",
"           Cidofovir: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/10/6308\">",
"           Famciclovir: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/13/44244\">",
"           Foscarnet: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/25/17815\">",
"           Ganciclovir and valganciclovir: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/11/19640\">",
"           Pharmacology of antiviral drugs for influenza",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/13/44249\">",
"           Prevention of seasonal influenza in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/46/22250\">",
"           Treatment of seasonal influenza in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/19/30003\">",
"           Valacyclovir: An overview",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Arboviruses",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/13/15576\">",
"           Chikungunya fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/34/18985\">",
"           Clinical presentation and diagnosis of dengue virus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/55/4984\">",
"           Epidemiology of dengue virus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/5/5208\">",
"           Japanese encephalitis: Epidemiology, diagnosis, treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/5/36953\">",
"           Pathogenesis of dengue virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/50/808\">",
"           Prevention and treatment of dengue virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/8/41095\">",
"           Ross River virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/21/15705\">",
"           Yellow fever",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cytomegalovirus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/62/22504\">",
"           AIDS-related cytomegalovirus gastrointestinal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/28/7623\">",
"           AIDS-related cytomegalovirus neurologic disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/21/12634\">",
"           Cytomegalovirus infection in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/2/29738\">",
"           Cytomegalovirus infection in renal transplant recipients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/25/8597\">",
"           Diagnosis of cytomegalovirus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/25/13722\">",
"           Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent hosts",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/24/28041\">",
"           Overview of TORCH infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/51/37688\">",
"           Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/59/6073\">",
"           Prevention of cytomegalovirus infection in lung transplant recipients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/12/44230\">",
"           Viral load testing for cytomegalovirus in solid organ transplant recipients",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Epstein-Barr",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/13/12505\">",
"           Clinical manifestations and diagnosis of acute renal allograft rejection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/55/14202\">",
"           Clinical manifestations and treatment of Epstein-Barr virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/63/31738\">",
"           Epidemiology, clinical manifestations, and diagnosis of post-transplant lymphoproliferative disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/18/31018\">",
"           Infectious mononucleosis in adults and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/50/23338\">",
"           Treatment and prevention of post-transplant lymphoproliferative disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/2/3114\">",
"           Virology of Epstein-Barr virus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/33/1558\">",
"           Pathogenesis and diagnosis of viral arthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/51/23354\">",
"           Specific viruses that cause arthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/3/38968\">",
"           Viral encephalitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/41/9879\">",
"           Viral myositis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hantavirus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/33/13848\">",
"           Epidemiology and diagnosis of hantavirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/14/38119\">",
"           Hantavirus cardiopulmonary syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/51/4920\">",
"           Pathogenesis of hantavirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/60/25544\">",
"           Renal involvement with hantavirus infection (hemorrhagic fever with renal syndrome)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hemorrhagic viral infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/37/1624\">",
"           Diagnosis and treatment of Ebola and Marburg hemorrhagic fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/16/19721\">",
"           Epidemiology, pathogenesis, and clinical manifestations of Ebola and Marburg hemorrhagic fever",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Herpes simplex",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/20/40265\">",
"           Clinical manifestations and diagnosis of herpes simplex virus type 1 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/21/29016\">",
"           Effect of herpes simplex virus on HIV infection: Implications for HIV prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/8/38021\">",
"           Epidemiology of herpes simplex virus type 1 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/12/28872\">",
"           Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/10/9386\">",
"           Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/14/33001\">",
"           Genital herpes simplex virus infection and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/31/6647\">",
"           Herpes simplex virus infection of the esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/62/1001\">",
"           Herpes simplex virus type 1 encephalitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/24/28041\">",
"           Overview of TORCH infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/62/34789\">",
"           PCR testing for the diagnosis of herpes simplex virus in patients with encephalitis or meningitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/54/29544\">",
"           Pathogenesis of herpes simplex virus type 1 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/15/21751\">",
"           Prevention of genital herpes virus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/47/39669\">",
"           Prevention of herpes simplex virus type 1 infection in immunocompetent patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/14/34024\">",
"           Treatment of drug-resistant genital herpes simplex virus infection in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/32/7690\">",
"           Treatment of genital herpes simplex virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/52/41799\">",
"           Treatment of genital herpes simplex virus type 2 in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/40/36488\">",
"           Treatment of herpes simplex virus type 1 infection in immunocompetent patients",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Human papillomavirus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/33/1562\">",
"           Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/10/13480\">",
"           Clinical trials of human papillomavirus vaccines",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/38/23144\">",
"           Condylomata acuminata (anogenital warts)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/6/21610\">",
"           Epidemiology of human papillomavirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/17/19738\">",
"           Recommendations for the use of human papillomavirus vaccines",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/39/26229\">",
"           The life cycle, natural history, and immunology of human papillomaviruses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/53/26455\">",
"           Virology of human papillomavirus infections and the link to cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Human T-lymphotropic virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/54/40808\">",
"           Human T-lymphotropic virus type I: Disease associations, diagnosis, and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/48/5897\">",
"           Human T-lymphotropic virus type I: Virology, pathogenesis, and epidemiology",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Influenza",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/31/35320\">",
"           Avian influenza vaccines",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/4/22599\">",
"           Clinical manifestations and diagnosis of avian influenza",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/1/18456\">",
"           Clinical manifestations of seasonal influenza in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/58/15272\">",
"           Epidemiology of influenza",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/2/31786\">",
"           Epidemiology of pandemic H1N1 influenza ('swine influenza')",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/48/14090\">",
"           Epidemiology, transmission, and pathogenesis of avian influenza",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/11/19640\">",
"           Pharmacology of antiviral drugs for influenza",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/13/44249\">",
"           Prevention of seasonal influenza in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/8/37002\">",
"           Seasonal influenza vaccination in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/7/39032\">",
"           Treatment and prevention of avian influenza",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/21/38234\">",
"           Treatment and prevention of pandemic H1N1 influenza ('swine influenza')",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/46/22250\">",
"           Treatment of seasonal influenza in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         JC/BK and other polyoma viruses",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/7/6266\">",
"           Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/7/44151\">",
"           Clinical manifestations and diagnosis of JC, BK, and other polyomavirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/44/1734\">",
"           Epidemiology of JC and BK virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/45/42712\">",
"           Management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/18/23843\">",
"           Ureteral stenosis due to BK virus infection among kidney transplant recipients",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Measles",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/11/43192\">",
"           Clinical presentation and diagnosis of measles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/16/42246\">",
"           Epidemiology and transmission of measles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/16/22793\">",
"           Prevention and treatment of measles",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/52/32583\">",
"           B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/13/41176\">",
"           Coronaviruses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/14/43241\">",
"           Epidemiology, clinical manifestations and diagnosis of norovirus and related viruses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/26/7591\">",
"           Overview of hepatitis A virus infection in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/8/41095\">",
"           Ross River virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/55/24440\">",
"           The common cold in adults: Diagnosis and clinical features",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other human herpesviruses",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/1/10265\">",
"           Clinical manifestations, diagnosis, and treatment of human herpesvirus-6 infection in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/37/6743\">",
"           Diagnosis and antiviral therapy of human herpesvirus 8 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/47/19192\">",
"           Disease associations of human herpesvirus 8 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/55/14201\">",
"           Human herpesvirus 7 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/27/30138\">",
"           Virology, epidemiology, and transmission of human herpesvirus 8 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/14/40167\">",
"           Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Paramyxoviridae",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/11/43192\">",
"           Clinical presentation and diagnosis of measles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/16/42246\">",
"           Epidemiology and transmission of measles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/61/8154\">",
"           Epidemiology, clinical manifestations, diagnosis and management of mumps",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/33/33304\">",
"           Human metapneumovirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/36/42567\">",
"           Mumps virus vaccine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/38/617\">",
"           Parainfluenza viruses in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/16/22793\">",
"           Prevention and treatment of measles",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Parvovirus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/54/22377\">",
"           Clinical manifestations and pathogenesis of human parvovirus B19 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/35/32312\">",
"           Epidemiology and laboratory diagnosis of parvovirus B19 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/29/40408\">",
"           Parvovirus B19 infection during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/1/31767\">",
"           Treatment and prevention of parvovirus B19 infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Picornaviridae",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/49/34585\">",
"           Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/59/19383\">",
"           Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/26/41383\">",
"           Epidemiology, pathogenesis, treatment, and prevention of enterovirus and parechovirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/52/17223\">",
"           Poliovirus vaccination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/45/5849\">",
"           Post-polio syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Poxviridae",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/43/6842\">",
"           Molluscum contagiosum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/3/16439\">",
"           Monkeypox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/61/35797\">",
"           The epidemiology, pathogenesis, and clinical manifestations of smallpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/7/40057\">",
"           Vaccinia virus as the smallpox vaccine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/47/18165\">",
"           Vaccinia virus in the research setting",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Rabies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/59/29624\">",
"           Clinical manifestations and diagnosis of rabies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/21/2393\">",
"           Rabies immune globulin and vaccine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/58/33703\">",
"           Treatment of rabies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/39/20088\">",
"           When to use rabies prophylaxis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Rubella",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/24/28041\">",
"           Overview of TORCH infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/14/26855\">",
"           Rubella",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/60/6087\">",
"           Rubella in pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Severe acute respiratory syndrome (SARS)",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/21/17753\">",
"           Severe acute respiratory syndrome (SARS)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Varicella-zoster",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/44/33480\">",
"           Clinical features of varicella-zoster virus infection: Chickenpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/20/2378\">",
"           Clinical manifestations of varicella-zoster virus infection: Herpes zoster",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/4/77\">",
"           Diagnosis of varicella-zoster virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/8/23688\">",
"           Epidemiology and pathogenesis of varicella-zoster virus infection: Herpes zoster",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/48/22278\">",
"           Epidemiology of varicella-zoster virus infection: Chickenpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/3/41016\">",
"           Post-exposure prophylaxis against varicella-zoster virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/6/21608\">",
"           Postherpetic neuralgia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/28/32200\">",
"           Prevention and control of varicella in hospitals",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/26/37289\">",
"           Prevention of varicella-zoster virus infection: Chickenpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/22/36200\">",
"           Prevention of varicella-zoster virus infection: Herpes zoster",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/50/21288\">",
"           Stroke caused by varicella zoster virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/20/33096\">",
"           Treatment of herpes zoster in the immunocompetent host",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/36/23110\">",
"           Treatment of varicella-zoster virus infection: Chickenpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/28/33225\">",
"           Varicella-zoster virus infection in pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-C8ABE57B19-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f7_56_8065=[""].join("\n");
var outline_f7_56_8065=null;
var title_f7_56_8066="Noma lesion";
var content_f7_56_8066=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F70829&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F70829&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Noma lesion in a 3.5-year-old child",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immediately prior to complete perforation of the swollen cheek from inside the oral cavity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Cyril O Enwonwu, ScD, PhD, MDS, BDS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8066=[""].join("\n");
var outline_f7_56_8066=null;
var title_f7_56_8067="Mechs of IGF-1 receptor";
var content_f7_56_8067=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F74671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F74671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 557px\">",
"   <div class=\"ttl\">",
"    Intracellular signalling mechanisms that are activated by the IGF-I receptor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 537px; height: 338px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David R Clemmons, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8067=[""].join("\n");
var outline_f7_56_8067=null;
var title_f7_56_8068="Ethambutol: Patient drug information";
var content_f7_56_8068=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ethambutol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/7/12406?source=see_link\">",
"     see \"Ethambutol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/13/6357?source=see_link\">",
"     see \"Ethambutol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F168048\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Myambutol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F168049\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Etibi&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692117",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat TB (tuberculosis).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ethambutol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703774",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have swelling in the eye.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any eye problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698493",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have a monthly eye exam.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021088\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697966",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in eyesight may rarely happen. Eyesight most often gets back to normal when this drug is stopped.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698711",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have red-green color blindness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11207 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-190.92.87.104-A2ED1F3088-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8068=[""].join("\n");
var outline_f7_56_8068=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F168048\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F168049\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021083\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021082\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021087\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021088\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021090\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021085\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021086\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021091\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021092\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?12/7/12406?source=related_link\">",
"      Ethambutol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/13/6357?source=related_link\">",
"      Ethambutol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_56_8069="Pityrosporum folliculitis 1";
var content_f7_56_8069=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pityrosporum folliculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Follicular papules and pustules on the upper back of a patient with Pityrosporum folliculitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8069=[""].join("\n");
var outline_f7_56_8069=null;
var title_f7_56_8070="Erythema marginatum close up";
var content_f7_56_8070=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F71804&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F71804&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema marginatum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 333px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFNAasDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwAtlhbyGVYZpmZtqruZWX/d/u1da1uFt5G+wrCsjfMytt3fw/d/hVvl/wDiqzIpLe6/d+YszN95l2qv3qvtNNZt8qtCu1V+ZlkX7275f7v/AAGvDj7p9pKMpfCOZrqOPdOrLD8v3lXb/d/hbczVFPN5jKrSWkK7VVV8ll3f3aja1kuo2bdC27c21m3Nu/3at+XJa2sMass0DNuby41Zvl2/K277vzbaIhIjljmaHbA1vtb5dsnysv8A31UitJcXSrbLaMy/NtXcu1v7vzfeonj8ltrTNcL95oZF+ZW/2V/2vlqSBdyqsk3lsq7Wt/J+bbu3bv8Ax5arlJ5iNrhW2re+St2q7lhZW3Mu77ytu2/epsFnDdQ7Y5lhVW+ZVkZWZtv8O7/2WrEDSRs0bTeWq/LGvkqys25tytu+793/AMequtq0l4y/ao1v41Zt3lr8q/7Lf7X92iISK0dva7WaP7TGyqu5ZplZt3+yrf7VW1uJFt1jWaC4jbcy267trf8AfK7d33qknt5Gm3T/AGS4kZVZm27dv+9/tVCsyx/N9s8tZPlkZZF3K3+yv/fNHvAUlW8uoVhgt1jWZm2rC21m/i/ib/4mpntZFkVWs42VWbc3nbfm20PNNHbrJBdXPmMqsrbVXa38W7+KmtJIyrDPdLMzL8qt93av8StU+6VHmJVVvs7QwQqv91d3yqv95m3f3f7rVFLJDMzKvmTT7t27dujX+9uaiOH7PcK0EPnQN8u3avysqtuZf4v4v4qvrcWMMm6HT5Jty7WVo1Zd3+yyt/st8tHLzBzcvwlBVjby5Fba275lZlkVv+A/eWo7uaFbiP8A0iOGSRmWGNv7qr8zbf8Adq3BJYqq/bVWGP5m8tV+b/d3f/s0xvstuq+Q0KrI27zF3blX+JWVv4dtHulc0iNpmVo1trW2m2ttaZlbav8ACzbahnaS38yaS6WFY/mby2b7v3m+b+7/APFVdZWj3NBJaNDt2q0KqrMq/N8u7/gVVI1uGbdDHdqqtuZpP7u3+6tMqJdW3aNf9JWFZ2+VfJXdtXd/FubbQtvNt8vbHMys23d8qx/7Xy/K3+7VKCOx2sqws038W5ty/e+Vv95asx2fmQ/LHMq/e2t8u3/a+9/wH7tKJMv7wjW6tG26xg8jdtZo5tvzbv8AvpWqOC3ba03y26szbf3zMy/+yrUkSySW7K1jI0yttX99827+827/AHqdPCscK/a7fy2+6qsvysv+1/tUxFWfy9u2dpmnVvmWaRWVfm+6u1v7tSTqyx27brRmZd0car83y/7rfe/3v7tECrIzSR+TJ8qrGzQ7VX+995vu/NUltHdL5jLDGrR/Myx7m27vl3N833d3+1/FSiOUiuskjTK265mVmXaytu+Vv4t38VSND821vtMasq/LcSKqsv8AD8v8X8VQyxzW94v9rSSfN8rKs21lX+Fv4qdYx2LKzW0N3DIys3ls25mVfl+98393+7TAkXdGqySN5MKs21VhVmb/AGlXdu/4FUlzJCzNI15Iu75V3Kqszf7u35f++qnnj8uHdaXVyyrt/fNMqszfxKqttb/x2qzTQxxzSNNcrN975rhW3bW+9S+EmPve8OjjVbdVa+nhVW3eXuWSTcvy7t33f4futUbW6xzKq3Tbm/57W7MzfL8rNt+WrCrJeQ+cq27Rxszbpm+ZW2/e+X5Wpy27MvmNfSW6su1WWFtrN/vM3y/w0xkdtIysy3LTXDL97au1du75tyqqs33v/HaerWrMq2TSbmVWVfJ3N/e+b5f/AGaq3yzMqrdW0iqyrIzTMqr/AOPfMv8AwGr6xzNHGtpcbmXcqta267dv+027d/s0ClykLRws3ltcTtN8rbVZdy/N/Cu35aazSLJ/pEc0bMytuuFVmbdt/h/4F96neTC23yrjzmVW2qsKxr833l3N81QTWrW8jLGyt/sw7mX/AL6Zt3/jtQV7pZVr6S3X7N9tkZm3Kyxqu1V/usy0bprdd0H9o7vlVV85ZGb5W+Vvl+X+KoYFt49yz3TbWVd0bXDL/wACVfm3fNQ0dm0nmLeQsqttXbbtu/i+6u6rMx8X268mWRobtt3zbY4Vbcu3+Lb93/d209ZJreby7aaGzkkbb81wysv+8rLtoWNZIZo7aaZtys22aRY1ZdvyttqP7LfLC21ZprZflZYfLVdu75mX/wCKp/4Q/wARMt1cSRtuuIWZWWBWZVaFV/3mZW/vf71RyyTWsjQ215aTKu3dMu1WZv73zM1QLdLG0bNYyM1v935VkVm/2m/3d33adFdQzTSSNu3NuVlZlWNd33f7zVXMTy+8Kt1DIrTNuut27/WKrfN/ssvzLTGt7qSNlaOOOHaqttmVVb/vn5qs/bpJo1W51K0Vd23y1VlX/eZvlqhPHHMrTf6I0m5mZpIZG+Xd/tf8BqCgmWzW3VltbSPav8N037xv73zf5+Wifaqqqw+Wu1Wby7zd/wAC2/L/APFUyeS1Vrba1lcbZFZtysu75l+VafLrEcki2vywqzbl/hVW/vNtZt22n7pMeYbYqrMzRx38zfd2wzfL/vf8C+Wpmtbq3knVla1WP721lbb8v8O75f4mqhcrbyL/AMhZrpm/5aKrbfl/h2/eX7tCrCtwqrb3azqzfMrbd3y/7XzL93/x2gr+8DNDMrLbXDTeWvzK0O35v9pl3U1bG6VvMtrfzFj27plb5Vb/AIF97/vmneY1xHJGyzSbWZW85lVVXarfe/i+8tTtZxyRx+fYtaybV3Nu3bl+78qttqglLlKTWLKu6dY9qszMqsrN/sr935aHt1WNo185vm3Ku1VVf733fvVM0dusbf6PIrbvlaRW2rt/uruoZVZV/wBHmZvlbb8y/wC992gCtPbtu3LbzMzKzL821WXd975qqy2sjW/ywyM0i/KvmL83+9VpY1Zv3bSKyqzfLu/hZt1RyrHcQssbXLfMu5lX5V/4FREmRE1jJJZwQz+T8yqu1pNzK393dVtbFVGJJLDf3+9UMqyND50e5lVtrN/Fu21B9om/5Z3jbO37taonlOqZW+ZpGjjbbtVt25VX/Z2/3tv8VMazkjjVpGtJJGbduX5Wb5VXdt/9mqONo2mXy2+98yxqzKrf7K7lpzKyx7rS3VlZdzKytuX/AIF/6FWRtEsrYzNIsk9ruXczKqttZf4t23727b/7NRJGuI9sbWfyszMqtukb73zfNtX5W/8AQqi+zzNJtkhktZNv7tWuPl/3m/vfxVO3yzNJIt3cMvyxt5jMqt93b96gPtFSBWkh2tdXsa7vm8tfm+98rf3qtrZwwxtM14zfLuXc25mb+63y7qLRVVmmktZluY227o23L/wJvvVG0lru8yPddN53y+Yu5l/i/u/d/wCBUEy5uYinWG3b9/bs0m75lWZlbd97c396p2j8tWjkhaFW+8yqvmfd/vU1pGVm/czK235tzMqt91vlX738NNi8tvPjkmkkZtrLH8y7W/ib/P8AepRKkQRqsa+TbW8iq21drR7mZtv97bUlos1vcMyttVl2+Svytu+bbu3f3ttW9ytHH9muoY41b5o1b5l2/wAS/wDfX8VRztDIqzN9mkj3fxMu7d/ut/u1UY8pPNzDGt/308k8K27KrSLtbdub+H5vu1HE3mTLGszTKy7VVlX5m/3mqCOO1WRlst0O7azSTSbdv/AaltLWFpvO85mZtyrM0i7fvf3aRYNJcMyqsjfL8u1VX7v8Pzf3ab9qmjjZoLqFVZvmWNdrL/DuVf4f4f8Avqhobe1/c3P2m6Zlbayt8qt/d/2al87y41ayhnVpt25V2ttVf7v8X8NAys141vZtDaQ7WVd00yrtb/eb/a+b71TfaNSjhWPcq+Yu5WX5mb5fl/8A2abdwzRzfLCysy7mZm/h/wBqo5riaS6ZoLi0VlbcyruX/vn/AOxoK5eYbLIrSMs63LXa7d0nlr/lasPJuVlkulkZm2qrMvy/7TN91aPtzTSMrQqqsu5lWRWVv9lv++ahto23bmjtrdpvuqy/w/7X8O35aA5g/efZ9vnWkzK3zNCqtt/3mqaRvssfnT3EkKtH8vlr827/AMe+Wq88fy7Z4YWVmZl8tdrM3+zu+apN1nb2sf22ORWVtyqrbl2/3flpRiSVItW8uFo4ppmjk+Zvlbczf3v96rbXTW8jNbWrNtVWZppl3btv97/gLVHPdNI262maGOT5vLbbt2/7TNTVumVWWC+aSLd83kqu5f8AaXd/DTATULyS4aBrmS2j3M27zIdyqu75vut/eonhWFZGgmhVZl+ZYVZWb73yr826mr9hWFobmS5ZmXaqxsqru3fxfL92q87Qx+RG0yzfN96OTcv/AI996gImmzeTIt000K/Lu2svmbtzf725moXbMu2e4aPaqtuuI9qqrf7K/wC793/drOlbTdvlqsnnKyszMzK275vl2r8q02zWHzN00e5mZdqsys23au75m+b7ytTAvNfQrCyxtYbtrfM0O37v93duZW/z/DV1LqO4hWPyba6jjVdqrCse1WX7u3d83zfxbqzPtDR27N5dozMrLHtZmZV+6zbV+63/AMVUrM0jbblY7WNl2s0kLbv9ldrfxVPvByxGTqsMbLCreeqsrK0KyK3y7tq/7W3/AIDVtvLZmVbdlZmVVa4h+ZW2/N8u3a1RwfKqq199j3KzMyx7V/3V2s1DTL9oWZppJG3L++ZmVl3f7Py/+PVIE/26ZWZWaFtu2Pb9laNV2/N93/gK/wD2NOgt/tTTTfZVm+XczLJ83/Al+WooGWRvLu21GOSRl+aT5m3f7Kq33fmomjVbiRfLmZVb/WXSyK3y/wCz92q94PdJ9qxq3nwx26r91WhZl2/7u75ag+0RxzMyxweevyszMyqvzfdVau2UimRZI1sFk2/KszMzNu3fw7drLt+Vasq10z+ZJa2jec25VmZmVmb+827atEYkykVLRVkZtt4s3mM25Y4Y1Vfl/vNTrtreO3aS5mtJJFb5vM3K27+6u1vm/ipt9DMtuq3sNpGy/ejWbaqt/D95dzbapQSLHI00FxbQqvzL8q7Wb+FVVqrm5SeXmCKS1jRmaG0mWNt27zG2t/dVV2qzVZaOxuIW8+4aFtvyrHartXbu+X/9qnLcXU26S2mtvMX7zNHGrN/D8q7v+A1A11NJcRzXs0bMq+WzSTfMv+1t2sq/LQTy8xbj8tmh8trtl2su5mkZW3fdVVVVVaqSM0MyyRxwWrM38VrIzbt395vmqWDzpIVa2W7VY2+aSHaq7tv3dzKv/oNMa4aGT9/NM0/3dzLC0n+838VVzBykrXSq0itqE1uzfekuIW+b733V/h+7ULXCtIsn2y0m+b5mmVV3fwqqr97b97+GrCzXEjfNJIzbf+Xxl/3vl3LUd7dNeN9oubiGZl2qq28Lbvl+7uZf96pAmkkkjs42W8sri5hXau2FvlX+9urMuZJJF3NdW6yN8zeTZ7Wb/gW3d/tVN9oXcyxxtHI21VVVkVtv97duWmtJC0ytJcant+bcsO5V+Vdu1fvf99f7NVzBGIQKzWbSWituVd0knyqzMzfNtXb83/fVQrGskjSTqqqv3ZJLhVb/AMd/75oj8vcq7btWZvmWaRtrL/tLTJ2jWRV8xvlX5maH5V/u/Nto5iiG0uG+1XqrcNcMv3ts3ytuVfu/L/dqe2j+1LIqw3u6RvlaSZVVl/2v4ttVGaRri5VbpflZdyttX5tv97/d201pLhpGVmhmZm+6zbvu/wB3b/6FQBNOu1ljZVVtzbtzMzf/ALNSXbXCttXyZFX5Y28xm3N/e2/3dtPu9rNAv9m+SzLt2wtuZvm+981Vm+VZI/JkVlZWbzG2/wCfu0ANaOZYVmnmVmZf4W+7/e3VF9qZY2hW6VVb5mVVZVb/AIFUbW825dyxqyr8zbty/NREq2szNIysrfeVY93/AAKqJkDXDeWqxyKyrt2su5f4ab/aV5/z0g/75WqTbVulW2kk2/N8u35mZvl/9B3f99VOZLqM7PLbj/pmv/xNBJ17SQtIsk80y7V+ZtzK23d/Ev8Ad/3f++aIVVmWSZpmZvlZmVt23+8v8LUKyqyzQKsnlr832hlXdt+8qsrfxVBqV8rNHJezLNM21Y4VXcqrt/vK3+z/ABVkafaHy2fzfv7dmVZP3aySMrNt+X+L/PzUxoVkbd5Ks0bbfvMzL8v3f92p1X7Qys0M1xBt3Ltbcsf8Py/xfd3U5bea3jb5YVtmXcrRru2szfxfxUuUrmI9siqrfZdrRtt3bVXb/vN/wKoJJF/d2qw+SrKrKsbKu7a3zNub+9V1WksVZWjVV2q0bMrbV/i3N81SwNfMrNOqtGvzKy7dqq3+z/8AFVUSZFaNZrVdsSyRtN8yzTMrbv4v4qgvGmW4VmjZmkXc0m5Vb5v7v/2NWdszTSQtDNJH95v325dtUp47VbfbHHGzfNtWaZY9rfwtuVv7tESydZFmZftNvtVdyttX/XN/vf8AAaY0lvG3nLDMvy7fmVW2/wAVV9IaRbNWgmZpFVd0yzL8rf7X96rc9q0duqrNJcLIu1m8vdtXb93/AGlqpcwojLSO6vm2rNtZm3K021m+b+Fdv3qjWSGNvLuVgaFVba3y/vP4f73/AI7Ui2qrDAq+S3zfKsMnzN/st/31TWtYVVpGhtmVV2r5O1lXb/eWpGRr9jXa0EPnMrbo1jZtqq38LVMsMcMjXEiyNu3fNNtVm/3fm+X+KpomvpLGORWhkjjb7y/Ky7v4vlqNfOWZmjhj+2r95t27d/e+98tICNWby4JNs0m7+8yszf7u7/gNE/2hl2xwttZm+7GvmN/vN/3zTp7W6mVZrm4WRlXdtjjZmVl+9/u1DP8AaLeRVttSX5trTMzbWbd/C3/Ad1LlHzRDdH5iraWcfmMu3b53zN/ssv8A49UlzHNHcLCzWSsy7dzLuWNf+Bfdpts1ruk3NHb7fusqq3+z/vf3qoNDY+SrWzNM0m5ZPl2qv/fX3qPd5Q97mJWurVVkjuZJGZflWRfl3f3vlX+H7tRW10rW80do07Ltb7u1WZv4lpsSqszLAsDMrbVkVV2x/wAW7/8AZ/u05pP3atIv2pvu/Mvlqv3vl/2v4aYEUtw0cKrPcNarMu1tq7mZfu/M22ns2n2a7b1ZpmkXcrbm2/Nt/h/2f9qmqqsrTRqsMjNuba21m/2l/urUUciqzLJCrN/CzN8zf7X95v8Adp8xXKPtpLVlZoGWFWZVVZIWZmXd/e/9lWpFuG8ny7byLdd3zTK21m3f3v4qkWO4bcrK3mMy7VWRV3L/AHf4dq/8CqWe1aORlZZFhj/hkVvl3f7u7d81HLIogtpJlWRY2mZl3N8rbV/3vm202S1uNrNOsMzMu7as25m/2Wbb8tWrmbT44WWGSaafdtj8lWVf95l+Vv73y1LHJGse5obi6VV2szbY/vL/ABfxUcpPMUvJmhbbumWONV3Ku1VVm/2mq2sdxCvmM32hflVdsLSRtu/vN93bUTTW8KrM14y3cjbo1Xd8u35dv8X/AH01VbRYZGVYGZoJG+aNvl/8ebb/AHv4aRRalsbhWbdNbQ+Z95tqqqs38X/Af7q/3akW8uGjkhtNSby2+6ywq25l/uqv/s396mRw/ZW2/wChKrNuZlZmVWb+Ftv8P/jvzVUZmkkZbZbRV3bmZYdq/N8v+1QTyl/c0e77SzLMrbWXarNu3fxNu+X733qdBcTTMzSX1hCu7du87c3y/wDAvlqtBbxyKq/uZtrbVby1VWbb/e+992rZktY08me8VrVV+WOSFV+b/gO75ty/3qAlELO6+1XDK1rp2obfmaS6m2s27/ab733f7tWPJjmuJFubeOOFl3LHZsqt/s7dzbm/iqnPJYwwrbxtaKq/Ky7m2s38LNuX5aFWNpGWNVZpPvKs3zL/AL33dq/w0uYnlJls/OuN2nWs1xPG3mMs0i7dvy/e3bqt3tjfeX++htIWVd25v3m35fuqv3V/4D/s1VuVuJPLbybtV+9taNZFZV/uq3zN96oFjVZGZlb5W3MzWa7d3/Am21XNEnlkSLY3zRx7WtGjX5VVrVdzN/D/AOhf3qtxW8lmzQrNDb/L/roV+X/a+79771Umax8z5rq0uPmZVVrVoVbd/ebd/dq20aqu2CGFpFZdrQsrfe/vN95aOaJPLImnVmj8ma8v2bc27bDtVv8Aa2tt3f71V2Zts7LdSLu2q2612s33vl3Ku3a22nfaI7dljZtRjk/vK275v4tzLu+WiC+0X94t6tzJIqtt+838Xyt/s0fFIn3oxKyWbLC32aGOTd/E3mfN/eVd3yt8392neddNHHD51hcKrL5bMu1tyr/D/wDFbaaGWHarNdyMrfdaby1+ZtrfxbqktGmVmk8zyY2VW2rdKzKv+8y0ipEt20kccczTKrSN96FVZv8Ad2t81VGbyVkWSS7Vm27laNV/75/8eq2slvHdKrapNbqq/M3kq275vl+Zd392mNJDdK0kupMu1d0jTNt3N/srtXbTJiV7ZWVWVprtlbdtba3yr/wH5qgVf9Ytz9vk2rt3btqrub7v+7U8DR3zLtmmupFb5VWZWZmb/ZZaLtWjby7nTW2q26RWZVZv+BK38Py/980FFKe1aO+kbyZIV2rtZm3bm+Zd38X8O2h2k8llWSRmX7yrGqqq/wAW5vvfe21JOsP+iLGqxqzMrfN5n8O75lX/AHf/AEKnTwqrKsEcM3yq3mbdu3/Zb5qqQR/vDYNPmkt1baqxr8rNuZvm/wCA/wAVTtZzTW7NBtbarM3777y/3v71UmZVkVlWFv4mVmZVWnN9jaZWkVW27fl+Zlb5v9mpCXMQ7tsbK21ZGZdzKzKy1BKyszKszMu7cqqzblWrt2sKyLJHD8zfdVl3L/8AZVWubpm2xqq7lXczbdqqtVGJPMNn85VWbbMyqv3l/hWoCZic+c1Iq/Ntn85m/wB75ai8yb/nmv8A3ytUB2yq0itJPb2jRqvyt/E3ysq/w/8AjtNWRZo18+1Xcu5W2srbVVf7v3t1VrSSG4kmaaG7t9v3ZGXzN23+827b83+zU88kKx+d50nns23buX5v9pqzKHLJCqr5bfKrbtyx7Wb+7ub+992o7ZbGNZJLm4kb7u1dzfe/8d/i3f8AfX+zQrfdmZWb7y/K33V+983/AHzVuOb940MFqzLN8zMyrt3f/E/wtREJe6UluIZLhVVbSFdy/NHIzbtzf+g1YuWW3mZra3X94vytI25VVfvMrL/n5qaqwszLc2sKyK23azKsa/7K1NI100a2qqrQsu1t0m5VVv4VaiJRDaR6hJIqrNaMrL/qd3yqvy/eX+H7rfxU27t5pLfbBJaQzKrNMzKqr95W2stNjjhVmhnXbN95lVdvzf7TN/49TZ7OSSRvNkhkX5V27dy/8Cb/AIFRH4QkMnjWRlaaa23fxK33W/u7dtNi8n/l5aSFV27Vh3bdv91f4qc0klrCytDbSN8v7z7u1f8AZZqLtZLe3Zblmbzl2rIzfd/vN92j+8H90N0caqtsq/M21mhj3Kq/wr838X+7QqxxzMyrHJHu2qyrt3bvmZVWoZI5pFWG2+bc33oW+Xd/+zUcFvcLeNGs21lVmZmh+ZdtAcpduZJJI23WKxx+Xu3Ky7mVai3M1juW1kt1b7zSNu3L833flpsm6ONYZ7pZGX7rKrNt+b5l2/epzRyNIt1eqy7fux7dqsv+7RKIRCfzJIVkhVoYdq7mWbczN/u/3arbVWRm8mOZpNv3lbcq/wDoK09mWS33fY1+VW3MzbVX/gK1WaRpLeRYLVZJPm3bW2qu3738NI05SGfdDI3nr5attVVk+X/gNO+0SXEzNctaNDGv/Huq7V/u/wAPzbqLu4VWgaC1XcvzfN825d38VUmuJriZVWFYVXd935v/AEKgotqsMkyq0Pys21mVvmXd/dqRdPWONmaFtzfdbcrNtb7vyrRBcQrD5iwxtJtZW85dy/8AAas21ruVZGb5dreYysqqrf8Asy0uUClJZrHIsjQxr838Xyttp0Fu015H9mjVlVvMWNm+VV/i+9V3y1uGVY5mkVvvecq7Wb/Zb+792i7W6uJla5WGRVbayx7lXbt+6zLVRiTKRFctC10zSWq28fzKqqqyN/31VmSSFreNbaNYflXdcLNuZvl/i+Wo4FVvlgtba6aP9+satuZW+997+L71R/bpNqzSK01yzbdsLK0e7/aX/wCJqg5Rl3JDbsupWV4qtC37z958u35dzfN8zf8A2NC3TXCqzQwTKq/L9l+Vm/ib5vm/vU77Q1xJJ59rubarL5kaqq/8B+9VXT2WOxuYbm4tI1jbz4WVfmZd33V/urRIPhJmjmXayxzRt8rKvys3/fTVoz7pIWVm+0LtVWVdqt8v+yv8VV45LfbJJPfTbV2r5ituZm/2fl/3t1CzabJNtnkaaPa21ptzNt/h3L/8TU8oSkSQRsq7fssitt3bd25WVv7qs33ttQ2ysu1mmWHd8yzTbVVW/wB3buqxutZlWS7vIbeFfmjXy/vbfm+b+7/dqW0vLhZmaCRWWRdu6aH5V+9t2ru/2v8Ax2jl/mJ5v5SSBftG7/SLRVb5fMmVWX5v9nbuVv8AeqBZvLhaOOGe4b+Jo/lVV+9tXcvy1Osc0zRs1ut1PHuWSTb5e35t21Vb/eqRoZLOPbJp8bNu3Mqybl/4Eqr/ALtHKEpRKlyzSRrG00NuqsrKskKq397duqeCOGNfOvZoZm27V3XSrtb/AHV/z8tSXMN0q7mhtY42Xc3ksrSKrNt2/Mvy/d/8eqhJo8l5J50cMyxsy/MzL/7N/tfxUcsuYnm90csdurN9mktJNyq21VZmX+8u5d3zfL81UmjmbUFt1aHzFb5d1qzKvy/7P3fu1qS2K6fN81rNbqsfyqzLub/ab5vlb/dp0/k28bK0Ny0nzNtt7hWVV/2v/wBqjl/mDm/lMdZrpmZVaGRo23blVlZl/wB6rarMtuzNDaSbtu5lj27f+BVNaXS3FmsdtDfyM33VWZflb+7935aFWSa3X5r9drbmZWVljX/K0BzArMsbbftMir8q7Wj2svyqv91qe11JGqw/ao7eNvlkWb5ZF/i+VlVv7rf+O1WgWRm3Ms80caszMrKzKq1YgZVWRla/85m2xq0aqu3bub71EQkH2ia82+RJe7Zmba3kqy/Kv3t23c1Pnt5FXzGuLSRl3LtaNmZvvfw/eqKa4umkt1nZpFjb5fMkVY1Vv91qsxRtHDIzQ6dH833lVmXb/vbt1UTIhjs7xtvkRzMrK3zLIsO3/eXbVZrGa3m3QMqyL8recysu7/gS7asssLbWg+yTKq/NGrSKu7/eqL7VJ9nVvtC7mVlWFd0m1v8AZ+b5anmD3hu26uFWa7+zXDSbVVYWVdq/7yrt2/7zVG1vDGzLHarCvyq3lssjbd3+1UTLu2qzMs6r8y/Zdu7+JvvfNT1kVVaRZpFZflVY1Vlbd/eb/vmkVykE7RyRxrHbs22RW85odvzfd2tt/wB6pmjVY2WNY4/lXa0e5m2/3qoT6g0bQKv2maOaZm2xzMu1lVvm+7t/u1ZaSFW+Zb/cq7tzfKv+zt/vUySVY4Y2Zpbqbb8y/Mq7mX/0Gq13tjt2ZbhWZflXau5f+BMvy7qdIrKqyNJGy7vmVmXav/xNT/ds28hraHb/AMs1ZmZv95f++qIgZcUc3yzeZI21v4V27v8AdqRo23M0qzMv/jv/AAL+9Tlt1jt2ZbqHcvzKzNt3f7tPaOSNdy3CzKy/wtu2t/tVXvEyK0qxq0kjW8jKu1tyt/F8tZ8s5aRmW3kw3zfeXvzWkzeYrK0zNt/urt2//Y1W8kfwrPj/AHqoDdRt221VmXcyru2+Wqr/ABfd+9/FUzW9i26T/XMrblVtyr/u7v8AaqVY5lm2qszSLtb9y25WWj7OtvIytIsO6RV+ZmZdv93b/stUlf4RyxwtGq20kccLN8ytIu7d/srV1Gj+zs1k12ytt3bm2/7Lf73zL/6DVRvmXc0itNG21Y412tt/hbd8qrRcrNNGqs0iwN8vzNuZm/h+78u6j4QlHmJlsVt5mZppJv7y7tsiqv3W21HArSed5cbKzfM22Ta1Nto5FkkWC6m2rH/E21v4vl/8db71RSXEe2BlWRlX+GZtu7/gS1nKJUZD900Ma7WZVVlbdJ/D8v8Ae2/N/wDZVIrQ3VwszKqs38S/uVqpHIsbLdLcK0m75VZd27+Lbt/h/u7qvrcbmVtShVoGbcyqzNt3fxVUfhCUSoscdwzXE8jSLG21dzKrbv8Adb+GpbmNZIZJI7hvmZlWFWZvlX+7TZGtY5I44GaH+83l7mb/AIDRPIsKs08ckkitukXdtX+6vzVXuh7xFtuI7dlbzoWX5ty/Kzf/ABVQzzQtbyeRdTW7K26NpI9zN8v3d3+9toWRZJNs7SQs0fzbVZmX73y/N/7L/eqTbJIqrbTSLDu2qzLUFRI2ZWVfPVlZtzedI3zbW/8Asqinjjuo4WaSSaD+GFZty7f9qlZZpGaOC4WaGNtrNt2/7X3v8/dqKC3kb/WNujXdt27dqrQVykqrJcMzfdtlb7qyKq7f9r+9VZmtWjVY2maBW3LG21t3+038NSNCsi+XAzKv8Xyqv/oP93dTYGjVV3fLHHuVdv8AF/vVHMURtH50y7mjX/d3btv+7TmsZvtEjQMs0cO1V2rtZv8AgP8AF/7LV2BV8uRVVfI2qrLN95m/vbmqBpGjkWG2mVdzMv8AtfL/APtNVRAIo9txtXcrbtrbmVVVf7v+9Vuez8632r5Ks3zbW27tv93/AHaj3NNGsK3VtHCrbmaZdq/d/hXdVZ7iNlaZYVZflWNbeNW3Nt+9ub5a0iTIatmsLeZBNbN93dDJ825vl3L8tOa4sY7NZp/mZW+aOORmVW/h3LVmBlt9yzwqysvn+Wq7WX/gNSLCzSNCsbL5PyrbtHuVlZWb5m/io5STOkuofJ8triZWZtqqq7Vbdt3N8v8As7ac0azWcbNeL8qsrecysyqv8Kqv/AqdLNdRzQLJGvlK37uRW3Mqqv3dv/xVSrNDcRss6s1yv3mmVVj/ALq7aCuUiW3ZoY9q2zNt2t8qx7tzfxNu+b5Wp9zH81orLaW6rJtaT+Hb/wAB/wDiqkn09ZIZPLWwby/m3K22NV/u/wDAmapJ2ht7dbdrVrjarMsce3aqsv8AeX/d3UBzFtreSO4ksYPs91u+XczKv+6yt/wL7q7qGum85prmHzJGb5mhkVVVv4ax1mtYYYP7WVY1k+ZreGPayrt+9ub7zbttOa+sbeNWWS0VW3KrMrLu/wDHd1AcoXPnahdLJIskzbVX5WXcq/M3yr/e+arM7WNuyqsM1mqrukaaNWb/AGdu35t1R2ixtMyyLbNukZtse5du3+8qrUkDW8cKx/aoVZlVmkkh+7/d27qkBs9xDGv7i1jZtv8ArGmXcv3dzbf92pIre1kulWJY2VW3M01xtX/gW371NaRfmVbqFW+Xcy27MzfN/wB8/wB75qszyRtuknaZWZlZWax3K3/xO6qJKl9HYxqzTsyszbV8mZW2r/Ft/h/vfeqRZFa12rH506t8v75mb/gS7l+b/vqmtdRrJI39nyXDfe8xflbd/d2/NVuP7LdRyLd/bY5P+eKwsyyfN/e/hoD4SCdlhhZp45mmZfm8xo2+8277zbqj/wBKZma2umVWZm8lfvN/wH5fl2/3q01jtYbdlgtVtdrfK0N0u5v97d/u/wB6qG6GS4Zru4uV3K3mNCrNub/ab/P3aBDmVryNo41Wb7q/vpGWbd/dVVb5qrbZrVl87T2mVWaPc0zMqt/ur96tL7RMyqy3VzCqtt8yTczLtX+7tqtPJGsjKuoSTRru2s26Ntzf3flolyjjzEMnkrJultYYZPlVVVZG/wB3d/n+7To5JlVlaRrWNWXaq3DN838TbWWmz3FnNJ5dtqUysys3lqrN8277zbm21HOzQqrSXTLt+bduVdzf3tv+7UFfEXLFYY2WFdQjjXb8ytDuZtv/AAGlWGPzN0l8yqu1VaaP5f4t235f4ay4GvriRlWZo4f721WZv4tzfL92rKqtuv7++mZWX5t0e3d/E25t1PmM5RLbMyyLtuIZIlZl3NC21v8Avn/gVEk0atG08ltCqrtX7PCyszfwszfeqK2ms47dvMmmaZmZY1WZVX/dbd/u06K4Zmbyrho2Xc21WVvl/hXctIOUdJdTXVwvlzTNIy7VXa0m7/eZvm20QNfLIscLRr8rbWkVVVf87at2jNcRs32q0jaNdzK21ZGbb937393dWOsLNcLutYZNv93dtb/a3U/e+In3fhLy3EkbbpFkt/MX/njuX7396op1X7OzLeNM25tqttZV2/w7f/ZaGby7jbJDaSM3ysys37v+7R5axqqxrZKyr8u1mVmZv/QqonlK0cjeZtXyWVvm3SKvzf7VNkk/cs08is3yrtX7u6p2aZWaaSOFWj/iZtytt/urVaK4kZmknkVVXc3lrGv+VoiUQtG01urNcKu1t237zMv93/x2hlhWFo2mkZtu7bGu3b/tVA0zMv7+1Xy1+ZVVvvVJO27czK0Lf7S/d+X5aPhAh+zqvyxzTMrfxM33lpEt5Ng/dt/38p7K3lqrSfKvzfdphRWOdy1RJvys1uu6eFo5Fbcsc3yt/vLtqW7+zybZFjj+9u3SSMzN/uru+XdTmt5FaRmWRV3NtW4Xdu3fw1BPHtbasccjSLtZfuqv95vl/wA/NUyl9kqPLL3iedoZLdf9BVlZtzSbtzMv97b/AN81GzeWu6COSNl+ZVj+Zlb/AD8tCwq25oLpVaNd3ytt+6v+1U32iGZvJjhtoVbayt5O1tv8XzLRy/zBzfyjYLdWmZmjk87ase5m3bm+992p54V+zqtzC391V8zbt/2v/Haqf6LJGrMy+YrfKrMzN97du3LU3mNuZlsVVY127m+bb/eZaAIJ7e3jX5ZPJZpFZY41+Vv9r/x2hlW3jbdGrM3yqyybvl/i+WpNzK26e6hmbcrLuVVZV/8AivlqOf8AeXCrqTXbN8zMrbVVl/h2/wAVBZHLdR3Em1o1mVVZVVtyrt+996o57qSFVjgj86RdrL5LNtX733l/u/3mqRrdo4Wmtpl27tyxt8zKv/fNEUKzMsyw3MkDLt+Vtu7+9QL/AAlaC6maFpoJI5pLht0jSLtjVlbb8u7+Fdu2pWk3SKrSLcKq/Kq7vvf7tG6NoVaS3mZVZVWNm27Vpq7mZWjZlk3bV2ttVf73zVMpFRjyxI1aRVVp2VVVvmhZdv3f92mT3kMO5Vt1ZVVVVtzbty/+hVPcqscy7mXarLubdukb/gNTLJG1usasyqrMyqy7d3+1SNCgqtMu5pm3SL91l3fN/u1fjVoZI22wssatOu5tv8VRq0M0yyXM0LMrbV2r95t3yr83+1UWoWe5fOikVpGZv3at8sf+633f+Bf7NLl/lJ5i7BJdRrN5EPnMzfNIqqyt/u1G0jRzK0jN56q21tyqq/L/AHlWjzIVs1a0uJpoJo1bau3arL/eb+9VTULy8tYVtZmVmZdzLCu5l3bfvVpyk832idrdlVd15HceYu5m8v5W+b5lqJYWk/49pI1VW+WNl3fxf+O1Xg2tYr9pWSb5dqsqqu7/AHv71SbYbdWkkWZWbd80LMu1dv3W/wCBfxUcpUR32eaS3Zls4Vh+6zLu3fxL93+Krdosy28bKrRqzMu5plX/AMdb/wBCqtA1vttpo5plnX5VVW/+Kp8cirNtjjv927d9o+VtqrR8JXxDJY4WVWkt55mVtrMzKqt/ut/eprNcQ3DKsM0MbLuVptrbl/3V27qjbUI5FWO287cu5WZtrK3+7/n+KrcG1tv2m6Xay7l8ll3btv3VX/vqpGOiX/Qdstnc3DLt2/LtXb/D8tR20LL92xnm+ZWVd3ytub+8rfLTYJGWb9/dXaqzKq/Ntb/gS7f87qsSyQ2NwzLcWlwzKyqszfLu/uqyt97/ANCqviF8I1rdpL75rOZpI9u2FlXarfxbl/u/7VVlkhtfMhkhazW4k3K0y7lm3fMq/d3Lt+X/AL5+WnRyRxqytD507fKvlzbVVv73zfepsa29ncNcfZftDNI3lrMysu1f+BblajmJ5QgumjuPs7XEk0aq3k3DRsu3b95WX/x75v4V/wC+p1uFmVtsM11MqszSbvLXaq/3WX/P/AahuxeXEdu032SNYG8yNVm3MzKrKqt833fm+7/eWrG6S4bbO03kfxNHD8rN/dX71EgjEmm1BWVY7ma0k8z5vJj+Zl/ur/D/AOO0NcXDKzbZvJVf322ZVVv4VVfmZv8AgP8Au1G0lnDIsdgyybfl2sqrubduVm3febd/Ey/LRp9rdTXyySTQrcqvyxtGsn3vl3f3f7392jmJ5fdCK41BofJ+yw2sKr5jN5e5l+b73y/NV+eG4mh3NfQssy7dzfKq/wAW7arbf4f4v71WYlupI2hiuoZJGZVZdqx/Nu+6zL8397+GqDNuVY2sbe6u2barQ3HmMq/3W3L8v+81afZM4/3RqyXTSL+8tFg+VvmhX+9t+Vd33aiia6aTct80P91mjjZdv+ytTtcXEcLQwLIrM25lhhj+Zfl3fN/FUS2qyXDfbbq4uIF+ZlVWb5v7rL8u3/gNSUNikulXc10szN8q/NtVf97+L+7To7do932n7NJtXc0cd0q7l/4Dub+9Ud3b6btb7IzRqzbtskbNIrf7rfLtoiWzbczTWkbR/dWOHarbd33ty/8A2NTyjJbu6WONtumwrHMreWzTMqqq/wALLt/h3bqpLaqrQKqxsyqqx+S25V/u/wCzVxoVm8loJmbcqtIzLGqqu75vvfM1R3MbXDMskzahAu5vMt42hXc38Py/71EoykKPLEqNCv2pmudsiqzNuWNtzf7qrtWmtHcW6yNIs1uu75V3bVZf++q0Vt9sKtF9ohnaRWVVmZm+X/ZVv4qje1W3mZZ7e5WRm+VZPmX/AHvmaplErmI2a4Zd21tyqu7dGrbfl+7uqCCSFmVbZl8z7skaxru/762/dojkkt1ZYoWjaRtrbm2sv+781PaRY7dlWaFZP4t25vvf3m+9SK5SZre3t5vMj85lVtv7uFt3/j1N3LJH80N2zN/d3K23/d+7uqJmW3VmiaGZWbczRzMrK237v/Af9n/apVkVpoFkuvJaFflbczN/tfd/i3U4+8Zy90sMsMcK7YfLjXcu6ab5mbb/ALS/7NUFkVlVlhWNY23LJu+bd/u1NPG21WbyZFX5dzL97/a2t/FT5WX7OqwfdVfm8tdtAyBlhVV2qyt95tzM27/x2msrbtzQqyqu7a0LfN/8VU3ltJHG1zbyMrfdZW+Zv+A1Gy+Xu2/a4d33d3ysv/Af9qggr3ci+YysrNt+bcq7f++qcsLNt+9Ju+Vtrbqm8mS6WZdrK21W2yNtaqrSMrMv7lWj+8rN8zVQDJJGVW8tm/u7VWpo7WXy12xtj/gNV2WSRm8hVVdrbf8AZqWFriOJV+3LwP7y0RJOiZoZP+PnUPu7mVv4t3/oS/71RtIsMjNHJczMzbtrfMqr8vzf7VSNa7o55mWFl27VVvvbf7zbf9mqzRqqrIqtM21dzMu3b/8AFUBHlLfmSRqvlMqtcKzLujVqh8nc0E0kbXG5tzK0nzN8v+z/ALVSMzLG3kTblb+JVVm/3fu0eWzSTNu/eMq7WZtrLt/2VX/ZoAkWG1ZlVpmhb7u5m+ahltYWWFpGZVbd95maT/a/2fvVHOq27Qq0jTbv4mj+Xc3/AKDRctNHMsNzDJIzbW85mVW2/wCy3/AqooaywxtJI3ls23avk/Myt/u1WZZpIVZpmm+7tWRvmVfu/Mv/AOzVlvtSx/Kvlxr8yyfLuZf/AGb5azWktVuFWOaRV+8zNtVm/wCBf7zVPKHMT3K28ax+YzNPt+aNW/h/2f8AvqnXK3UNmq2yqsbfKqt8zK23d8237v8ADVdZGk+7NDtZdzLuVm/2adcrNbx/6SyqzMrbt25tv3ttEioxIFkVm2z26zRqrfMsm75v4fl/9lqWLbcL5Maqq7dq+Yqqyt/FtpjW7NDuWTyWX5mXb91alnhWZVjXzGj3NuZtqq3+VqChttZtbzNtmbbtZd23d81Wmjuo/laSFWj+6rMyszf3t392ofMWNlktm2qv/LNm+6v+1UjXDKqw21rIzfebcu7b/F96nGMSpSkQztcfaN1zDG0asrbvMVdrf52/9805WbcyrCqqy+ZuX5WX+7tX+81VptQha4VWVmmVfmZl3bm/u/7v/wATUis0cn2drVZlmj3fLJtb/ZqvtB9klgaby/s6tJDNMzNtk2tu/i+X5amgZvsc8kENpt+Xc0jbWZv4vlqFLORljkZpoYV+bdG33W2/xM1RbV3Tw20zbVXc3nL8u7+8vy7qIkyjzRLf2Vmh/wBGh3KqrtZW+VV2/wAO6qs80lrDGrLDasq/eVtzMv8AeZfm/wC+loZoY45Fa6hZo12/xL97721aZqDWsmmrNDtjaFtyqvzKy/dZm+X5m+9VFfCStNHdN5cE0M0e3crTKqszf71NjWaS4na5a2uGVVbbDIyqv97au2qjXVu0dt5DRzQMq7V8llbd/d3f3vu/981Ynjkt9y3NqsO75laGTazL/CrbVoKHafJfWNvctOy27SN821V+X/vlqIJN0asv2RmX70jRszL/AOzVDFDIyyefYyQySbWVlZdzbtu3d/E1WbmaZVVdShkWORtrMsfzKv8AD8y/7tT70ifdiNvpmjkb5bu4mkZVZo2+VV/i2q3+7/6DVieZVhk26T5bMy7WmjZt23+7/tf7VRx3UMdu266a1hVW8tlZpFVv91qbBJ9oVVjupLpVZlaaOFt27/Z/8eqiST7RI2myNNNPC0m75VjZV2/3d3ytVKxW1bzJvL+b7ytcLtVdrfwt97722rawtbssbSMzfeVbiFmZf95vl+992rKyXVvDttPsi7drKzNtVfm/2qz+I0+EqK0bNOv2qOFoWVVkhhZt3zfN/sqtEDKrbY4fMZWZVWSTc3zf3V2/LU0Fwsaw+W13cTN+4ZYdqxqzf3W2/wAVOnWFvLbUr65t2VVaO3W3+X+L5fu7m2/3ty1XLEmUpRGxR3kMcjStaLMzbm+X5lX+7u27f9mrb2MclvumayZlVWk3N++Zm/ur/e/2qoM1isO2BZmZmVvLjkZV3f8AAv8AZotrW1jk3TrYMrbW2szM3+zuqvdCXMC6fDeLMttatHbNtb7UrL+7XdtVtzfeqRVsbVZIUvJvOVmWFV2qrMv95v4flolWzkb5ZrD5vlZljZVbb/C1WdLjZoVbdB5CruVo7fcrf7O3d93/AGqmJMpFayumVYmnvpI5Gbb5KszfN/wFl/i21dgsbqRZ1Wzgk2/eZZG85t3zfM3zVO99ZxyKsbWjTt96NbdW3N/d2/e/z/s1n2kclxt3W92yyN8qwwrDuX727/Z+7VE+9L3i7BJqy26w2kNsqzKrfNJuZVb7vzf3v/iqoNa6lNumW1tmVV3MrSMu75v4v4f/AB7+Gra2tvtVY9Nv/syszbmm2r/F975vlqtcR2Md0rNHCqtt2xzMrL/tfdb5V+WiQRHy3ElqzM1jYeZIvyxtIu1W2/eZW/2vm3VEmqTM03/ErtFZmZZF85VVvm/hWnyyWM0bQwWtpM275prfcqq3935vvf7tWrS3mkkkZbVreSZfMVluFZtv95v8/LR/hD/EUmkhaSFfsczMzfMsatuVVb+83zfN/u0272ybVsobuOdm2szMzM393+Jvu1fkt9UaHzls7mZpG3edcXS7V/4DUarqXkxbmaGdmZV+xw/+zbqOUOYqW0OrTKvnwtNGrbWVdq7Vqg8bLeTrHayQrIv97cu7+9u21o7vLuG8+4uGXarMsm5drf3VVfl/4FUN3JbzQq0G1W+6yxybmb73zVMuXlCPNzFBo1VVX9y3zfNuVm/9BqS2htYdqssfys21o2bc1OWSZbdYY7eNvm3Ky/e+WmrMrSeZA1srRru+aTc27+KoNJFmeSFVXbbsrbWWSZVZm3fw/N/DVZpppJGhgmZlb5WXdu3bf7y1NFHdXC7vOtIYW+VVaT5m/vfK38VOWGNY1aNodzfKyxr83y0yCG2W+hZpIL5bdmbb5cf3m/76+7UrRssiszTXDNu3M0itt/u/NTrSNVVt0yq33fuq33agaT93t2sqqzbmVvmb/gP8NUQRzW6tM0knneZu2syt83/Av71NX5pNscKzbvl3Mq/d/wBqpFaFbdt03zMv3Wbay/8AAqpNfQ+W0O5mZv8AgNUBPLDMrNM0K7WXcrbtyr/s1U8uD+JY8/7rVI3mNDtVWaBfvNu+61UJVk8xvlb/AMdoA7aCRtzL/o0dsv3t21mVf/sakkjjWGNpGZlX5oWX5f8AdqpPdRrcSRzqvl/89Nu1tv8A+1UqzeWytHCv3trKq/e/2qCeUkbUGZmZoWh2/NujVdzbv7y1Zikt2maNmaGdVbzGkjbazfLt+b71VIpGkknaRm+9tWFlb7yt/D/49VlY5of31zbtuZdqr5is3y0c0ieWILcMrNN5kd03yqscys33vl+Wql6s1w0kkfnMy/K235tq1MsirIzeTMszKvzL93/Z/i+7TYrq6kkaGCFYWh+ZmVtzN/eVlqeb7JUY/aiUmkhWNWZblVVfusvyt/wGo1aT7G0jbWVflZdu35d38P8A8VV+BlkjaRmaZmZt3y/w/wASr/dqBW3KywTNbqy7W3bW3f7P+zVFFeWS1kmX7Np/2dmj2su7cq/7VVGaNZNsG6SdV2t833v/AB2p5/LjtWZmaPy2VVXduamLNDHarDE0K7l+Vtu7d/vVnKXMaRjyhbK027crMv3du3crNVue3jtYd1yzQqq7WVm/ib/d+9Ve0ZY5lhW1kb5fmWH5V2r/AHf+BVctGsbWZlkVljVfmZo/Mbc33fmojEqUivbSWskbLYSMqxrtVZG+b+9uVW+8vzbaI/OVWZb5WnZVaRo12qrL/dbdUrLYyQsrRqu1dqtIv97+9TJdPtbW1Vo4ZrhWZWZvur97+L/Z+WqKKl3p6rCywTL5zfL53lqqr/8As1QWNrGTyZFhkZW+abd96tSRo2ZmaHbGzfLD91d3+9UEbbpF3KszL8yqvy7aJe8ESO9jhjk3fvpoVb5oVkXd/wDY0QXVjHGzSNdx7V+WNVZW3f7W77y1IsM18t6zKtqyszbV2ru3fNUMH+ixss9uy+c21ZPvMq/7X96qJ+IkiuIWmgk/dwzKvyt935v/AGb7zVYlkWZZGnvvOZW27VX+9/46vy1naas014sM8ys0bbVWSH5VVV+83y/L/dq3Gy+W32lrRvmb5rWNf738TN92gojeaSO4nW5WNYZF8xfJXb8tW4POVWVYZmVV3MzKrbV/4FUC2rSXElxZQyNcrH8rLNu2rUd600jMv2pmjjb5dq7d33fl2/8AxVT/AHieb7JYgt2bUFaCGZZ2+Zmb5WVv9lm/2d3/AH1T1mX7Y3kNJbszMrSTbmVagiZri1ZpFu90fyqqszbm/u/LU0EnktH5bXcbKrKzTf8AoKr/AJ/ho5iiWWS6kVY1aGRWZV87azL9773zfM22mSNdW7La/amWNfmZlVVVt3zL93+L+9TYLdWhkZo5m2/d3Mq/8C2/3qr20MbQsqwySMrNubd/D/D/AOO0cxMY+8XbaGNbdmnmaZpNzNtm2tu/2vmqCWNZo1ja1m3SLuj3MqqvzfeXd96tDdNG0bK00m5V+VYVZV+bb8zUXMdwszQ3N9aLuVtrND8rbdv3anlDm94giuJo7eTzJIIVZdsKszTMzf8AAflX5f8AZotLFdyzXMM11IrLuaaRdv8AFt/2ttNima4umhjvvMj27m2x7VVasrax+T50f2S4ZWVtrK25vu/M3zfLVBIGuNzNC0dtIu75mWRlXb8zbWbbuZqRWW4jZYIbSFdvzN5zN/s/d2/e+WpFuLiP5bny2VdzLDHtb5W/76+b+FWqN9U+wzbVhubdvvbZJtzL/tbfurRzBy/yiwtNHbw/NaWqqy7pF3Kqtu/ut977v92pPtFjcNIzNDdT7mZZvOZWZv721V27aijZbrdfapNeyKrfeaFWXdt/u/d3battqFrIzbrFt1uvyzeSsKq3+1/ur81VEzlzc3wj/tHlwyK1rC0aqq7WmVWZV+bavy1A1m00zMtjI1lIysv2Wb5WVvmb5m2/5aqDahp9xMzNMsLRsyt9nWRtzf3v8rTYrFdQmaSdr+3tvvMrMzfM3+zt2/eo5ub3Q5ftF7ybVVVo7GdY2ba11u+b5v4du7b8v3afqEc1r++ktVt4GVmZmm+9t/i2r/u7qjnh+y28m66nhaNl/dzTMrN8v3lX7u371U1urP7Oq2Vrqcl0rMzMrKysrf8AoNARNRbq4jaSGe+ZfOXc2632/M38W7bu/hqlL/ZsazNP9iuoV+VWhWRfmpzXWpXFu3226hjZV3eXcMv3f7yr8q//ALVPVbpVjZb6wb73lwrD8y/3m/h/u0S94OXlKjNDD8sel3LTxr8zSMy/8B2r97+GnLMrbVkt726kkb5WWZo/mb+Hbuq3PdSSL82qM1xu+aHy13N8v3ty/wDAqrLJDHCyz6xMzN/DGvyr83+7/wDE1PKV8RHdyNDI3mWMyyMu1Y2m3Mu35dqrTmuJmhVp9JWNV2rI25fut95t3/fPy1OqzR3Ui218zMu5t3mKzN83zf3v4qrMs0jM09800bL5m1W/ib+9VAZsE11HM32K1j3R/wATfNU7RrH8zW6wq33trL/6DUrLcNJ5zfaZlZV+Xzl3Kv8AtbaiimaRWWO3VfMbcrfeb/d3VnIrlJp7do1jaK3ZdzbWZmVtzf3qGtd3nMse3a33Wb73y1CrNGyyeTJ5jfKytJV37R5kMiyfaZI23LtaRW3L/DuoM5ETQ+W0cjRxxsv/AD0+7UN3Iqx+ZaNCzMrLIu35f/Hvu0LJD8qzwsy7vmVfm3UNJJJD5aqqwbvvbfm/3aoZUaPzGVo/JVvmWRvur/wGq93+8mb5dv8Asxt/FWjIq27LIqwM277rbf8A0Go1ZWbzG2q0nzMzfdqiCBo2a3XdCrMrbvmaopXuGkY+XHz/ALX/ANjVnyfMX9w0LKrfdVv9lv8A9mq/lzf3V/76oA61VmuLpmaHzFVflXaqrt/vN/tf/FVXa3bUJlk8lWVWVl2ttVW/h+b/AGasXm1ZFWD9y0a/MrblVf8AgVRsqtGvnqzLHJt3Qr97/vmpkZx+EPLmjVf9WvzfeZt1EEk0bMsa7l3Mqr8zf8C/2aLuORmVlWRWk+7JuX7v+7ToFmuNsO6RW8vcyt8q7v8AZoK+L4h3yyfvGaZVb70K/L/30tOZW+x+dDGq7m+byV+Zv9mntDNJcN93aqs25m+8v95qiZrpo2W2khjVl+7t2/8AfP8AtUcv8wc38o1oWuNrQMzN/wA81+Vlbb/3zVa5VpGVVmaZVX5m3bdtWWZppoZmb5Y13fvm2szK38Kr/vU122yT+ZGscjfMu3733v4f4aColCe3tWVZJ45oWb5VWT5lXazbW2/3v73+6tCs0cbK33WXarMv3v8AdoZma1ZYFaZWb5mk+Zl2/wAW6jcyszXO5lX+HbuqDSJZSORoWZlkhjVvm3fMzLt+b/gNSKzW8axqywq33WkVm+X/AHagn1BbWaFVjmVW+VmVWVm3f7NNa8W4k+X5WVtu1tqt/wB81fuk+9InWSZrNWW1W6+barMu3a237rbqgnk+0K0bSNGzK3mbV2r/ALq1HqizMvltMq7fmXb/AHv7tVFulbbC0ysyqrNuh/zuokaRiX7m+Vpo7dmjmZY127V2/N93bULrHMywz3i2/wArMqqrNtb/AGm2029WO6/fKtkqrNtXbuVlZV/ut/vVBAslvdM03kySfd2zbdrLu+9/dWgIh5zXStGtwy+Xt3NUs7eXZtDHcbVVt26aPazf3du6mM0kczXSsqt979yvytt/u/7tS3cm5YLhriG4ZlZVWRtrN/tf7NBRSu5GW8a4a6jhaRdsixr/AKxf727/AIDTo5IZFX+0vOZW2ruVl+b+7/wFqjXy/JkWe6Vp5GZVbd8q/LUm37PZxst43zL++VY925l+9t2/w0AOijjjZo7aOH7vzN5jM1R2lvGscflwyXDM26Rl2ttbazVfn864hZtts0e3aqq21tu1fvN/F81VtItV8vzJ1aGH+KSP5l3f/ZbaCeYvs0LNDDZWskaw7vmX5VZv4mZv92hfMkkZlW7VV3NtVl+Zf4vvfNUbbZI18iRVgX5dsjfNu+791v71DxtHCy/ZY1nZWWRvOVty/wDstH2hfZKy29rfTbZ1u12yMrbmXayrt/i/vNWktnGtuzW1u0yt93zrjcv/AAFV/hrF01ZI7fydUZmWP+FZN3y/wqq7tv8AerVVoWt9tta/Z9q7fMZW+Zf/AEHd8tEuUUZSl7xPBDDb26zX8N3MyttZbdWX5d3y7fmqpKqtDJCsN225tyq25W+b+827/dqRpLeFVWOa5Zl+bczfxfxLt/iprX0awqrbrhd27bMrKy/5/wDZanmK5SzFDdWsKs0czSSMq+XGy7drfKu7/wAeWmT+ZMrM0Myxq26ZW2qv+0rN95qj2xx27efHcxtt3blby/8AgO3/AL5qzBp6yLGt2scMHzMu6ZWVm/vNubczf+O0B/iHLcTXE0Eem2awqzbV2yfKy7f7v3as+Yunqq39jDcSR7mbzLhWZf8Ax2qSfZY41VfLuImk3bY4Wbav91m/+J3feqRoWVlmjtfsrNu8tpGXavy7f97+L+KtPeM/dkQNbwxtHCyx7ZN0/ltebYdv8PyrUt5DcXEbLc+TDAsm5Y45GZVX+98q/N8tW57O+jh/c6bDC0a7v3fyrtX/AGW+81QSw3DW801zDZMysrNJIu5m3f73yr92j3iuaJWtLq1tVbyLyRo/m+ZYVjbd91fmb7y1O0d5Iu5pFZVbbt+1eZu/u/xKtULy8mhuPLlvlZVXcu1VZt3zfLt2/L/9lViBYbxo5LfSZJpW+XzJpvl3fxMvy7aOb7ISj9oswWtusMci2tvJIzbljkbc0y/xfMv3f4qrr50cc6qt6qq25lhmVVVfmbb/AHvlp7RtNM0K6bpkbRrtb98zNtVWb73y7f8AgP8Aeplxbwxqrf8AEsjk3KzeSyqqr/tbvm/i/wDHaAiWoI5ltWmVYYVkXbuuFVmZtu7au35l/wDsaoXOqQrHHHdzQKqt8qwxszbf4vm/u7qjjW1ZJFbT2uJJG/css21VXb/7M1W2WS1aNoLe0tfOXcscnzMvyt83y/3mqeaRUo+8VPJ+0bWstPZZI9zSSeZtb7v91vu1I1jeTWszTzQ2qx/MzSMrSfN/e/4CtSszSKzXMaszLt8xo5Nu77u5mqtLH8qtutI2Vv8Ani3zbvvNub7v8NHMEuYrS6LM0n+k6lC0bbtrLMu5m/hWrekaXarMu1tu1tqtdfKv3f8Ax6p5dqsrLNaTSQtu2su3b/u7f/QqrTRyQ7ZJ7O0kVvmX7zKv+ztagPiiC28McjLaRxq38MyzbV/4CrVSljWGNoVZWVW3fKq7v++q04LjcrLPZwwqy/Kqrub+98rf5+9TWt4VuFZYZl2qv3lX5f8AgP8Au0SiTzGZLaq0bbZJJmZvuq3zLRAqrIqyQ7VVv4mq2qtdXW5lZdzN823atO2ssm1YW+X/AGvvVADmWRlbbt27fmXb8zf7zLUFyzQszKsaqv3V3My1I0lxcNt/1a/d27v4qjW1VVZZGaNVX7zRs25qYiNWa6jZmkVmb+JqrrbrcSL95trfxL8tXdzRxyNAzKrNtVtv3v71EkclvC0O5tu1WZdtUQUoI1Vmk8nay/e3Up8vP3mp7KzKzblXavyqq1B5y/3moA6ee6ZVVWZYZm+Xdtb5lb+GjayrPI0LMqsu2RW+X/vmneYrXTNBCqw+XuVmbd81Foq+Z/x6zMy7mbavyr/tVXMTylVWkZWVWVlb5Wbd8ytUyyeXCrMqsqrt+Zm+ZqklkWRtzQ+Yq/8ALT5V2s1LuWNf38LKzMrKsnzL/wCO1JQjSNNcK06q0m35drfKv92p2t1Vo1nhVZNu5WVmVWXbUjRrDt2rbeXu3eWv3v8AP3qjhupFZlVmZWj+8y7dv+zR/iJ/vRKk62+3zrmGRm+9Ht+ba1QX0ar+8VmZWVWWNW+b/wAe/wB6rbLDbsvmRsrMu5VVvmZv722qV2yyK25Vh3N8rK25qmRpH4ik0ax7m8xmjZflX5vlb+7ToIW/cSMysqtu+ZWqVYWkZWXa0Mi7WWRvl2r/ALP8NWIGXyf3DeWu75lVvvf5+7UxNJCwNHM3mSRs0nltt3N8v/fVRfZ1kt5JJbdZrtm3blk3M1E/l7vLW6Vl2/6tV3bf727/AL6qH7PC0KwwNuX+LbuXb/vVpzBGIyCNrebcqwtI27zNzbW+7U7N5kjNBGtuzLtVoV3fL/db/ZqCJZmmjZpo5FX5lVV+Vf8AZapVhW1vGadV8tV3MsLblqYyK5RsCrcM0i7fOVtqq21v/wBmmXMaqyq1ivnq25v3m7d/tVLO0nlwNPDDGsnyqsKqrbf+BfxU2eGFZGWNW2sy/u1b5mX+7QMbctIyxrtkZlb5V3fKtQXsaya0qsyqqxq3zbflb72373zfNU7R+W0K222FWZl2s33f+AtVaaOG1ult/wDWXLKytNCyt838P+ytUIIlk8yRoJLZtrMrMqtVm23RzN9ph/cK37xWbczN/wDs0SxzW67Y1VmZtzLG3y7qYzLDZrMyyM0jLu2srN/tf7v8VTzByludbq8jjuFtdtovyr83zfe/i+b71QN5e7yWjbdJtVVZtyr/AL22nzLDJu2yTL827azM3/Am3fxVYjaaNV8hmhVl3KysrNt/9lpE/CL9l3N+8a03R7W8lV+Vv/sdtRLH5zStJbwxqqsyqrf+y/xVGyt5cm23naRmby2bczLu+X/vn7zf7NSLMtrthjm8udl/eMsfzfd+7/tU4lEiqq7m8m2t5G+9JMrbf7vyr/C3/wAVUttJ5jbYI11Btu5fMZljh+ba3+9/wGnXMkMkiqrXd0yr80kjLt/3tv8AeqCVd1nunhmmbdt3Myxqq/3flX71EviJiTrdTWO6aC3hmuPlZdrfKv8ADuVV+7/wKoI1azbc8zLM3zNMytt3f3qnWO1bdJHYzR/NtaaaTcv3f4f4qkjuFWZWa6nkkb5VaSFWXb/FRKQR+IpLI1wyyXczTL833V+9/D8u7+Gr62MMyqyrDHCse5muGVm/4CtQq1wrSRsywrt+621Wb/vlWqadWW3VZNP/AHe5WZvlaRt392iMo/aCXN8MR/2X92y21u0iq25pIWVVX+L73+7QyzMqszXawr8ys0yt/F/dWpvMt1t1WfTZpmZv3asq/Mqt95ttUtQaRoVhto7m3hZvlZbXaytt/ib+7WkuUzjKQK1rcMzQN5ixt96FmZW/2v8AeWo5Y1aaRriG6mZl3K00jKy/3W+781X01RVVbe2ksFVVXaqyN8u35W+bdtqOe4aaSNru6VVh+VVXdt+797d/FUy5QjKXMVF22qxqt9CzSblaFZFbb/st8vzfe+9VpluFhVrlbS627VbdIsMa7vlXbtb733qja3s4zCsl1+5ZVaRmt2Zfm/4Cv3ajik0uaFVsrO2mk3fNMzMqsv8Ae3UR90Je8WfLvLqFYVktmVVaRmWHdu3f7TVntbzMrLIts3y/NHbw7WX5f4mqebS7fznhnvLRl+9+5bd/vKzN93bUiW+m2arJHNbN+72tG0bTbm/4Cqqv8NHxBH3SusbXSr9vaOzhVd3ltMqt8u1f9rdtqB5LGObbDIqrt+ZmXczf3fu1Ivk3F4zM32eHb83l2+5trN/d+6v/AI9V20uLOxkZlaa4nZdqq1r91d38Tf7VVGMZFSlKJTlVZG3LNdyN/Cqybdvy/L/F/eqxBb30aq1lIzL95mmmVtv+03y/NTrm6tVuJpPsc3mSfMq+Sqq27/Zb7v8AvVXVvtkat9ngtVbavy2rM3/fX/Aan3Yky5pEjRzM227vlZWXdJth2/Mzfd3f5+9VlbWSG1VoJvsrMzKu6bd8v/stZd3HHHcMttNczMqsrbdyr/DTl0maRdyyXKt/CrbWVd25v/QqCv8At4ey/Z7fy1uGkVvuq0ny/wC8tReXazMzW1w0zbdrfLtb5fut/tVfnjkjVmX7Sqxr821VZaqQXFvcR7mvFkmVfmXy2Vdy/wB2qJ/vFNoZlk+aRodq/Mu7d/6DTI1VbhfLZmZtyszNt2tU8EfmL91du7733du7+9UbL5dw3yr8vy/M33qyKJljjWT5pJl2/LuX5qbdzbvlkkZvl2rtb5vm/iqpPH5yr8yr/C0atVuW1jWNWgtWj3fMq7t3+zTiTIiZfLXavnSR7t277qt/ndULRr5bKsLbd27czbm/3attJMsLLIzL8u3buVlqJflVWVmZlVvu1XMTykMqstuzblXc23btrN+b/nsv/fLVqMrfZ1Ztrf7O6n7ZP87aOYDbtreaZZ/sywrtXcy7ty7f9mp2W6hZlgZdyqqsytt3bv4f92oJI2WFlZl2qvy/L8y/7tOW3vLi4gul2s0atGzL8u1WZW+Zfu/wr81ETOXNzFOe6W1mhX7PM0k03l7lXcqt/tVdWOSSNmZmZd33l+Xa1RTssbLuaTzGXay/dVv9mo13TSM0EiwqqqrL8zbqOYqMR3nQyNJNJHJJOqrtVVb5qkVpI7eSSBWVpPl3M3zKv3v7vy/eqXy2uIWafzvLX7rKu3bUDKrTeXBMzM275l+7t20FRI47dZGXcrSTs27crfd2/wC9VTy2kkbc0arGvzbW+b/gVXWaGNYl3NG27asa/wAX+1/n+9VVoZGmWRo1VmbdtX+KpkaRIJbpo5lVo2jVm+VW+ZW/4FUn+leTIqzKvyruVV27t3+9U8si3DKsi+Y0bfKv91f/AGWqzRySSbVZWVV3fMv3f9qjmNBqyTRqrKqsqq25tvy/eqy0lxcMv75Y1kb7sartoVZI7eTbcQrCy7du7crf3v8A0Ki0aS3jby12/L8rN8yr/wB9VRP+EgZrezm8mdfM+bcu1vl/76pqszXDLGq7WZtzK3yr8v8AFVm7tV+zt9mbzpGb7zLtXd8tUo41aFWXzFbcvzRt8q1P2iokSrJJdLD5MK7ty+YytUk8MlvIyyfe3bV2r8zNRc7mvGbzmk3fKzNH8q/9802L7Q22ZplaFd0aqvytuXbtoLHMy26wKzQs23duZWVlbd92obtY1kZo2hj2r8yqu7+7/F/n71SSXTLNHI1urK0e1fMb5mao2kZd00bNHIysu1V+Zlb71HuxF8Q62WFYWW5mZV+Xb/7MrVZWNo12qyt/EqxyMyr/ALVMt2tY7WHdCzSR/NuZVb5v96p3WG6VpJN0jSL/ABMq7VqZDCK4aFladVkbbt3M25W/2Woh86RVZYYZpFXcyx/w7m+625qstJJa26w20kMnzbV+VVVfl/4DUC27LGzTqszbvmZW3L/urt/2qZEQaOPyd269kaRdu1l27W+9tXb/AA03zJGZVnmkh+ba38TN/wDY1JtZW8yC4W3jVVZVj+bzP9na38VCx3V1Gs32pfL87y2Vtqsv/AaYwjhWNmaRmaNfl3K3kqzfN91qIFhaFmmZl2t91W3fL/vf+O1DcrarMsKrNJMzbdzMrKq/3fl/3adAzQqq+X838W77v/AqREeYs2kdvCqzbl+VvljmVfm+X+GtFWk+ztIy7YVbb5cbKzKu3+H5fvN8tUrJmkuGW5ktJtqttVm+Vfl/u/w1K3nNIy7o2+XbutVZdzL/AA7qcfhCXvSEnW18xWgtZlZm3N5jMrK1QqrXFwyrJDbqq7vm3SMrfxL8v+9/6FVmdZI41addzKvmbWmZmZf4d23733aF875tunww+dt3L5m1mb+H/do5SeblBpGjVre0hmbc21mWZlZm3fL975v9qiKO6t5t1/NbKy/eWRmZt33fur/wKo9rLMyyTNCrM3zKrMqsv+9/dpJJLNY41sri5mmZm8xlVm3KrfM25qoCdLe8uJI91rYQqyt5KtCys3+1t/3f/QqL2SaNY4WuJFVVVWXbHHGq/wC9/e+WiKO4uriNm86SP7qrdNt/h/ur/D/tUk9va2O1pFsoWZm3K0e5dyt8v8XzK1VymfwyIftnlxrJPdQ7pmX94sjTSKv935vlqNrhvLWG2a7ZmZdqxx7Wb/x7bVm2uri6mkaO3tlhVlVmVWVW/wCA0ydl8xf9Iu4f4la3jaPc275V3N96p+IqPuyLcFqumqv/ABKWmkVtrNcMrKrfxbVqPzo2Xaum3c00n3WVl2q3+zt+X+Gs+8W0juJFvW1O4lb5l3Lubdt+7t3f+PU9fJZl8uxu7XbtVfJZlZfl/u/3mqvh+EOX7UhyrfSKrLa3cflt5jNC25l/us3+f4astHtZm87U5J2VtzSRr5n8P3VWqkDbpJFtobmFV+VlmmZWb+98tCyXEdxM0FrCqttZt0zSM1EZcoSjKRNJCtw0K+Xc7V+811G25vl/urUcEf2hWaCZWW32sy7WjVv7v/fS7qJG1Brhfsy21xMv3tsjNuX/AGt22nWkN01n51zJDNMzbWjZVaRfm/i3f3qr3ZSD3oxDT/tTW7LaWa7W3Krbmb/0KmzrdSQr9phZY9yqvlqq7l+98zVdbc1m3lrukb+KaHy1Vv8AZaqiq27dctaXjLG21VXau77q7dv92s+UIyK6xqqrtVlVf4ZGZmb+7/FVSeZpmWG2kVmZtrK0O1Var89uzMyyWscbNCrKysu5v+Bf+y1SuVZvJ/c7VX5tqyfe+X+LbUyKiRx28yzKy3SsrbfmZWVV/wB7dUixqs21v30nzbl/2anaNWk3NCqq3zbVb5f++qST5Vbcqqyt8qq38NIJBOvl/NIrKzLtVY1WpbndDDGs/nKzLtXc23b/ALv/AI7US+XJMzTzTfMrNtjX7zfwrVdWk8tVZpGbdu3M1MnlkRSrHJuVo2+X5tzN8zU1lVlXarKrN8y7d1W52VbhlkjWRmX5m+9822qEiyNJ8rKse7bt3f7VHKHMVm/eM3lyfL/E391qPssH8Utyx9d1WUhaPcsaqq/eZmp32P8A6af+PNVEyNxpN0aq1uyqy7l2t/FU63Cxxx7WmXdtVlVfl/4FUDNHHJuVtskk23dJ8u7/AHf71NaTcsqruZt25f8AaX/Zaj4SfdkW/tTTKq+Wytu27mb5dtRs32iHatr5bK3zM235vm2/N8tNjVmVvm8tV+bay/e3VNGsyxzeTceXuXd8y/Mzf7NHvSD3YyJGj+zx/wCp2qq/Nubdu/3lpse2RWZVWGPdtVmXdt/2qrrJNbq3lKsjSKzNtX7rf3qmguJJFVp2+XbuZY1+Xd/DR7pXLKJHPcQqsm5Y5lVmXd93a396qy/N8zTbtv3VqyzfaI23QxxqrfM0jbdy/wAW2mMqxwtbwMzQsu75l+Zf7tSVEqpHNuW4jZo1kZlb5fu/w02D5luVbbNHIu3cy7fl/iqZlVYV3NNIv3mb5v8Ax1aa119l27laTcy7VZfl20jYGWONY4dqzK3/AAHb8zf99VFeR+ZtVlVVVVVfLX+H/aqedlm+ZtvzfdhVv4qqR2rR27eZHNGzN/E27ctARJJbVtysysq/73y1GzbZFaPbJC3ysqtt/wAtQzbWkjVo13bfmZvu/wDAmp26NlVoo9scbbl2szbv/iqCxs7K37lVbau6Rfl3bm/2v+A0TtG0cHl2q/KvzSMvzK38O2q0k3mQq0EMzSNJ8rLuXd/s7al1Caa1s4/Mt2WST5d33VZv7vy0uYXKQ3cLecytaxqy/Mu5vvN97/2amRLCsbSNJG07Mvy7vu7v4alkVY2ja5uG8tm/1bfL8v8AEtQTxwsqrBCqruZVhZlb/K0yizp8kMf7ldszMzeWscyt8tXZY2uo2kkaBZFbcsKrtZlX+81VJ1hW4Vp/JaSNdq7fm+Zv7tTRW+1YJFhjkVVZl2/Kzf71MQ1ftF0zRtDDGqt91V+X/gK1ZtFjaZljW0Zo/wDlsy/Kqt/wL5v4arLJ8rMsLLIzf3vvK38NSrHcW8bSSQwr/tMu5lWkQMaFpGZZFWZZG2tI3yqv+7/FUlyrWuntMsNpIzboF+Xau5vl3L/n+Gryws22RryGa2X5mZY2VVX/AOKrEnuLWS+jmuYYI4I12wr/AMC+83/xVPl5SYy5i5p9vNHD+7hhZl+Vm3Ku3/vr71TQMsMi+Syxt/Du27VX/ZVabA1qyyNOsbKvzRqrNtZvuq26nRLbtC03nfNtZljhXcq/3qRX2hsDLHJtZWmZm3Mqxqq/L/e/u02dY5rjdHa20ayKq7lbay/8Bb/2VasSSbY2jZVaFVXcske3dtX5d3zU1Y28tZmhtmVW2qszfNt/2VoAa1rDDI3l2rKv3laSb5l3fxL/AHvlpzW67laJrm6Zl3M3nfKrfwrtao/MjmmZm0/y5F+ZmaZtu37q/wANabSKsfnNdSKzL8sf2dpG3fw/NTjEmUiO7uLiHy21Jdsi7VVZm27f++flapEtZpLFfOWwhjVW2szKzMv+z/wKqUtrNGyy/arWGRW+7NHub7v+0u3/AIDRZabHcQrJcX1tDGzfdh27v97bVRlIzly8ofZbdbhvPtZGZl3eXJIrM3y/xf3akgWzs28xbr7G0e1m3Nu/u7VVV/3fvUSLbwtDHZTXMjMvzL5P3fl3KrMy1G1w0aqqq0jMysqyRqqru/i3LR8IfETxTfaNzLatIzK37yaZlX/vn71Vp5JGWZbm8+xwKy7o1jbazMvy/M33f/Hd26pVmmkZWaFWVWbbIsO5VX+997dUECzKyrc3DRruVlXy9q/7TM21qqMg5Qgj+yyLJ9smmmZdzLCq7v8Aa+bbu+6tWds10qrAt/cSSf8ALaTau3/a+b+JaRrr7DdSNDqyybm2ttXc23d/Cu3/AHqrtqFrIrSXN5dzfN+7h2srNtX5vmX5fm+7R7oe9L3gntW27WurmSZl2tGqq3y/7VOZbpvOWO1tIVX5VVl8lm/u7qdBN5kzeTp9xb/KreY0zbtv/Atu6nTrDdSLJbWd7M3ytM0zfM3+63zVXLEOaRPHcXjQwwt9mkjjXcvkr5iq3+03+zUfyyMrSXTQ7l+bdGq/L/sqy/NVaC1upFWFbGdt3zKrXDbV/wBr/aqRWZY1aS1jbduVmab/ADt/+xqeYnliSvIqxyKuteSu3aqs33vm+7t/h/3qJ/7NuI1VpoY2VVVdzbmZf9n/AOyqCe1bc27bDtbczRqrfL/srTW0u1VVkVW8zb95mX/vploK90iu7eOGNVjbzo9q7m+6yt/31UMCxxw7pPlh3bV2q1TtDN8rKsK/L8u75Wo8y6kVWZlVV3K391qxkacxArLcMsKw/Kzbl3feqe2+0Rrug2tOrbV3Ku1V/wB6oGa4a4ZlkVvl+Ztq/dqSC3haPzGvFZlbdtb5VX/a+aiJnIL1ZIZlZmVVZfvLu3Lu+98tV5418zbubcy/dZdvy1IrR/aPJbdMzKzKyr8u2o4I2WRppWXa3zKrMzf71VIIyGxW7NIqwLtVvl+Zt1VmjVdyr/rFbay1ZaOGSZWgjZdy7dzSbt38VSK0PmM08n3f4aA+EpMu1VVlk3N/Cq/dqz9n/wBlqdF5cittaRl/2fmqvLEyyMPOk/76qiTpGhZlZp9si7tzbvvK38NNdmVWVlZV27l2t93/AGaFXdcM0cjNtj+ZWX7rf7P+zVmRVaZZFkWZmX5mVf4v7tHxE8xBK3+j/v13Ky/Krf3v71Rqqqsfyq06/dZW/h/uqtSbljjZZ1Vlbcqr97/a/wC+qbAu6PzPOVtvyrGv3mX/AGaoIxD5VhjWONtzNt+Zv/Qlpyq0fzNtVmXbtVflpu6ZVVrSFWg3bVjkZt3+9uqRY12r5kiw7l+ZW+9u/wBmp5Q5iGSOORdvzbVbcqsv8X+zUm1vtHksqqzfdbb8v/Aqknt1k/eMyq33VXduZlqNftVvD8u1lX5WZvlapNOb+UJ41jvGhZl3bdzKy7lWsmVWj8xVZZt3ysy//FVdnjmWNZvMjXa23bu3N/3zUK3Ct5nlr937ystTL4jSPwklpDubbIqyTq25dq7fl/3qrsrNqTefuZmX5WVtu3bUUUk32rd8qrt+VV3bqs3yssMO6OTzlZV2q27+H+L/AD/FRGRXL7w11VZFZpFZVba21fl/4FTlZpI9yxszfd3Mu1WX/dqJY7hflZVXa27ay/dp92yx2cDecqs021tvysv+1/n+9VfEV8JUnWZljVpodqtuVY2+b/gX93+Km6hI01xAttC37lf9Z/Fu3feappdsm2O2hVWVd277u5qr2kbSXCtezNC3zKyq38PzKrbqn3g90SK1kkmVmkaRpF3SNu+bd/dqeeNY41bbBCqttVv4qFjtYZG8+Tdt+7821qdBcWs0c6rDJMrMu2ZWVvu/eoj8ISBriaOGO4jWFmb5VbduZf8AgNSRLDuW4nZmaT+GFvmZv9qmywrJNJ5DKsm35ty/980WkcMas1yrSSbW+VW3feb71MY+O3mVVmVWh/55r525l/h+apII1kmghaaZlVvvMv8AF/n+KqUcayXytPIzRxr/AMsZtqq237zfdq+yr5i7YZtrNtbzo2ZWXb833afKRzEmqTbpljkjbbGu3du3M3+6tUFaG3ZWtmnWeRW2syr91v8AZapLBYVmVVk3TbtyrC21dv8AEvzVOy3Cs3kbpmZtqqyrJ/tfL/dX/aokVGMYjla6a1jkWH+JfmZlVvu/w06SbzLeFtUmmhVt3ywwqrbdvy/N96qDfLHtnmmjbb8qwrt+b+83zVZ09WX/AEpbWSaNl2t5iru2/wCzQTyjYrhZJtts1zt+Xc0kaszVZlt9zKzedMq/Krbdu7/2amLuaPdPDJHB93bGyqzf3f8Aap08ckk3lrNMv8MMaru2/d/i+Wp5QJYGuI2/0TzreFmVWkVfM+Zv+A1FLJNbtPtuppF3bZG8nc3/ALLUkHnRt5O7zm2/L5y7VX/a3K2371TrJqFvtjgW0ZVXc3kszbf/AIpq0iTL3ZFSBlZf39q0zbdq+c3zfN/sr/eqzdtIrbpLG2tYvlXay7m+Vv7v96hrfbGrM0LMrbmVY2Vt3+0zfNUUFutxIqtb2kbN8rbpmZd27+L/AGqI/wApMuWRHK11DIqyXE1rHu3MzfKv/AdrNVeW3t1Xct1C25lZd0cjMq/+zfe3VfgjaS6ZbKxtppFVWaa4VmVV/vbd1E8N9GzTSK0bLuXzo1X5mX/gXyrRylRl73KRKzX0yws0jKvyxyMzQq3zfK1Odfs7LNPpsm1Wb5ZJmZpNq/xbv4ajX7dGsl811DIq/L/pSqzL/uq1EUyru86+vZtysqx2sbbVVmb5fm+792tI8pnLm5gZZvOZV0+0tW2rIqtu3bv+A/3abBDM1vM3lwyKytuk3My7W/u//Y1IrLbqyx3F75m7buhXczfw7WZl3U9luLi4VoLOZo1j2/vm2tt/i+992pKC7upo1gkjhtJpFXav7xl2r/dZfu/8Bpy3EkLRLPa+dJtWRlhm2qrf7W7/AGflp0EMyr+4s7KFY28tm3KzN/tbmrNtIbqa3mj+ywrCreYzbf3kjbvl2s38K1XvE8sS3e3X2yZlaGH7qqrTSM3y/wAP3anWP7RI0P2qNtsaruVWjVf7v3qrWjQw7ZP9LhZV+ZmbczN823atR2mmwzK11drd3Ct8zNM21d3/AAGpjIJRjEuwLIunzW7TWDNG3yzKzL8zf3f73+9VbT5LhplVWWRm+9+5Vl/z81OaNYWVoLeFoG+7Gzf7P92o1hjaRlia5VWXd+7b5f8AdqZSCMSP7RJ9sk89VZo2bb5K7V+X/aqttVpmaNty/MyxrubatW5VVo42VZ9235tq/KtSQKyxqqrMsjLuZvl/h/vNU/EV8MSsqzNtXays33lVfmZakW1aNW8tW/iX7q1LukuJljVblmVtrSMyqu7/AHqqXLXCyKrKysv8O7btpCFufMVVVfOVdq/K235aYu6RmZo1VV+9/tU+SPzPLaSZm3Nu2q3y/wAXytTmjXy22zL5m5flVfurS+0L7JRmkaORWXb8zfe27t1Nl2xyN95tzfMtSrD9ojVdrKqtuWRW+9/8VTFXdN+/VVb725V+XbVDHrG0a7Y127fmqpKz+Y27dn/earHmRxruWRVb+H5fm21VlkWSRm29aBROxgka4jbbN5O1WX5W/wDHWqrbTLbsrSRtMsi/dVvmVqurJJbsrQ26xrJ8rKzfeXbUFy0cd4rLtjZfm8n+Kq5jP7XL9kjaSH7QzRRqq7dqq3+9UiW7Las3mL97ayqvzVO0aySLM0O5WVvmZtrbv+A1UbyVmZoNzbl2srLuoD/COkX7LNt3NuX+Ldt+9/FTVkmjkXz5vtC/w/L8y7qkVla327W8xm+Vm+6y1Osaww7VZY7n5v3e3dQV/iKiybvmZt3zbdrLtVaGkVlVp90jfwsvy7vm/wA/981M0fnTRLcsytt27VX71VVkVW8ll3Mrfdb7ytUle6DyRsskm3arfeVfm21QaNVjkVWZoG+ZW2/NV9o/LZljk8tm+X5VqJVZZlhbavzbW3L96s5G0eUj3MyqrKqwLtXzKcsa3HmbZFaCPcu1V2/+PfxVI0ckbfZWZVVWbcv3lqv924nVlaSNfm3K21dzfxfLVRl/MH+ErW0kdxasvltuj+VV3fNuon2s0DNatN5asytt3L/9jVmNWkkk3LGsLfN8v/xVVlZvtEn2SNmVV+7u+X/x6maRG+ZDcXCr5awsqs27czf8BVaazbrhfIZZlZvvMvzVZbctnIqyLHu3eY3/AI9tqBo44bNVaPcrNuXd/F/n5aAiRsyxxsskatJu3bm+b5f8/wAVEcatHHHH+73Nt2q235mb+KnRSMzLtZl/3ak8mZm+VVZV+9tXc3/AqjmAdc2e2RbdVbzNy7mWTdu/4FTmjt41ZZ7ra27b5P8AEv8AtVHA0KwzqyqrN8zMq/KvzN/49/8AFVZib7LNGzLH5m1trMvzKv8AwKrD3h1srSRyRs0KwW8atuZfm+9Va/1C4kuo1a82tJtVYVX5WX/eX5flVW+838NQyW7TTTNHas25mbczbfu/d/8AiqcsLKywtNGreYqyMrfN8vzfKv3V/wD2Vp8xMomjHDM0ls1tb2jM3yq237zL/FUdztt7hprttrMrMyx/Lt/vbqmgjb7PHDbLbLaR/Ntbcrbd38XzVX1BvMZv3Kxxsu3dC3zf5+WpkEfekOlaG427VZf9lpt3y/8AAqkbzFhVrZY1aNl2stxu/wCAqu3/AHak3TTW6qtxCscf/LFV8tV/2mb+Kmz3CtbtJBYrtjXb523crM33dv8AwKmEh6yXEMas0y+czfLuj2/M38TM38NRXLLJIrTX3nNIvzLGvzbv7v8A9lTmkt423LZzXEiruZbibbub7zNt/hqNr6Zl2/Z5t0Py+TCqqqr/AL38VP8Auk/3hyyWcf7lbdlmVvmZpGZvu/d2r/s1O0cf7loWj8xV+VoVZW3bv4mZqbtZYVWC1ht2VmZmWTc27726i2j8zdMzNMv3W2x/d/8AiqRPL9ojm/0dmW9hubidl3LHIzMq/wDj3zUkUNxdMvmWszRqu3yVXaq7f/HvvUNJa2cnnRzNCzNu3NGyt/u/7VC3kNxeNHNfMyt95ljZW/3vlp+6BK32dZGZo1t1VW3LGu5m+X7u5qzV+zyWvmQR3LMzKzNM3y7mXc38VXVWFVWO2tZ2b737tmZv9lvm+7Uss0lwzK32lo41+ZVj+Ztv95v71aB9ooxaZFdXCzMzbdrKqq3nM237zMq/MtakFvIu2RbHbCrMqt5zKzL/AHtv8NQr5MMitbWu1dvzM0bMy7vl+X/vqkZbOO1kZYbvZJGqxsy7f7u5vvfN937tEeUmUpSLMDSRsyqs1qvy7d10rNt3fe+b5vvVPPHZ3Ss0l4sny7V8yRmX5v7zbqoM3lqq21nGscjbVmuIdrNu/wDHv71EFrbxrPJc3FozL91t3y/K1VzEyj9rmC5tYWWTbCrLu2rJtbdtX733qk+2Xk0bK11Nt2+Wqxw7vl/3mo3QxqrNatdbm+6rNGq//FVI9jdW9xH5lqqs33Y1um+b/ebbR/hD3ZfEV5JGZpFu7qZoV+6rQ/Kv3l+Zf4f/ALKnT3UMNrAv2xm2/d2w/dX/AIEv96prtbizjVWa0hZm2t5LfM3975qduvo7ONZ4ZNrN8qzLub/vmmT8RXv7qZpo286ZY2VVZWhVW2/7NZzSQw7pJppJN3+rjVdv/fVaNs119oZmt1kVdyqzNt27v4dtVFjWzkZmaONpGZV3N/E38K1hL4uY0jy8vKOljkjhXz22tt+7u/8AQqa1w0kax7VVVX5VZW3Mv97/AMdqzE21V3MrMqq3zNu20K0cbbmummZvuqrL8qtSJ5itBIsjNDL5kaxtuZY1+Zmp0irH8zecy7vlVmqd5LWG6X7bJcyMyszMy/e/u1Ua4W6Zlg3L838Lbd1Mn4iSeRreJlWFVWRtv3lqpIzQ3Csu3ay/Mq/3qstbtJCvlqsf+0yq1EkdvHGvkNG0m77rK26iRUSoqtNG22FljX7rf3v92i7VljVdq/3du75lWrMk0jM0a/L8vytVaW3Vdq7dzfxMrfeoJ94hZVaPd8vy/Ku1fmqu9u28/wDxVXpI/LX5l2qv8S/eqOJm8tf3jVQHTzws0iqzKsitt2s3y1WnWORW+Zty7mZv7u2rbMu5fLZWbb8yt8zLVJrqRVZWhVlb5laP7y0e6THmJ2jaNWZZmZWZfu/3qJWka33bmWTd8vyqtQQNH/EqrJ/Fub7zVJtZm+VVZf4vl+781QUNWSRlVZWVmb+9/d/3qkit23TyTzMsjL+7Xb91f97/AL6pWkZY2hVVaOT5W+WkWNZI1We6aPb83yqv3f7tMOYVlVWZvMm2r/Ft+98u3/P+7UE9vJdN525WWNvlkVdv/j38VW2ZZF8ueRoVZd21W+9RE22FmZW2/d27tu7/AGqqUQ5pFJt0aqzKs1yrbo2X+KnXcc1vIs08LLHt27aiu1WaGZVVWXb8rbvm/wCAtTYpJpNNWGRWZmX5tzfMqr/FWf2TSJXZmZpN25Vb+L727/doVpJoZG3eW0bKqttVqmkZtqsyqqrt+X+Kmqqq3mQN8u7dtb+Jv87an4Tb4okjK1wzKqxsu35mZfvf8BprR28kbNbLtb+Lcv8A3zVlpmWFZIYV27m2szf7tQssjSMrTRrArbtzfd+638X/AHzVRJ5iC5jb7G0aqqqq/Ntb5W2tuoaOaRV3NCqqqszM3zbf7tEixs33ty7tysrf980QLC1wzSQttX5VX5W3N/u0zQgZVVlVWWRdvyr/AN81Ovysvn7WX5dscbfNVZoZLiZpI42jg+ZVZfl2/wB1aswMqzSNDujZvu7l3f7tQBHKy3EzKsK26x/Mqt8rN/s0yeTy2WGO6ZtzbdrL91v7tNX5pmaeZtzNu2qy/NUrSLJN8sisy/NtVdzUASS2sKqyyTbpmVlaNf4f+A/7VNb7K0awra7mXczNu/ib5d3/AI9Tlt12tcT+c0zbWVW+b+GiCNWWS6ZWZZPu7lb5f9qrCJZe3uLpYI5Ft7dWVmVmVtzf7Tbf71RSw7lkjWZY51XbuWFm3N/s/wB2nQMrXDNJM0cartXbuZvlX7v+zSweYzTLP5yqq7trN8zN/ep+6T70SCC3umjW3aZVVdy/vPut9773/fVDXF5JcRxrNCzLtX92rfeqRmVo2jj2wtu2/NuZlp0G1ozDHNb7lb70aszM277zK38VEiokv2i4kXyWuLJtrNtXa25t38W5v+BU2K1kjk8v7U1wrMu7y/lXb/vf99VYXT5pIWVlk8tmbd5kPzfL/eb/AMeqlPJJeau2nq0cduqruumVfm/2VXd96qMftE8li0dvuabyVVlZVVlZqbGyrGy7ruRmb7qqu3atSQR2cce5rpWkjZtrLCzLJ83y/N/u7aIJFjmabbJCytujaZmWNf8Ax35mqeUrmkFpf3EbMttHJ5KszM00Pyq33d22mz+cqrNNqW60VWZW+z/L/D95f/iqY2oL9oj23jNIzbpGb/Vqv/fO5m3VXuZJry63f2h9ohjZdrNJtX/gK1XN7pPL7xcW+a4ZpGur9VXayrHDtX/e3fdVabAy7WVbyaOHbt8yOFmaTa3y7v8Aap7TTXFv5K3VosKs3yszNI3+7Qt1bQ7ljZlZVZWaab73+6q1XumY6Bd1uyx3Vyu5VbasLNub+8zfxNTYofOm3SRsrbfvTLuZf91V+VfmoS6sY7hlkaa4hbbu2rt+7/tbvu1B5c0iyTLHDDbwr8sLTNuVm+7u/vN/s0FRLKNNDtWBlkZVVd0kLKq/N935v8/LUcEjLcbW+yXk+35W8ltv3v8Ax1adbW8yqsltNMski/vGVWb+L/aqSdlhk227XrMzbWZtq/w/Mrf3vvUfZJly83KRz295MywssLLI25Y7dfu7v4dzfLR/Z62MreZa+TIy7m8yTdt/3v4Vp0UdvJ8011M0/wDErM21f++f4qswXEMbSLaNGsjKv3oWZmquWISlKPulZmWG33SWMbNH8rSQr93/AHttR3MkkKrI3yxt8zedJ8q/71TXdwtvItrbKu1v9Z+5Zf8A2b5qhnWGOP7LcxrIsi7WX7y7f7v3qzlII/zEXneZIs0citHt+XbJ8rf7tPW18yNWubVpPLZWXbuXa3+9/eo0nT47OxW1tlb5d21Vb5V/76q60cm1fMaZYFbbtVt27/vqpCUitOv2dv8Aj3X98u7y423bVqtPZs21maONdqttVfmZm27WqyqqyyKzMrfdbb8zNQzNH/yzkhZfveYvzMv8NHMHwkDWrSNtnWab5fmkkX+L/Zpqsse1YF2srMzMy7mapImZY2aSaRmVtrKvyrQy+YsbeWyrt+Ztrf8Aj1BIk8m5V27Wbdub5m+aoG2szbmVWb/V7V+X/aqSeP5VZmZtzbd0a1SaNdyqvnKq/eZmXc1IqJPd2/lwttbzGb7yqq1UWRpo1jgVmZvmVl+6y1MzNDM32Zdqt837xt1Em2NY2ZlVlX7qr8v+7T90n3ig0MklwzTt83yqqrUwmEQ2Bfu8fepWkjjZWXczf7VTecv/ADxX/v3VRA6WCNlVlaZVVl+9/Ev8W2qXltIqx7fmj+6yrubb/tVdWZvMZl2qyr8zMvytVdlVmaTzPJbb8yr95mqAjzEE7LazbmXdu+8v8S7qmtGjkZdys3y/Nt3fNQ37yNvvbW+VmZas2lrJHHtgkjWFl+ZW/wB6n8RPwkbLMsjbV8yNvuqzbttR3cPmKyxsqq3y7VX5v9r/AMeqSeRvL22y7fm3fe+9Ue1tqyMzNu+ZmVqOaJpGMiC2j3Xy2qsq7VXazL8u3+JakZf3c0LbpmX5lVW2sq1Pdxs3kbVXcy/Ky/eqLzPs6+X5Krt/5bf+hUf3QjH7RHAyt8vk7l+7tb7u6oWXy75WbduVfl3f3vmq6u7y2WNY1b7zNu+8v96op13KrMvzKu5mVvvVPL7pUZe8Z2oSTSW7MqrI21mWP7u5v4fm/hqSNWkby51VVVV2t/d21HHHJHGq/wC1u3N8235qdcxtIyq0m1l/5aKv3VrORtGPKG6SRdvk7d33l/2qlVfl8mPcytGu2Nl+Vf8AgLUyKNo4WZpGkZvmX/a/+JqyrboVZtq7V27f4t392qjIJFRmht1aa5VVgjVmZd25V/2ajtGt5LdWtlaRZG3K23bTpZJLez8toVbczf7LVdWPy2VW2yKq7m2/LQMzpbFljaZdyqzfd3fL/vVJbRzLaqzTL8rMyrt+9/vVJfW/nRr/AKxY9vyqrbqLm1j+wxzLMy7m+Vf721f4v4vvUDGtbx+SrM0bSsu5vl+7u/vVXVVjVvIbdN/Ey/L8tTSR3kiqs7Rt8u5VVVVVX/0L+H+9TWjmVYFVdsm77zSfKtBURyq0jLJH5kO5fm8xvmb/AD81SWzbWba0m5f9XGzL/n+7Ue1luNzTSSfK27+Hd/vf3qgVpmvI/LsVVVX5WaTc3y/3flqyfsmo1vdTQ7pZpF+b5mZdu1v+A1U2x+dtjVpvm2sqsy7WptpIqyMzMsfzfd3bvm2/xVdVVWNWa6j3Mysy7fmVv4f9771Ac3KMWPcskNytyrKy7drK21ab5MMdx5c9w0m1vl3Lt2qv/s3zVKtvM0zNNNDMsa7lXdt3L/tVBFIsjKyraKse1WXd80jf/E0CHz3DXy3McLTMq7fmjk+Vv8/NRHHDDC0a27TNGu5m2qrNt/3abAszMyqqsqru3KzbateTDIrbbeTc33VWZfmZf7392nzc3vC5Yx90j8yHG2CzuIdy7maRmbav+yq01bq32s0003kRrtVZF3Kzf+y/7tSeYy2arDp7N823c0jfL/wH/gNRwW8jXHnXdrJIrKrRqqr8q/3v/Qvvf3qOYPs+8NW8jvLeOZrVreBflVof4mb5m3fLVuNo2WFoY49qtu3TN8zf8B/u1J5jLt2zMyw/dVYW+X/Z/us1FsrSSQ7o5JlVfmXaq/8AfTfeqviM/hiEUd00jTLDYbm/eNtXcsa7f96mR+S1xIzTLM0e5Y1VV27v95qnntWt428+x8ncu5WZl2//AGTU1pI5mlkaa33Ku1o4Y/u7V+Xb/vVp8PumMZR+IarTLcLM00dvIyrtVV3bv4WbbSQMskreYv2xYWb5po/vf3WVafIsLNujt1kW3Vm2tGv7v+L5lprXEd1DGsFmreZubdt27v8AZo/xBzc3wltW8mRmghjt55FZvM8xl2/8BqD7Rql1IzeYq20a7dyx7tzf5/8AQqjaRYbiRYrVVZlVWXzmb73+1/vVJBDMzfNCqwqv3fMba393c3/fTUc3N7pPLGPvSI5Lq6VVaOORV3blWNdq1BK1xJJ5kbXcLNuZlX7qt93/AL6+9WlB9oaRY4JoFjZfmVm+VWVv++qgnXbI0m5v4lZV3bf9n7v8NT9kqMve+Ezp4WWTdcwzTSN91pP7vzfNViaO18tVhs2Vt3/LT7zN/tL92pbto1k/0aaaRV+VmZtqt/e+9Qqqu7a25m+b5W+7WcjTm90iZWt9q7VZmVW+X+H/AHae0cnltuVtu1mVWk+VadG0LQru3TM33maTaq/7u2qiyRrcM0jeczL8se3d8y0e6Z+9IjaOaRWaORYV3bvvfdXd8tSR/MzKszXHy/NIzfe/4FTfLZpG3bmVVZmVVX5acrN5K7lkWNl27dv8X3vlqYlSiRwRtIzQ/Nu3blb+HbUitGtu0bSMrbvuq3ytVaZZpG/eeYvzblVl/hqzBHawtJJOrNJtbb83yq1VEJFa5X5m27tq7fmVmqvHC0k26dmaDd91V+arEEjNIsny7f7rNubd93/P+9Tmkhj3NIq7mX5vmo+IPhK08cMbNtVmVV+X+Ko9y7VaTb8y/wAK/eoWSNZmVZFaPd8rbm+ajcqqyqrMy/xUhla9VVZVZmb+FflqPax53NTol8ySTcyszKyt833W/wBmo/OaP5dy8VYHZNCrbpo1j2qvyr/CrVGsLNJ/CrL/ALXy0m3yW3Kqs392pUjhWFmkhZZWbcqqy7d1QL4SNlbzGXczfxbdtE7eSy+fCvy/3W+7UjbpG+Xayt8u1W+apfs6yLun3L8u1d3zM3/j1L3glKP2iBZFupFbcsci/K0a/wAVRM21Zt0aqqt83zfd/wA7qF/d3DQrCzbV3blWpYFaTcvzbW+9uX71SMhWSORdrRssbNt+b+9UU8M0kbQrH977u1vmarcDR2cbeau5vu7d3y0LJuVptu1d21V/iqxfa90qafta3VVh3eS21lZt22pJ2hWRoWXb/dZv4ahWRVXy/uszfKy/w/71SXc25VZfvbtu5tu2o5iuX3gVWZmZplWNY/l+X71R2y3Elu3nrDuZmZWVfur/AHamRttwvn7W8zd8qq21qhtJFaNmWRY9v3VVfl20SKj/ADEasyr8q/Mv8Tfdpt2y7Y23KrbtzbadtZo9zMqqv3V/ib/aqBm2w7mZV3NtVWX71ZyNojZW/eKzMsjL/D/EtTMzNZqyyKu75m2r/DUKLtk86BVaRl/75q2sbNattVfM3fMqt8tVEJEbQzNb7YmjVmX5dzNtaop2VbmHy1bdt+b5t3zfd+Wp2kWO3jWdfMmZtyt/Cq07y90bXCrDujXdub/7Gqj7wc3KN+yszeSyr+82r95t23/aqpcssLeWrL8rKvlq25dy/dqa0hWSaRrm6k3N8y7V+VfvfL/6DTm2yTKrQsqqu5mX5WZv/iaPdCPNEjgkuJN00rL5n8St83+7Tp7Oaa4Vt0aqv3Wbd96iC4kjaaGTy4WXczbl3L/vL/3zU8Cqsysy7mXdt3NtX5v9mgJDZ2a3hVmW2b5trSKv3WqSBWmj+ZYLhl2syq21mX/a/u/+PUT7WVlWZdv91V21AzRrdQs1vdzR7lVt3yq33fm+X+HdtqvtBIlnjmupF2qscKsq7Wbd8v8Au1Zn3QqvmTRxrH8q7o1X5f4mqizKu6Zo41Zm2rG0jbVX/wBC3VOqwtJG235m+ZWk+6zf3WquYnlkFpuWNW8tpl3fNIsbKrL/AHf7tTSqsass1qy7m/1cMi7l/wBpqju5mkVla4hjZl3L9n+6tQxMrTSSW00zblVfm2qzM3+1/FR8JPvS94tQMvlszLdrubbuVvlVdv8Ad/vVHJGyyKyyXa/N96Zt38P91f8AZqzaKy/vPOmZlX+GHd838LVBPJcLNuVpG3btzSKrf98rRKXukxjzSJ1kWFVbybtf4VmX+L/vqomutrNHAsnnbfl3TKv/AH18tPVYW+a5VlVdrK0ny7f9natWrRt26ZWtlZdzKyqzN/31VR5iZSj9ooLJ9nVVa4aZWXb8sO77393d93/gNW2uJmkX7NJMrKqr5aqu1f7vzbdu6nQSTSQ7o4WWZflVljZd27/eqdmjXasjXbSK25mVfvN935ttVEzkUotPhjnaa/VpL2Zvm/iVvvfN/tVdgWSNma2juFZV2qqqrbf97d93+KqUitNdK0ax7WVlXzJGWmPbtcfu4YWm8tf3jRyKqr/dojIOU0II7pmZp5IZPl2qsyru/vbqiXVmt5Gja6aNZNqssK//ALXzfLUN3atHCzLCyr/y0mbbu/3V20ybascNutstvtVd21fmZf7zVMpSiEYxkPlhW6kVlhmaCP5vlVfmX+9uoa4t2m/0KGZW27VVW3bf7zNQ0jNbqs812zMu3av3fl+7U09xIqqqrBGqrt+VdrLuo5glzFOTbGqxxw7mZtu1l/8AZak8uZWa3Zo2X5W+VWX/AL6apIJFjmXzFZp1VmVo2/i/2v8Avqo52ZZGVm+aTcu1m+apj7pUvekCqq2bQ3KxrGrbl8uPaq/L97+9TVaO3ZVtNy+YrKqrG26nT/LHGsCrGysu7czMzUydmVdqzK235mVVbcv+yzUSCJC21drSKu77u1d25aavmfZ13M0n+0zfKtSQRrGrbo5JpGZtvzfKtOWZmjaNmZmb7rN91amMglErtGzNu8xfPVW2+Wu7c3+01QXce2aOOfarbfu/3qttG0bMvnRtt2/6v/x6oWbdH8u5mX+JqqQR+L3SCe3k2qscKtuX+Ffm2025s4ZFXc25lXc38NTtJIy7d0it/db73+7UDXCrI0LMyyKq7v7u1qPdD3hs+2GFVZY22tuVY/vf71VmkZlWOCHazNU6tG0K+WrKyt8zN/CtOtLiFdsLQ7mb5t23dtX/ANloj8QS92JWi2q3yrtZvvf+zUwx8/eWnyyMrNu+VV/hVfmqH7Q3+1/3zQM7H5oW2+Wq7l+Xb8zNUKtukZZ5G3Mu5Vb722plZo5F3MyrJuVfl3f8Cps7TRsvmbm2/L96pkKI2CFY7hmn2+W33WX73+7R8rN827b97czVJCqyK0c6x7Y/m/2mZv4qrz+Ytxtbdt/hZv8Adqeb3Q5feC7umjX5mWFlbbu+81On3M3lx7tqru3Kv3acsayLu2tIqsy7v7zfeqSdZJlVoI2VW+Vo1bav+9VhH4ihqWn/AG7TVhZmWTcrfK33drfLuqdFVmZZ1kX7u5m/iqSdt1vt3fMrU2O43MsbM25V+8y/eal/dD3viHeXtVVWFdzfKu5fvfNUbLukVdqrHG21m2/8B21Myq0m7b++/wB77tVYmaOSdWbzNzbv91qYe8STxszbVbayt92oII1VVhgbbt3M277tTq26Tcqsu5dzM3/oNRxsscnmMvltu2r/ALVQaR92IMqyNI21W27V3f8AxNVII/8AnvD8u35d33qvrHNHbqrKrKzfMrfe+aiKOFlZWVlZV2/N/FRIqMilaNGzTxzQ7V8zbtbbu/3lp0SttaOTcv3W2r/FTnVlVmX5tv3f9r/eqWRlaNfLkbzNtZ/aNPslSf8AeLujj2sv8LL8zf71Nu13bVaNtu5Vb5du5quq0itHuZdv8SqvzUxo/Muo9zN8rbtrfxNRH3Q5h8sO5lVVZd33dzVFAsjTMreXtVWb/wCJ+ap1j86ZlabdG3y7du3c3/stNvZGjkjt1jX5W27f73y/+O1p/eAqLJHCsjNH+8+ZlWOPc23/AGai0vWIdW0mHULK3m+b5dsyr8u1mWtKCPbMrLuh2t95m2/+O1NFHDCrRxMrRxt83lr97d/+1R9kmUveKUcP7tdzRss3yqvl7VX/AGt1S3a3FqqruXay7dyszf8AjtM+ztJcbp7hVVVbarMyqv3d1W52a4tdqxrJt+bdG392q+yHN7xWePyWVvL3SKrKzMu771W0tWjZWZbSNVVdu5m3My1VljXarKrSfN8zMzVMlq3meYsM237vzSLu3URCRDqkm2ZVZVVmb5tsf3f+BbaikuF8tV2yMy7WXdGqsu6p52uLddrNtb+Ftqt/s0z+z1jbc0m6T5d235mZv/QamUpfZCMY/aJYLi6kt5F+1KsG75mWH73+z/s0NHIrMqwwsqruVm3bmaratIqrtk2x7d27b/8AE0ySGSZVh3Mq7VWNlVV3VZn8PwleK+8tWXy2WZmXarN8zf8AAf71WFvLq6ZV+ywwqqsqqzbWb/4r5qjW1t4WZpJNsnmbt27c1Sz3Ekaxw/aI42k3bVZVZtu7/vmrjKX2jOUY83wiM0zKrNu+ZtvzSKqr/wCzVXkuGt2WO28uaZm2rHGzMu37u7d/wKhrdmm3MyqrfdZm3f8AjtWLZljmkWPc0KqytJ8q7tv8XzUc3vFcvKRq0kjeXJbtuXa0nzKqr/7NUdzHCu5lZYYW/hVWVd3+zVj7Qvls1tMzKyr8zL8qt/d/2qFkaHbIt5HIy/Mqsu5l+X5v9mq93lJ97mF+zwxx/KsjTsu5mbcqt/wL+Gs/yYbdt3zMzfN5jNuXbVt5JrhWVbhVhZtsjbWZtu3+JaasMNru3XCyMrfe8tmX/Py1nL3vhKjzR+KQ1lhkWPbIrKu1VVVb726nQbY22yND8rbmVl+9/s05pJGWPbIscCqvzbVXav8Au1IskbXm1ZPM+Xc0zQ7tzLSJlKQrTM0jTNJbQqv3lVvmai7jh8xpraZmkb+Jl+63+9USKslxIyqzMrM27aq/980QRzSW7NOu2NfvKrLT5jPljzcxIslqyxqt5M0m394qr/F/d3VXnmkVlVWVVZl/1a7tu7+Ki2WPy28mzaNVZl8ybb+8+Zvm+WnKzTSbdrbtu5VjXbtqpBGP2hrWrKyzM0zKvzLu+VWb+GmrGy2+5mVWZvu7vmqSdbqS3WSdm2r8qq33qha4mt2nVVXcy/e27tvy1Pule8QKrLHOqzMyyfebaq7dtNZVVVZWb5fvf7VOn2rawtNNubdtZVX5lqs0km7asi7W+6qr92iRUY8xP5bM25flb733vmqlctG1wrNt3Mu1dy/M1WFVbe32q0kkzfeZl+Vab5iqu5d26P8AiqZBGJWaTcqqu3cy/MqrTVZo9yqy7mX5m+83+7Vt5GZmkWTczfxMtUtsiyMyzKzf3mXbTGQqs1xdNN+7WDb8zbvm/wA/ep22H+9/47V2ORVWTcytI3zbv71Utyfww8UwOtaONty/dZW2r81SSs25Wj27lb+995qGVWVW3KzMu7+JajtpN0m6e38mRW2rub5mX+9SAjkkhby/Pj2svzM26rKSSTfLHIqsqtt3fLTmt/LZpPL2qzbdtVoGjVWhg3Kyt95v4qXvC92URySMszLA3yrtbb/DRJdNHI277zLtbbS3KzMzLuVWjX5mVdu6omjaNZGVlZpPvK1T7xUYxJJVZZlWTasbL8u373+fmWpXaZVXy4VZmX5v4qig/dx/Ku5vl2t97b/u0QeY25l+Vlb5mZvl3VXMTKIq2/mNuXcrfxN97d/u1AvlxrIyqzMrbdtTK0kbLGrbmX73y/eqXbCzSLbKsjbfvL/D/n/4qp+IOblkVpI/3bMysrMvzbqrTs0it8u5oflZl+X/AD96rKrGsm6dvLZl/u1HuVZPLjZmb+JVb73+1QUE8bLbqys3kqu1m3bmZv7tEDLJCrSNuVm+b5fm3f7tEK/aJJIfJ8xtu5WZvu0Rblbay/vF/u1JoNaP5WaOPczfK235aZArMyru2s3y7WWrMjN5f3WVmbazbdtRwW7XF5tgVpNvzbmbbQVze6NZfs7Ms6ruX5dytUSxsrfLu3fwtu21POqrJ+7jZWVtrNt3bqayzKzNtbb95f7q1JUfhKUF9HcahJbr+7mtWXcqtt3N97c3+9Vu0VmZl2/N/EzLu+aqk8as0kkEKrIzLubau5qmaNl2tuZlZv4fl3N/7NRze8EY+6WVVluGVmaRV+VVZdq7v87qjnjmmZljkVdzfeVf4f7tW4LhpPm3Mqq23b/C3+9u/iqBma4uNyzLGu75mZf/AB3/AMdrQzGWFxDdSSL9nbd92RmXd935tv8Avfw09o4/utCyqrN80jbV+ahZFWZo1ZWkb7y/Nt+996pFkjX5ZFmaRt3yq3y0c3MHLykcskduq/MzfNu2q3y7qsW0ayMrT/NIvzNtk+Vf7q/+g1C9u00kfmMu3d91W2s3/AqtwW7Mqt5cLRr8zbm3LREmUvdK0yq0O77OrL8ysyt95v8Aa3UM3mNt3Mqs25VVVb/x6rLNHGy+esLL/dVvus1N8uNWVlVW3fN8vyrRIqMiJY1Vo2aNVVfvNuZW/wC+aJFhZmjaFlj2/L+++833tv8Au1JBC0jMy2qsy7tu5tyr/wDFU9Y/OhVZ7VWZW+83zKrfw0RJlIjtrWRlZWjWPczMqs38NTNayNH5awrtj+ZW3Kv/AH1UKyLHtWSSHav3tq7l/wA/dq01nJcSKtz5LNt+ZY/m/wA7fmqomdSRXaaaSGNbm6Vbfczfu9rfdpk8i71mjVrr5fmjaHau3/a205lVY2jjVl27mVVjVmanrdLGzRrHMqsv3Wk27f8AequYI/3SiYd13DdNBJcWv8UKrtVf+BVZW3jt1kjhZWZm3eX8zeX/ALLN/wB81L9qZrdm8y4ZV27Vj+63/Av7tSQ3ENwzQrceSzL8zMvzf8B21pGMQlKRWhWRY42Zmmh2/MzR7d23+FqnkaZt7Nbx26yL8qqy/wC78y01bW1VVVmkVlbdukZlXd/u02eO1kWOTcrbVZV+X+Kpl8JMfiIItzNuuZm8zb8zL/dqeBVkk/cwrDH/AL33v4f+BfLTFVWuP3Csq7drM3y7qnWOSSRVZlaNd275vlX/AGaziVIay+cqzSNbQsrMvkr/ABf7TVU8uOZtysu5VXdt/iqdZIbWNdyxszf3vmqRZFkVZLaOZYf4mb5V3f5Wq92Rn70SBFbzJFaNmVl+Vmb/ANlobyVVVbczL821W/8AHqazNNHt+ZWZm3SN83y/3fmp0/k/Z9qxyM397dtqeY05RrLG0a/Ky/N8zM3zfNVZlZo/LVtqs25mVqLaS3jmaOeNppNvyqzfKv8AtUsS7d21VVWb5dzfe/3aPiD4ZcpEqqscMaqvzMysy/MzVA21Y9u3av8AeZqnWNY5v4drfNtWpJLfcrLAqqzKy/Mv+1TGVGjk8tVXaqs3yyMu7bTZFVZFZm3L/Cqrt3U6WNY4V8tWkkVvmbd8tQtbtcN8sjbdvzbW+WgAnk2q3lszQL/DtqvLJujVm+7J/D/FVpWj27Y1Zl/vVHPtaPcsys27dtpSGUpI2abcrbY/m+Xb95v96m/aP9pl9qs3Mit5bbt3zbf/ANqm+X/sr/3zTA69reTcu7ayqu5dv3l/ztqNo/tCtJAy7l/ib7tSRK21drLt2/d+8zfd+am+dJDJ8u1o9vzKq1EiY8xHtZlhWdtzM38TfdqxPHC1wyx/KzL8qr/eqs0KtuaFWZfvbf4qlWRY2VlZlZlbav8An/gNBX2vdImVm/5eGX5drK3zVLeqsir5G5W2/NuqtO0i28jQR7m+7uXa1Sq0kkayN95V3M237tBX2h2nt97+FlXcrNTdzXDMu7arfN/tNTFVtrNIrLub5fl+Vvl/8dqe5aFYY5JNyt93y1+aiPwky92RFuVVb5mVWX7zLu/4DVfaq27LuZmkX5trMq1dnjZoY1Zl2su75fmqNpGjhWGNdzfd3UfCEeWRBaLI0m2dlkVv7rfKtNuWVrj93Cq7fvMv+f71SfLHt3fKzN/Cv3qlZdq/Mqq237qstBXu83MUVaNl/dqzSMv8NT7YVVpN379V2szf3acu6GHaqszbtzbv4adJIsiqzL/s7VqQ5uYay+ZIrMqsqttVt21d33dtDXHkwrHBG3zN95f4f87aa0ccaqsG7azbmVqa3mL935dvy/7NHNylcvMN8to93ls3zfe2tUyxq0iqskjL95vl2qu6iVY2t42bzvOVvur91v4f+BUeY21t25W/ur83/j1HKHMR3arHGqq3mKv8Kr92pGk8yNY1ZV/753LTZWaNt3mbmZfl3LUO5m3bdsm7/Z+6tUVyjmWZflVo2Vm+833dv96pIPlkbyGZlVfm3LTYmj2szKqrH93duokWONdrMrKzfKqr8tBMiVm85dsDMvl/e2r96omVlhVZGZdu5l+X5qkgVY1aNV2rt3bVb71TsvmM0jRsqt/CzbloDm5SJYZpo2jkVV+X7u75mqzFIqqy28K/N8qszfd/3qb5e2b/AFa/d3Ku7duqNvlbasbbdu5VVflb/gVHwk/EIqsk6wqiyLIrM0m1WVf/AGb/AHfloaOSSNpGVpF/ibbtX/gVEbM1wsKqy7m+9tqzKqtuhgWTaq/Mqs21f7tHxBL3ZBbQq1usclw0LMrbVVvu7V/8eqJWaRmjWP8Ad7l+9HtX/vr/AL6qdreFWVZ5Gbd8y7tyru/+KonVbi4Vbbcyqv8AE3y0SM/tECK0bMzLabVb5tvy7m/3v4qnVWuI93kwqyruZvM+Zv71OjkkjhbyIYZGZvvN8qr/ALrU+O3XarXatIqqzfKyqtVEmQ1vvbWbyV27tyqq/wDj1VIVVRthWRvm3Nu27f8Ax6pmaFY28yFdrNt2yMyqq1FHGrKy2yqyqvzN5jbv++d3zVUioltvO3Ks80bKzf6tflX/AMd/3qa0kduqtaLaQt825V+Zm/vbqhW3hVvmaRmZvlX/AJZ/eoaNmVpFaFVb7v8AeZf8/wDoVVzSM+WJJLcTSSL9mVY52+60zfKq1BbSSWzSR7oWkbcrSR/N8v8As1O1uscjSSRsrMv3mbczf/E1G0bW/lwqrLu/utu/i+7UylIqPL8I2BlaZlkWaZW+Xarbfmp08bWrfvYVVl+60jfd/wC+abJ9oa62yM1uyqrLubc3+flqxd7pIYtzK0jbtyqzMzUcvuk83ve6Qtb27bVVlmm/iWP7q/7u3/gVNZWaNWaRvvfLC33tv+9UiyfZ7dlW3jjWRdvy/M1Nlt2XarTKrfeZW+Xb/F8zUB/iI1tW85VjWNdy7vmb5V/vf8CprRxyKysyrtb7q/eakn+b5YlVdrN8396o4JlWZfIhVdq/eZfm/io90rlkRsscbMqxqvzbm+b5qFhZtzMyqyt8qs1SN5LSMysqtu+aZV/iqNrdVbzGZmZvuq3/AKFU8ppzDVba25flZV+9t+VaYyqzbp23Kv8Adb5manwbbiby52aOFf4VX5mqJreNW/cMyxsq7t3+fmqok/DIjWRvJZVVY1b+Lb/n+9VRLfzGbcyqu75m/wBmprtl8tljZtrfK1V1b5fL2szf7K1MpfZNI+77xJPHGu1fO8xW/hVvm+7ULNHHtWddvzfLUytCs23btbb93d/FUM8e2Rmbarfe3NTJiRNcQxs0jMzN95V20RTPJGrKq4P+zVdmX5m2qzfMq7l3LuqUM2P4f++qXMHKdb5yyfdZVb5v96nXKx2+1Y2ZmZd27/apkeBKzEcMuxl/vH1ouyGaNQoHljKnvuXOG/8AHRU/ZCPxCWkkix7lk2/w/MtOaNpGkafav8K/3qt2tul3A6tlGIzvXrVG0KyzR+YpLBAAQcdKP7oc3vSkTzq0dnNCqtt27m3f3fvVDBu8tVZWZm+X5Wq3A/nrJI2QV7Z60trCsymQkriPfgetEveJjIjaRlVlmVW3fKrbvlVaqLJutY4VVVZW+b5fvVMWJgjO1P8Aa4+9TSzQQMYNqnbvXcu7aaObmNOUjl86Nm2rtX/2Wm7ZJI1VdzKvzNu+Wq2l3crafbSTFWdk3vtG0M397Fa6kSWiyOPvDG1TgCp+0EpRjErNJIrKvzfN8q01lZpmZY/lVdrNuqzJEv7piXyWwcNUF8AkIl5IVuU3HDfWgCtOrKzMytuZfvbvvVIsbNCrKy/d/wCBLTbmWSNJQhXh8DK9qlMTSW+4yMAy8KBwKkogVmjmZm/efNtVakbzGhWSTdt3bl+7SGIBBH6HOQKbAVeOPeGKn5MFu/rVAPgbzFkWBlhb+Lc27+7UayNGrRqyszNtZl/4DT5pUyAsQUgYzmktFHlsSCW3feBqeYrlGr5jQ7VVZFj2t8396olZtyr5bK0jbW2t91f/ALGrlsTI0ig7Uxggd6SVRbRSKgBO5drEfd3daoP7o1pGVp1ljVW+6rN91lpsdwy26/dXcvy7vvU6a3UEltrAvnBWmhQIi7YyhyAvyin7wuSI6Nlt23Tru+ZflZt25vlX/vn+KrcazeS26FY1Zfut/Dt/2qp2KCYr5nLbtwYcEfNU8gXyBOwLK4ztJ5H404yIlElaNlhVtq7Y/l3L92oJ2ZlVVXau5W+Zvu1TvpAxKbeUGEyflX/gNXkANvErAHO3PGB+VEgjyhPcNtj2ttVflVlVVWr0VxI0KxwfLt+8235vu1SnKxWU0xjRnVd6jGBn39atWjxsCyxlSZhEPnOAT3x/SiPN9kmUo/CNZrjEatCzTM27c0nzf71RsrW8zLO0e3dt2t825Wq3LEqSD75ZyxJ3VGsSQbjENvMZ4P8AebmgUeYWO1ZVVbyRreGSNtv3WVV/utVdmjt5Pl3KrNuVWVfl/wB2rCRx+Ql228uW4XfwKbIFmd9285bPLZNVKXu+6RCPve8NtvJkkaZlaZo/9XCzbtrf3m/76qVdzbVVY2Vm/wBYq/7NOt3aUIsTGKN5duBywH+9VkxFpkVpXYBe+P8ACqj7xMvdKku2Nds8zSbVb5VXbt/3qzWb/SFZVaPb95Y2+Vv96ppL8xMIPKRldcndyNv931/XHtV9IJXs7uSKfy0VgpUICSMZGD25xVSiTTqEMMcMi7VhaaZfmaRpNqqtNdpI4fMaGFmZtrM33ValidpBbgEBZF+VSM7fr61IZYp5ktfs6KAu8sP4j9KAkVo2VpmVodu5flkZvl3f7v8A3zRBH5jLHGq/3trNtWo5Ihd6a5LPG1uyTqynksPX1qRijv8AMmXST5nJ5c+pqZR90qMve5YkMluyszRsqqzfvGWpII1hjZtqtu3bWZv4qbLwJFAGxNsgxncD7HPFR3Mi28MoKs5+Tq3y5bG449+fzqeX3ipVI8vvCozM0jRwqqsvzbfm3VXaPy2VmjaFZG+Xcy7v93b/AA1bvoz5w2FVMI8wfLkHrxycj7o71E0T+aoEpLONxdxuOPSmEf7oTrDDaqq27blZt3mN/wCO/wC7VeX5lZlZfl+8rNVmdsuINqsjqGJcbj0yaq/dmfP8YwNpI28E+vv2xSl/dKj/AHiuzbm3MzKu75tq/wCf9mhZIWm/d7pFhbayt/C22pbiRowibmOMIDn8z+n61HYRSTW93I8x/dtwAOv3evrRHmiVLlkRMzMzKsaqrbWVlbdt/wCA1FBut28xpGVW+Vvl3f3aPP2wZC/em8sDjH1PGT9M06SMs3zFSvy7V2/do+0TGUZR90hkVpLpmVmVdq7dy/Mv/AqjlZpl2szNu/8AQqnMzGPdgAyL27UT7reFeQRySACAfTvTKKLQssLKzblX7qr/ABU6K3Xy1+9/31UxBdpGbGV6YHfOP5Zqt5y/88z/AN9UAf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A closer view of erythema marginatum in a patient with acute rheumatic fever.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Binotto, MA, Guilherme, L, Tanaka, AC. Rheumatic fever. Images Paediatr Cardiol 2002; 11:12. Copyright &copy; 2002 Images in Paediatric Cardiology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8070=[""].join("\n");
var outline_f7_56_8070=null;
var title_f7_56_8071="Saprophytic aspergillus CT I";
var content_f7_56_8071=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F64248%7EPULM%2F77086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F64248%7EPULM%2F77086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspergilloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 363px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Small fungus ball due to saprophytic Aspergillus fumigatus. Incidental note is made of an aortic arch aneurysm. CT scan shows a thin-walled left upper lobe cavity with a small nodular mass in the dorsal aspect of the cavity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspergilloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 363px; height: 350px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFeAWsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5ctTiQH8K1lBwcH9Pesm0GZQD6962F6c9O/50AIB9elGOOfz60qjnv0o6dM5oAUD8eP6UvOCe9A9fSlxyR/KgBo9DSkHnv+lLjr16e9KeSQeo7UANHUZ9aDx0z19KcB0+vFLgHpQAzJ34AFOVTkelPCnjqKXGDmgBhXGDz/jSk+mRQTg0AdulAAc8jJoGT0/WlHTgHP0pdvBHNADWXdkZOOaFAwMZ/n3p5XBOaUDoeooAbjgZyPoKMevTOM08gYGfxpyx5z1Az6UARFcjB6cU9Rt/yaecAAbuas2Wm3t+4Wytbi4Y44ijZ/5UAUlIB55pSWPTK+wHtXXaf8OvFd9t8nQ9RAYcM9rIo5H0roLP4LeLJ4wfs8UWR0k3gjj6UAeYkvwS7Yx+dNK8HJOTXrr/AAI8VqpO6zY88Auf/Zazr74N+K7Tfi0M3GT5SOx6D2oA8yZffrSY5rsrr4d+LLcnd4f1ZvdLOQj+VZF14Y1y2I+1aPqMOD/y0tpFH6igDEwQePWk2+n5VbmtpYiRLG6EHGGGDUJ2nOWHTpmgCLGDxmkK4wegx+VTYBGcim7AByCM85NAEBBIyc5x0p2OCM9T70/aAPSkI6nPOaAIypyc+lIRlR364PPNTHkYbP1pCuOh554xQBAwwR1/Omkde/PNTFDwQDzTWUjOf5UAMABOGAKngg55qHVtINrbx3ls/m2j4DHGPKc5Ow85PA61ORjrk1u+GQl99o0mcFku02xA5P73ouPfkj8aAOFoqa8tpLSd4pBypIz2OKhoAKKKKACiiigCxZDMvOMe9a4HXgGsqw/1tag4zQA4jGM9KAOMY79aMcj6Uf3RigA/linY5OB+lN45HFPxzQA1dxXLYyRzjmnkH8OaTHoOKdjHUD8aAEVfXr9KeAemBSAHHQf5NHfPFADsc+/0pnccc0pBJPTHekx7YFAC46YFAHHTt6U7HI4pVXjPb1oAQr14Bz2p2M9MZPenbCRyOe3FTWdpLO4SCMux7KKAIAvPSnxxsW+UZ9OK77w18K/Emt7ZEsxDCeS0rqv5AmvY/Cfwd0bQmjuNblj1NwP9SbcBQeO4c5/+vQB866H4c1TW7pbfS7GWeYnoAFA5x1bA/WvU/DfwF1a6VH126j01cjdFtWVsZ9VfFe62wsdPi8nTLKC2jTp5cYBGTSkTzs2DyT9QOaAOQ0T4X+ENEQN9ka8lAGWnO5fyPSurt4NNsyDp2k2VuQAMxwKv8uPx61LFbjgn5sgcBenpmrK2jK2FVVzjqP8A6/vQBC11cMMAKMjjCjpSRm5cZO4+2Ac8f/Wq+tugIUgFunTH41J5alADHyRg5A9ORQBneVcEkty5YjA/LrmmmCVRhTgYPQj09M1qGFckYxjI5A9KHtyxYeWNpGQcdaAMstcI2CRsznoD3B/yKjluZWfbJbwy54O6FTn8/wAK0/sO0kgkAnJIA9e9QyW3Aw5wOvy549MfjQBlPHYTEmbSNPcHnLWsZxzx2qnc6LoNyGFxoNguQOUt0GfyFb32eQsCAuevbjmmm2dQC0Sv0GPTn1z/AJzQBxl18PvB96D5ujBCef3blfX0rEvfg34PuVP2YXVs2Qc7mcdOmCa9JaLaoDwIucc49jxnNNaNTgY+YntQB4pefABXTfYeIE+b7qPaAdu58yuO1n4L+L7LzXgsY7qKPnck8QJAGc435r6Ukik3jywu0ZPI6nH/AOuhvtCjKSMCDj5TnmgD4w1TRNS0ydor2ynhkGc/uzjH1HFZrKQcFSMCvty7EVxEY7+ztruIqVKzR7sj6ev+Fee+LvhVoPiA+bpTRaRLhvkgtl2M3HB+bj/69AHzIeOf6UxAQTk5yfyrufFvw18R+G0e4ubQTWSH/XwsGXHqcdO9cSVwG4/KgBjjByAMfSnWcz211DcRHbLEwdSOxHNIAcEMB+VIVIxkUAb/AI2srW4jsLy2QiK4toy7EYxPtzIB+J/WuAdGjYq4ww6ivQLBGvfCN/CAC2nOt0BjnEhWM/yBrkr+AyR70QFx+eOcigDLooooAKKKKALWn/6zNao6d/8AJrL0/wD1nf8ACtZF5NACHkD0pcf05pwGMc0uABgcflQA0A4HpTx1NGeMUoPcY/OgBOBS+vAozyeTQfvUAAwSO4oHPH60o68E/TNKByMUAIOvoaAOB1py8k9x3p6qSRjrQA0L0qWKIswVRlj0HrxWz4d8Oahrt5HbWFu8srcgDH8zwK+hfAvwtsPDsEF7qrebqK8+XnhCR04NAHlXgj4U6vr8kc11H9lsG53sRk8Z46+te6+GPA3hvw3E3kWqXdxzmSeNHK9CB90dsV0Uly0m9ArKgOMcc8f5/KmbNxeWXdlARntjAJwB+X4fmASS3crNgfKo42oOB07CmhWeT5gSMc8+9SAKAQMAKD6GpooS8ithsKTjDfdPuPz/AE780ARLEgHzgE5z29asrb79uQ20kcDHT6VNBHFG5AJ3j72cZ59qdJNtQ4GSORjnvQAiKqLiMKARweDSuwAGSBk9+neoGuWxjGFIAHzA459KSOYyDOCF+ooAlaT5AinL5yvIBJqe3jTAZvv8HjGOnpVMXSxruLjA6nI44/8A1VnXHizQLAk3eq2KuvOw3CbumemcmgDpRIpc4j2keoHFP3j5jnJXgkEZB64/UVwN18XvCMDMrXlxKAeDFGrg/wDj31rOn+NXhbc3lm/b/egUY/8AHqAPT2xznufxH0qC7jBRpMBCPTHPP/6q8+tvjH4auHCCSaMk8NKFVeo9W4rcsvF+lauyGyu7WVscCOZWbrwODn/9dAGuJEjcbmVQWwM456//AFz+dTK24hs/LgdRWf8AaI5WYS5BJGD681dt4QIspN5p28LkflQA6JIpHSMblyo+99D3Pfj9aLnTkdw0R2rxnJ5/+t0/WkMEjlTImCVGFA5B5zk55/8Ard6cs0seAG3AduOnPSgCpJp5EZzuBxnJOe1QS2rZzuVmHGAK0/tZIIdee4J7VK0SSKXjJJPYkenegDnp4fLjcybVGCQWA44Hr75qExKTnGTg5JI4GP8A61dBMqBiTnIGRyM9Kpz2u5T5Zw3JIOOaAMKdkWLy50jnikyGhmQMGHXG09a828b/AAn0zXFlu/Dyix1Bj/x74VImyeyhRt7969WeIyScBgynp0qrJCN7qnyt3AxzzQB8ceIdEvdA1KWw1OEw3MfbIORng5BI5rNBBGO9fX/ijw/p3iuwNnrUZ3rgRTKTmPnPsD0r5m8b+ENS8J6m1texsYG5hnUhldeecjgHg8ZoAPhotvN4ttbG/YLY3ZMU+cYKgEjOfcA1y8sTwO0UoIkTAbParNvO9tPHcREiSPBBx0rY8cRD+1Uul5jureCRTwQT5KB//Hg1AHDX1v5R3j7rHoTzmqtbtwhkidMjkdaxJEaNyjjDCgBtFFFAFzTuZK2OcVj6b/rK1x7Y/P3oAOcjoeKXOeh796Oce1GcKRn9aAFzxwRmlOc+3bNJ1z604dfr2zQAmOvNL+POaFDAsS2VI4Hp+NPAzx6j1oAReTjtTkXJAHI6Yqxa2zTSqgwXY4Ck9TmvVfBXwj1TVhFdXxhtLMkEiRjuYZ7YB/pQB5hY2M1xIscKNI542oMk17F4E+Dd1eGK71+ZbazKhljViJGyM4IK4r17w74W0Lw3bJFptojSgfNNId7ZyT3HHWtkPJIc5BB5BzgCgCloOlaf4esFtNGt1hU8M4xlj61ZCPIcudpIPPfp9KnIRCgbDE4H3v5e+eKeQXiYpx754HHv9aAICVVcLyQ2OR7U9FfJ3N1PGfpU0UWwkFCeCcluM1LIohDFRnrjmgBYIVVmduh6g9jUvmJ0JHuc8dfpVFpJJTgHao428irXlrt+bG0jJGfcUALuwcZXcDk4OQOmKbJKGJG8cc8H3pjsXHY85JJ5/LFQS5jBYsueo54oAZNJtwSeTjGTytYniLxFbaHp5ubyVAoXKpuwW44AqTWdRt9L06fUL65jggiGS8jBVUZx1PHfFfM/jPxHca/q808rEQZPlpu4Uf8A66ANvxL8TNZ1iR47WX7FbluBGcNgepriri5nnYmeZpGPJLHPaokCEjc3H1oI3xjB57847UAIGwKc2QpD4Gc4HtUbjk4P5mnNjyx2wTxn6UAIzENyRmtDTdSubCRJrW4aNlII2tis2PDMO+e2afJgOoPbqPXmgD1jw18V7qJ0g1iFZ4ycFw2Mc98/hXs/hjxFp+piJrG7iYMFLKrZP0NfIS5LMeoU+tWrDUbuwmSazneKRSCCDQB9wiQsVAIzgHIbOev41DIocfKwVkGTkjgV4H4D+MUtq0Nn4gUvAOswJJJx6Aeo/Wvb9G1mw1mCK4sLmGUYAYBwSM59/wDOPegBkrbJuW+8B3GMYzU6nap5Awfp61amiWZcSYIB3Iwb/Z7/AJ1mJKsW5ZXAIYnLNnrk4zQBoXCGRA4bJXnr1/z/AJ61X5x1PfJJ/Kp4JgCY3b5TkDn1xUbxmDlTmM5wAcAUAV5ot8sbq4DKeT6jI6/lVe6t9yyGPOeT1x3+lWwcqCBhs9M80HA4IGCccZoA52WMtu5BI4GOD1rO1rTLTXNOl03V4xNaydGON0ZwQGUkHBGSa6HULdSfOGAQORyc84rNkQlFZApGOckgj/PPWgD5Y8feCr/wdqax3JWezmy0FxHnDDng5A+YADNMvbZ9Q8BW9/uBOnXH2V+ecS5Zfy2H86+l9Z0mx17TZNN1dPMtpMDJYgoeuQRz6V4GunTeE/EGoaFq7I9tNBLE5ViV3yQMIn4/us6n8KAPNXHJyRkVnapFwJRtB6N6mul8S6PPoWu32l3e03FnKYX2tuBIHUH0rIlTcrJxznGaAMCilkXY7LkHacZB4NJQBb07/WVrjBGfXn9aytN5kx65rXHSgAGOOnSlXpQAc4ORxSgYNAB1+tPCk06OIsR147133gr4cap4hm3GOS2tBkm4mjOzoen5YoA4eC1lnYJGkjP2VQSfwAr0rwn8Jtb1dEmuIvsFuwJJnVlfGf7pAr1/wx8NfD/h8h5Ivt12pOJZh0PHQfhXah5pQQrMFHGFyQKAOd8G+C9D8KJG9nbh78DDTln+bn+6SQPTgV0yLJMoA3nAAG4knAP/ANepILUEqSCR05XgH29+auCIL1znODwfWgCmluQAMFmx7jHJqxDE4wXJyMYx/KpSdsZeNmyOcAdfrTZZtoHzHOOQAaAJEVRgbevuelMaUKoAz6Adzx6VXWaRz8obtxg0xZlESmV9rMSiA9WbaTgfgP0oAt2+2ebaeVxkjmmTRvGzbx8uOvOBUtm2xHdgTgFvlUscYGR6npVySPzmHzfLtPG3nPGD+h+ufagDLYEu4XqVIAPTpU6gsUjQN8owByST/Wpls/nJMn8ODgEcHFWI4gjgqSAQc5PfNAGddkwRjIYc44BPU+wrJ1GVlkC9cjJYnvmtfUpWEgUrt28k8/57Vz2ozbS8jMQqnrg9M0AeV/GzXGSCHRoj8syZnUE4KnkAjuO1eMXAXygoUMCuMHnIx3ra8TatPrmqyXc7FpNoQDJPArI8t3iPHIwP50AVVIGOo55rQgt5Fsnl2t85AHXnjmqmzaoLZAbvWveqVgjhRyFiUHPPO5c9PxoAxyuH2t36kVZ1FY4dgidXXGSVJ71BIMlsMT1ycVG5ODnn60AELbTnbkg5FSSuGZWI7AHr1zTQFVB6n26UpByuT1OcUAOjGWKnGOoH40+4j2eVzjcgbg00KfMHXnt7Zp97xMVySijAJz0oArhuRxW94V8T6h4dvElsbiVY8jdEHIRvqO/esDOG5x60JnAJOf60AfU/gf4k6f4kt47eQmDUDwYyxyx28kYH1rr7goSzgEMOMZxivjPTr+50+6S4sp3jlToykg5x7V9E/DXxuPEkbWt2yLep0CoRvAA/DsTQB6OX8zBUYAOR1GKuQSpJEV3bDggHJrNdHgAKkshBwccZ6VLFKNuDnOPrQBYfKsFbIIJ7n1poIIB5PpzU4lWTAlByD1GRnmlFqMDYxBXtQBVUYJBPH8v84qukCruBHyk5+ntTkF0+u3Fm8LraJbxyxXO0bXcu4dPvZBACEZA+8eeKlms5YiHiZpAOvHT9aAMe/smyHjUAd8fjmuH+IHh8eItEcIgOoWmWiLk5ZQpYquOp7DivTQu7apHUAY6ViahB5Z82IEA9SMjjFAHzb4/0a4vfDkXiKZGW4t500y9V2YyNMY2k8wg9toAJ9a80YcfWvrLxF4bTV7TUVhIH2yGSIQbflNwyELJ1xkf5NfK+pW7Wt7cwSKVeKRoyCO6kj+lAGHqq52SZP93n8az63Z4hJGynnIOMjoaw3XY7KeqkigC7pv3+vY1sAYGMc1kaeMSLxyQe1bUaFzgDPbp1oAQA8Y9K2vDnh3Udeulg061kmYkZKg8V2/w6+FN/rxS81MGy04AEPJHkuCDjAyOOlfQWjadZaFZJZ6VaRRKFVXdEwZMDGTz9aAOI8E/CjSdCt4rzW3+2Xp5Eew7UOBwRk7sc/wCFekRnCKkEQiiA4wu0AfTtUixBkzKOT/nNT+WzDAG0fkKAIUiBJLFmOMY5HpVpYlEePqMY7d6ckRQE++cU5vukYB+ooAVFCkuRhiNpYg5xngH9ae7HaSCchgpyP8/SqLzMG2lhgsSe3U8D+VSO52kDHT+tAEy7ifk5J4GM4pyoAF3jqB26fl/nmiykIDRqnzZ7joOanOGx8q5PXK5xx9fxoAgZMkBTsBABwKq/Zobi2aKT5oZByOeR1/nj+dayxx7QQABgcelRW8RaScNDJGInCK0gUrKNincuD0yxXnB3I3HQkAktoBFH/FkcfMSSeOpJ61MG+Vsggj72fXApScoSfzIqlLNuJ2rtjAwBj2oAt7gWf7u3GMnvUg5OBnryeazlbgk8AjPTtirkBLRDcOhx/KgDJu4zLcs4fkAqG25wDj+tch8THew8IanKjYkSMYYAj+IdK9GaFCPuqATnOB1z0rzX43oR4KvcBQOMn/gWaAPmLzOMJjLYOfxqNG+cckY5zim87ARjGPSkRSWJGeOue1AGrazszRRXG1o88Z44qteSGSdznCnaAB7DH9Kh5wOc/wBKJMhAcrg9MCgCPJUuB6EfhTSihWYsSfTFSyrg546HPHWomOWPTNAAF9euM9KeVBCjHbJ4PrShcMNw6jtQwKuQOh9vegBWZvO3ZyelIE3MfXFSLliFKcjocc9av6dEstzGpCZbAzigDHIKn05xxmlfgLgnH/1qkl2rcOijOCRyPc0yMFmCgdKAGRoSvyngdfpWnouqXGkapFdWchSaPOCM9wQf0NUNoXqc9f5UmFDnaCQPxoA+zfC2r23iTRIrqLBVywIH8PJHrUs1q0UnU5JOOuCO1eG/AXxSmnanNpt64EEynYT2fgAfqa+gpkMqOjcSLkqQeKAKKOQ2Cfp+dWIZtpOTnnJFQheoPt1HvUaDbIx2jB46UAXbrdhZYmOMDI5wKfZNK6jzsgt0B9KhglEJKsgKkDoPf61dX96qsmCD6/j70AQ3qHy1KZ4659KzZ1EkDo2c4PQHpir80oKiJGy44YjHB/GqezAIx2PGMdqAMC2lFvfssefkfbypHzbQRjPUc9R7184fHbQ00bx9eG2jK2tyizKcHlmUF/8Ax4/rX0dqe1LwsqjOcnHY4715d+0paGfRPDt6kYBSS5Er4GeVh2gn8/1oA+emHX09KyrmAee5VGweeAa1nGCRgUzjvgH3FAEVjbs1xAiDc7rgL6nJFfQnwy+FDQGHVvEyKNpWRLNkVg2G/i6jt0rjvgbplnc+MbeS8tln8m0aSNGwRu3kA4Ppk19NKnmHc+cHA+UDHXpQAzyxIscUEQijjUBRGAoAxgDg9AKuQRhFGMZxzkc02DblVXOBjvnNaCIFUADb03ZxwOcEj6igBotx90gZx0YdfT/PvUxB254C59OnFKOcjacEHI444/8Ar1KY1GzKhsn5iewwcdBzz9KAKpYfMMDGOf0qJ1JDHHByPwq/MFWJ8JtAzycAYx1+nNea+KviZoeiySQCZru4G4YtzG6qR2J3ZFAHYXGxMg8849O9RpKd5YIPvd/qf8K8Jvvi3qkrObOCGJAxwcEnkjrnP6VY0L4t3SXSf2vbo8O4ZaMfMBnnjcB60Ae6JJKj5UrkHOD6/wCcU+W/MTxiWNfnITIwADyeefbH1NUNC1Wy1eyS5spVdGAJ2uCw5PXB46VpKFZcEBs8EHoaALVnPtJGDg4PTjpVmO4DR5UAtjJxxzjp/kVRVxwCoHA6DiraKXUsNrj269PagCadBJHKjvtVgV3LwQMdc5/Wqk1tKsDqrbGCbRJwSOAM/XvVtF2NwTg59MZqRsc+2QfegCnFHJJJghCmw7m7547dP736YHPFzYFCghSoHcA8UoxuJODnOSMc8U1iSowATnkDB5oAWN1fdgk7SQeMd685+Nt0kfgjUInC4JCLx3z/APWr0GAMJfmBP0Arxb9om78vSRaqwDPcK5HH3fmH9KAPAlzgfh+dWbdktmDSRhiwwV7dDVJpCjDb2xUhJf5m6mgCWZkd8om1PQkfzp8iZVQQAOByPaoYgAWY5z9alki2RK/QN/hQBFcoUZuQV/vcVEhw+SMj2PSpWG/5mPXmmqoLknPWgCdNu6JcZOfyP9ajnOJmPB5OOPepUKjlxkjpiul8KeHG1m/glkV/sSkF2JAzyOOaAK9n4evr+NprKEPCgDSOWVdoOcdSKgMMVp5kivmVF24xxmtnxhrUr3j6XpLtHZriNgoADY9/wrl7wGJYbZQSSqmT1DUAZzqzSnIGTyT/AFpNp3Dj0zVlYMSZbJGB9wg1G6qCoA9KACOF2hD8bF6nj0qJ8D7owM9Knky9uoPG3oPwqMKMfMRxyenNAFvTJ5LG8huIzh0YOp9MEEV9beENc/4SDw1YaiCRMRiUEDG8AZx7V8fswbO1gF9DxXsHwB8S/ZdVk0i8mYWlzGRCgxgTFlAPPtnpQB73cJtxKqjLc4x0/wA81Td9j7lw3PHFXYgWjZM7dp4zjP3s1m3bqyuMoGAyRxx9aALUZyQwx0HYcc//AKqa/HHO7HCn1AJqGzZZbcMCMYBB9jVnIJAUcEY680AJGhUL6tzSSlXRg4BXuNvHSnLgDtjjgkVG+OcemefpQBiawN0pOADg9vb61yHxctVvPhfrskiKWtYEeM4GQS6A8/Sus1p2F4sfkS+XsB87cm0k8bQud2R1JIA5GCTkDE8cR+f8MPEybf8Al3HYcYdD/SgD5Fk7nvz2qPIHf86lcYdh6ZqPA7Efif8A69AHr3wFiZ/FsYErxr9hLMwAJwJTxz2OMHvzxg4r6QhVpiP3bKGHQlf6H8OP5V89fs9oH8ZxA4GNOY5DY58xv1r6USJzgQqhII6tgbS3zEcdhk++B65oAWztlAGcjjnPParFwzbFj6/ju/OpZHjiHJ5A7Gm2p3vvYgk+vegB8caomOec9fpTLiZLeGSW4kCRIpZmJAAGOp/Sly2C+4FTyOcDp1/WvCPjd8RTKlx4f0iTEQKiadXB38A4HHGCSOtAFH4tfFZ724k03wtcvHaBWEs6YAkyDkqeoHNeMPJJK5LsSzHJY85/xqIsOSTz25oMgBI6++aALUTFgwBye9RpISc5Oc8U+FkMbLu2scjpUERCOdw5Vs9fegDrvCnjDUvDlwGtp28kEFo+CG5Prx3NezeEPihpesTrb3u+0lIGGkKhWOOen+ea+cBznGPp+NaGnQSzzRxQ/fbpg45oA+zIWDxxtE/ytggjBz7iljcpyjH3HbpXPfDLSdRsvC9mmr3CuSqsi9cJtGAT17V1wlCKMAe2PpQAed8gOMHOcHHp1qQEGMlDwBxmq0jlt5DdSO9KG8snZ2oAkwRu5I64AxyKc7EmNsjOTyBzj/8AXT1ZHBOQDjp+FG1S5wwwPvAnkUAERyvHr+FfN37Q9/HN4rS0gfckduu9RjhxJJn9MV9G3DC3s5HdlHloXLduOf6V8c+ONQGq+L9VuQwKS3TlDnPG4kfhzQBz+z5cnHGPSnouBnnPTqKfuUMCyAkEcE4qEyEDHbjA9KAJJF2YXuRkVtQWyXHheWTzgHikyc+nPFY8Y8wY53lvw6VqafcItpc2yjlwOC3UjP8AiaAMxtj/ADBWC9skcUpwoIz0PFWQpQEYzg9B9KIIpLm7SOFRvbhTnvigDY8IeGbrXNQRSnl2keGdxgAL6D8jXYeJ/EOmaDpP9kaY5klTKu6kfKQ3P45Har17qUXg/wALSWFsyvdzoyswPTJP59a8klVp53kLZcsXJJ6knrQBd0b/AE/XIyu7buJO4g+tU9SmS4vZ3DFQxyOf8K1/Dey0gu5RzIdqpnjBJI/rVOGxiAaW7l+TgkKaAM+HKNk7mGB+NRcuwXkgepFdM2uafDYiztLMFGCh5WY5yOuKwUmiDsZIk6ddxoAQFDEFII56/hVW5AyMfhWlE8EjDdEuO5LHmoLgwEjCgYPQHOR60AUSv7wk9O5rb8K6idL8QWd2mQYpAwOR2NY8mdxCkD2J5pYWYPwR370Afa1nMsjQzbsxyorA5B6gVntZtFqOo3S3G9bkRhFUL8oRT36kkk55xgLwDnOX8Prw6l4G0iUzBpYy4YbgcYk44x6V016xM3X5WGSN3XkigCjpeVtihyuxmGOnc9PUVb4wuRkcHBA/P9Kq2zYllRWJGfuj65qy2VKkkdPvZ7f5AoAQ7GYbieB/nikYEj3+tO53/Mc8Z+o6VGScud2NvQZ9uO1AGHrWPPOFJ4wcEZ6d+ay9fiEngTxCpVSWtyuRjJ5U/wCNaWpSE3EvzDHGOegxVHUgB4R17cwGIGJGfdaAPjmTh2PTrUQwe1TzcFvqf51Dx3Iz9aAPbP2ewT42iAPTTW6n/pq3+fx9K+nYQI4tzY3nqMkYr5n/AGcwreOoSeGXTGwcnr5jf419M3D/AC8EnjOATQBTc733EKPYtzVuEnYgBBXHJDEHP0rKmkfeARg4AyD9e1TNOyRADqBwaAOd+Kfib+wfDF28bASSKY0O8Alip/wr5Jnna4meSRtzSMWJJ5r0b42eIpdQ8QS6bHIWtrcqTycbwuD/ADrzgnZ8xGT60AQSRnkj0OPpUOTu6DrVuWYyJjioYiqXAMi5XuM9KAGRtgn1Ge9SKQUBc9ahbiQ7c8nipbghUjUc4XkZ75NAEkbBTjt6Zr3b9n3w/FIbnVbqMMw8vyMk9Crbj/L1rwSNScMOh9e9fWPwgCR+B9H2n/lgpIU9+etAHoFyx3BVYgY/vdfaoF+5jI+gNDOXYMxJ5z1po78Z5x17YFAEgPc9evH0pQw37T/F19v/AK1RO6xxvIwbCgk4UkkdeAMk/QU5skn/AB6cUAOuMxSgb8Z6Z7/SrBuEG3OSAc5z71R1C5QRhpVZiAc7QSSPYAc09pAAC3K57E+v/wCqgDz744eLf7L0FbC0ZBLckh23/MACp4HvnvXzN5jbmYnLFuoNeq/H20kk1i1ljbdHhsqM8cJj+VeUMrDIA4B96AJmw0YfbjtyahjOVznkEd+3NSwyCOPPVj0Hp70Q3CiZWmUlVB+VW25yCOo596AGLIwjAycZzjPtUkMsincpwR6HHbvUe8dApBY7QFBP8qtWdnd3ciwwQSySMPuqp9KALFluupJNzAHaXyTjNdhoNvDZ6c+oIAZEkKKc85AXp+dc9e2L6JY+Rc7PtspJ2hslBjGD+hr1v4aaBbT+Hkj1NCZzIZYwxYblKIM56ckGgDx3V9Tmvb95LpiUJ4Uk4GfSoYoy8ykkFeoAPWvQfjHoVjpt3ZtZbEY+Z5ignPGz/wCvXnBmKDC5B6Z6d6ALc2oeSrRxKM+vp1rOmuHaIqWJBxxnpzUjR5Ynb0A7VHOnzAYPIBHWgCuhAUgLyeeKeE+YbsAYGRnpU1taSzTKIoixx1/+vXWaXpen6UoutcmjZsDbGu7I46HFAFPRNAluNJmvmKRwjKrvJG5tufTBrnvIkjlcAq+SRwTWv4n1+fUpQsWYbSP7kYPHTr0FY8pw29Txjnr1oAgO1SwOCT6GkjUM/HQc9aVyJQWO1X6MFJI/OpFUCJW4ySVPJ6UAfQ/wOuvO0x7Yn5VQsMnr84NelXbgJvyCQMZz9a8h+Bcvl3IUNgMjcjPYivVdTcC3wOWI6j60AV0nAugwwAQONxHc1pKcAcjt3781gROquPX27c1tqcoeMnj1xQA4t0I4478dqguHCo2SBwTnPbBqUtt2989s9qo6nOBEUBOeuM9OKAMOQ7nOW+bvk89Kqa/MIPAXiaXd0tWb72P4lq1KcMwAAGMDn2rlvivqsekfD/UYH5OqxPbR/MeGBRiffigD5gn+83GRk96g5/2fxNSvksT35NRjIHAOKAPc/wBnT/keEIYZGlkgHP8Az2Iz+tfRtyxhW4dDLMVBZU7nA6AnHX1J79cV82fs8SMvjqBULZOnNyOeBISR/P8AP619JTL5lwoQ4JIB65xnp+tAEdtbkwmeZSpwPkYcj6//AFuKwvFGrQ6VpstxdSBFxtXg8sQcfyrqrtQbdowTtAC554/zxXgPx71phDZ6VG5+ZvOfrnIJHr70AeO3t5JeahNczkySSMWYnPJqvIyBDjv9acIiRuAPTJ+lQyqcnulAFi0iicfvWKZ6HHeoLq0ljlZiGKnOGwcEUxnIQ8kA54Ga1NGvBJILS7G+JuA3dSSOee1AGKARIMgjBPODmnhS0nzA8nnr61p3mkzw3LhoXKZJWTaQCPXNUXjkwduTznjPNAAg+dQD344r6C+AGoTeRqVndyEKvlCEMTkgI5OB9B+leCWytCVdlO4YPSvT7TX10G90e/shhZIP30a5w5JIP6YoA+kH2hlZCQm3cTgj1pq5MeRyD0GM+tYnhzxDY63aQyWsgdygZ48HKk9vStpmUDlugzg59KAJCjEHLnJ6/lSMSGIOQ3J4prSKi8yfL06VW1XUI9PsLi5kJEcYJY54A/zj9KAItYvrSxi8+9uFhhXqWB9KwLXxdous3v2Cyvt8zjAILBjyBwfXntXhvxR8a3Gvam0NvK62sbcBWIBOB2/Csj4cGT/hO9CWPcN13GDjPTcM0AfSXiDwnaa3AqXaBiM7WAPHT357da8m8T/Cia1SeazuS8Y52smCecD+le+qxWJAWPHf3qrdBZjsZgBxuz6f5xQB8g3OiXkMxiMbs+RwFOa7jRvhXdTWC3usXaafblc5IJPft68V0vjLxp4V0q+P9n2a312uDuGVVSCfUD0ry3xV451rxA6pPcyQ2q8rBEzKv5Z5oA1L/wD4RXR3MVkz6tcI335Y2SP/AMdYZ6frTIfE93FDMNMtbayLoF3wB1cDBGASxx1/z35DSbcz3KIoJyfT2r374d/Dm1uLH7ZqSsY5BhUxjIxQB4W9nql5cNcCO5uJHOS+1mz9T/npXp9x4uutN0/TYbyNYGhiVN0YbcMADuf6V7jpvh3StOtxFb2cRUZxuTJ6evrWP4p8Lafq+1JbGEgDqEGRxQB4Rrl6utwrcm8lkYZwrkk8kf4VgC1SWQIqs7k9GHHWvatQ+FUAti2nz+W6jOCpI/KuXfQtY0O5MV7p8clqW2iYRYJGf72frQBw8lhcTzpBHGockLhM7a1vFPhb+w1tvtMyySvEH2KPfH+FdBq1pY6XZG+sJy5PzSIc5jJPr369q4vWtUOuQA3M7efAqqinJzz/ADoAz3vpIQFiBXAAB5zVS4ne4AaeR3PABJJ+lPHlm1V2c+ZuCleeOOTT7W5tlXY65U45oArMu8JGPmJOFIUnt7VUkYoWQdAehyADXVafrekWYYvp/mnBwSenH0rnb2WGSd5YV+RjkKQevWgCC3gfd5ahmXpk5PH1qzIU81YlJwnGeeT61Xa4kVmCtsHT5eKfCW3qTyfYUAe0/BMsLwDeRhT6/wB4V6zqpImIXpgAH8a8p+C8ZWbeGK7lYDk/3gf8/jXqV64Mp+dgc5AIOOvPH9fWgCmVKkhug9AcdcVt27+ZGrDJ6Zxn6VmTxiSMFTuIA/HmpNJuMgxsQQOAcdetAEmpzGPZtbnHB5z9ayZ5GcguSTj1P/66s6ixeX5s4AwKpsMnIJxjGOfxoAjHzFVPpk8EYFeO/tGanIdS03Rsr5MEZulOTuJkABz2x8gxivZodi3AMp+UkJ06544r5n+MV9JefEDVFdy4tpGtVJz0QkCgDiGPBPamDnndj8DTm4z+dN49f1NAHtH7PXHju2GM7tPft/tn/Cvpy1jAuc7AAFwBjge2K+YP2f22+O7X5Q3/ABLnHQHHznn+n419S2ibY3YgEgg+lAEifveCuFBxjHpXxv8AEvVf7X8VXU8Z/djCr0r67v52ttNuJoQCy8gdMk+1fD8hMkjuQDnr3oAEwpHy5PQirDWk8kO9EAVjggkD+dRBlXIRckDJyKknnkMO4sSDwPb/ADmgAWwiiiZ7iVdwONgGc8fWmreCMMIECgZA45qgXZj05we3SnlSV4UZ7/SgC2uoSD5XwV9KkjeC4K7l3AnkVm7QeX7f40+OTao2Lx1P50AdxpkOjvHFHI7b2xuXy+OvHOa7ufwlp+s6Lb/Yd6PDtw3llsjB968e067jiuIZJIhIqsDgjPGfevatD+JOj29lDbwaa8a+WA4VVXJA9m+tAGHo1tLoDXLzIfNhhEkUq4ODnGDz6Z/Ouv0T4nxyW8cF5bs9yfl3KMg8d/eqfhZLXXL+aJ5MRXa/6sgHAJzwM1o6F8K4bC7E8tyZEBLKDGATxxkH/PFAHc6dcG8h87ywpbqCOOnTNVfFGmPrWhXmnRyKJJFZQT69OfTn8q0YLZbWELGoVATjjA6e1KIkXIhVIudxEaBQenp9KAPArb4L+JJ73F2be2tuplEqOf8AvkNmurjsPDXw0mS5uP8AiZXoQiOSKPneGHUb8AcdetepyxyyK6x5K85Pf0ryv4geE5LrEyIN5yeg9T3oA5LxJ8YtcvSyaaqWUROAyfex75zXCjxJqragL2S7keYOHJOMk5zUmq6JPbTOskYypIP51keQ/mlMZbPSgBLmQSzO+BuY7j9aiCk8Y61fTSrp3CCE7iBxxXZeEPhrqWtXUbSlbe1yCznBOOe2aALfwn8IXWq39veNBizU/O5HsD6+9fSlrDHbWqRw4CKMdO2KytH02LR9HtdO0+JFhhUKXVApkIXBY474FXonfYAQMY6fhQBcZsLgfkOwpGG9GYkK3+1zj8M1F83UqPy6U9N6OScEY6deKAAqyKMgHtn8frUMkcVxF5cihkcgEHjPNY3j3XV0Xw3PJGUa7bhFCkADcBzz6V5RpPxPvbS3SDUIImiY48xAcgZ7ktQBk/EjTbuy11rm1i3WhkZWQL90BiOlee6hALa9dYj0xjjpXsk2s2uoxSP/AKxWAyrDJP19a8q8Q27pqMkgUAvgkcfSgCgkxFuVuEjLE8FRjA9+etIfLYBVXLDpxwagfcduVxx2qMHlDgjIGR6e1AD2PLLt7EU4xkW4IAzux09qjLZY+tSuCwXbgnHp14oAZIoEp4HT8DU0A2EEAcjAqJkIYowGR7VJAAxAOPagD2r4KgEk4B+UkfXIr1C7gkaQyKoKj/GvOvg1EBbsSOkbEcf7Qr0u6Nww2QLEqrtZ2dc7gX5AGeu0Mc+w9SQAUVlZMLhcHse3PNRhwDuUrk49PrTZlLMy5x6beO/ao2zkkgE5+uOtAElw29w3X0yKrnlsFccY/SpMZClcbhxkYzTQSSRgevI/zxQBieKHePTEaMfOLuIkD0zXzb8QZfO8c+IZOu++mb82r6P8TtiOKPgFiWCkdSOa+ZPFj7/E2rNgYNzIenvQBjnvkcU0H1Bz7U49TTMj1oA9j+ABH/Ce2ZC526fJjgf3j/jX1LbZbfgkEkYJGcc8/pXyv+z+w/4T+0HcWMnp/eNfUFvKqTgYOT1796AJNQiJ02VG6MvGe9fEd/Ebe5kjz0P+Nfa2qS8omOByQcc9a+Tfifph0fxVNCoxGygr7g5oA5LDDJbpjoO1JNISNp6elWCu+3JCjjsPpUWwGPPfPtQBXIB5zT0kKEk8qRzwOacFLnCK31HNQSKVlZT1BPpQA+cK7cfLjkUqbSOOOmaaVQAFc7jnP50+BQgA7g96ALUKHygw6YrvfAPg/UtevBLDEIrRBlncLzkEgD64rjLJhK8Q2lnyAq+9fWPg2yhsvDtjCqBSYlzjHPB60AReFvC1hpAhlihIm2gncQcN7eldCHCyEOrYz36UqhQAT6Y9qVyp4PUdeeuBQANiQksuBnPIHtUos9ybjxnkA46VGqordTnPPSpTKxYhXIABC8DP40ASRpHDGygF2PpzVW5tIbg7ZEB69venySIiMzcgcdsk/wBeTSq2CMYGMnigDBvPCekzOGltEfLf3R61WPhfQ7QyFdJs/OUg5aCNiDz6ium/1hXcxYk5B4xVW7RXDk5J6nNAGRa6Ppxy39nWueORCvIz9K2LS0hgjVIYURQMhUAGevpVFJjGE7suOo5qyLwMoUISeMng4oAuSOiR5QZz8vb/AD2qrExeUKy++arqXZ8n7/U806JWSTcO3pxn1oA0yo5bbzk/ToKbIuc8dR04pFcMvyj5s98Yp6qCOB7+vFAGbeabbX6lLqBJAQRgqD1+v0rxX4q+CotLH2uxGI3ZsrkELzx6V71tGM+vaub8cWcd1otzHLnaqbs+gz2NAHzJpkk1kskhJVCehHX6Vrr5ep2u1x+8K4BwOce9Uta8ppPJRMLGxwMde2f0rY0e30+COGW7uBDkAgEgA80AcddQSW05WRchOnSqW1VmTZnB55FeoX1p4Z1OMrDfhbjIwu5Ap61w2q6Z/ZjMpIYt90gjj3oAy4oQXBk+42QcVauJCGIQBVACjIGarf3So6flUrAyA+w7YoAYV3sxHWrSxAhWwcg5pttASWJUY9K2dM0+WSaNQheJmwQKAPa/hRZrb+HobjHzS7geB0yO9dw8McX2mYBvNkVVYliRgZxhScD7x6Y/GsnwvZfYtIt4cYAXIz17Vo6i4WIpnjrzjNAGYSGcbRkkg4/GmEcj/OaQkbQN3PrS8HqccdRigB2PkX7x6cDuMUx889SO3HXinMRsGc5ABI9KiJXjI59x7UAefeNL9v8AhMbWxBIWC0unfgdRCz/4V4DrD+Zqd0+OWkY17r4oUH4k3zE/6vSr9icDtYuRXgd42Z5CT1OcYoArN0PFRkEkkICPc1I3fNV3l2sQAxA7jH+NAHsXwEOfHlkcgbbOTq3uR/WvpyNvnhY+o549e9fMPwFOPHdm2/BWyl6EZ6n2r6ctCHCDcThwevHWgC3qSFpY2BBA4PPP5V4L8fNLDQ2epjG5T5TY7knj+VfQEieZOitjPVWJ6VxXj7w4uvaW+nu20FllUk4+Zc8frQB8oxylExGee/5VfaO1+wmTe3nljhM8fyqjcwS207JKAGTgjPfFNcnYqjGc9Tx2oAhd5dpWJiPUg1GXBZg2Mkcf41diXbEVDKAQQc88YqqYNzN84CLycmgCKPczN3J9+nNWUIjOOSSemaUTOkIjhIVDwffmniFlQFlx3BoA1fD91b28qvMuWUgrkjH5Yr6G+EfiBtYspoJnxJAI9oPfIbP8q+abRW8xVHGACRj3r1nwZ4ofQ7GJYYleSYqu7PIAyOw96APfoixOBgkHHJ6fTikRJFEgeUuxYtztwBjgDAHH1561X0a8+1WUE27DsoPPXpVoEgnGAMnp9DQBIqMyFmPI7Z56dabKweRpEBUqOFyMtx0/zilDMB98jPBPr/8AWoJBJKnjtn1oAN3zMAQevTABHT8qaxPHzA8k8HryPWlY8sew96bu5+U5znJH1oAcTtUkkDBOcsB/+qowuEILMcHjLZPX1pwyMcrjPrig8jHBB/WgDPIBJUexNMjYEphs7gMcgA0+VcykjaeAP/rUiA7wSevUc0ATRybygUjnDcnB6fSrQVmQ4wSPwqOBcpz3OM59qsgsiMAx3Y9eOn+fyFADMYLHIHf/ADxSs5DYAzjgkHpSg5zg9uxoZgpJZhn3PXNADuMBgemOPxrnfEAaTT7qFuE8sgAk56j161urvCBnZS/cjOOtVdThEsDYyXHGM9qAPlHXQyalOo5KysuenepfFUPkxadEHBZ4csFPT5uKZ4sjaLxFexZy4uHGc9fmNL4maOTUoHT/AJZxqB9cCgDngrK5XJUjuDirizvJCRLIXAAAJPPFRXEu/ByA2MVWQkjOc85oAtGEhFAIwcmp4SqwFMgMQev0qKFGDLvIIJwfb61PIipNgEY9KAJ7INGHxg5685rt/BcPm30Jjbgnv3ORziua02wVpefu9vevWvhtpLQbmkP3VO3nkfSgDvYd6JGvGAMe+fyqrqMhd2DEHB/Wr7D5MhuMetY0vMsjBmO48AnIGB0A9P8AGgCLGFyuOBkc470qnc4JOffPWl5dAAenv700AiQEYP8A+o0AOcFWXtnnr0qIYOew5JP0HrUrkkg7hkYrmfiBrr6D4bmmhXM9zmFW6bflJJNAHF6jqUOp+J/FGoQN+4TS7tEfP3i1ky/zrwuQ5JOetej+HZGTwX4huC3AjMAOe7ow/HvXmzHtmgCM9Tz69KhwCSSTn2qSTkHPoaYTz0U/Uf8A1qAPX/gEgf4gWQI5+xS9c88n/Gvpe1ykjLngDGP6180/AEkfELT9qls2kw6n3/z+tfTcq7Jgf4SBk9O9AF13KrDKM5GBycDgU2/gM8KPEvzjA4z0pAc20mT05A/CpbJzt2sPbrQB86/Gfwu0GpvqltHlJjl8A9cHJP5V5O5+YhyQBX154r0iLVdOurSQbpNrbeO+3H9a+ZfFHh+XTdUliZCAGwM5oAwYtoQu+QuCPrVOWTzH27cLWvNbbbRvlztBPX2qDTrDzHErrhSepPXmgC7pGk3V9JH9mCrn+8SO/sK2vEMq6PHHZypDdSgcspJ28njJHX/GsrVruSz03ybeTY/95Dg9R/8AXrJtdZ8+AQakDLj7spzletAG5osazypLIqeW5A4zxzXeaHbyW3iO0t0tkMEgJIbODivK7a7a1fKuWTPGCR3r1b4Z67b32uWkMp+cRsBuJJ+6fWgD3OzWNNiQoFXGAn+fw/KrCk7c8nHBP4etVpisEauxIDHGMexP9KdCRIN6Z+c56nrgf4CgCzkkHtzzn19aeylRtwdp9zxTYcDhz1XA4JNTmRNzgrgDoR06f5/z1AIPvE+gycUobnjPsMmkA++VG49sk0gU/IWIGCRxnGM0AOXPAHJHXn3FMeQhW3fKATkE+5wf6/j+FBUbgCeecBj19f6U/BDdO4PU/wCc0AV0QsQxBPTHJpvl/Oc8gdqsqpznJIxjHb6/5NKR8uTjHXNAC24Oxcjr1AOR9KcSRywP+RSRZBCjkHnqeTSQSxXECSwsJY3AZGViQwI4I9RQArMFYhgSST90H/PrSkksdv3TnJ3H8qCDggZJ/wA80gP3uWP1Jz2oAG6HHTp3PFRbi5BJPXPJ688H9M/j+FSlsdcnPfFRzKdyjaR+fHNAHzV8UbQWnjC5baBlvMCn3Jrjrmd3mDncc44z2r0T43kHxUCi4/coDz7tXnhAMKk8YWgCpIoZ+mc9qn0PT5tR1KG1QfMxwTz6Gq63DI/ynpxV7Srw2k3nq2HHQ8igDUe30x7hbVb0W7uCnmlWYKxHBxjtWrr3hm4tCHjRZYxjDpnaRz615ykr+esm4lgc9TXo/h7xzLcvbaTNb78tzIz5OMYxjFAGtoOkNK6Rv/EexPGK9k0C2+z2vKqCQenFcz4c01RdebHwozkY6V3KgAKF4AzwSaAK98xSLjLZ4xn3FZZzuc8gcZJYn2/pU893HdPJ5SzKI5WhbzIXjJZTgkbgMr6MOD2JqSSLbYq2zDnqc+/FAFbLdO3p/Wo5VIxyee34VIW5LDkDHTsM1ESCFwOn6UADuGBwPmBBzntzxXI/E63S48EXzTEAx/MpbIycY/PH8q6pyNo5PNeZ/G/VIY9Ds9OSXFx5/mSRgkEKYzj+lAHn9i/k/CvxDngveWqgf995rz9zyR19a7WeRofhgF5/0q89T/Bn/GuJc53cUARMRnGfWmYzzn+dObqc5x9abuxwCPzoA9h+AHPxE08HOfsc35YJr6hnQtC3UHOR+dfLnwAOfiLpvAx9ln7f7LV9S42jGOp4+U//AKqACwmywzkkgA8GnkfZrhSCcEdx+dZzN5U/A4PbH+fStDcLi2XByQB0HP1oAh1JG2rOhBUkYABHb9e9cL408NQatGJY0HmA5LDPHFegQ/PC8D7fmBAJHTIxWV5PlStGw5yRyDQB8563Hpeg3U1pqVu0kvIwQQOnXr1rM8611bT3t9Kgb7TDvYIASWHABAHfNdn8etJuH1GK9jtw1uyH5kj5XAHUjrXkuiak+kX5mVcAjY2RzjIJ/lQBn6gZo5mjmDxsDgo4II59Kq59c9e9bWuasl87fuYShJIKxhWznnJ6msU7RnbwM0ASRysF25O3+VXNOvrixvYbm3meOVCCGHBqinOB19xWhZafcXcyJBE7liPuoTQB9LaF4pHifwc8pl2ajDCrMwJ5IHJxn3wemQTWn8O9Z/tTT3WaQPJEcEdx9Py/SuH8BeGL7S1tJZdxim2xyIEIypGT1+ldD4Q0WTRfEWqQIxe3lwwbBwvBb19xQB6VeTbFByS2ccd6rx3Qc4JY/gawDq9i8vlNdKrqQNrHHOOBV2NwwYxkMB3BzQBtxsSh2sCR1P8AX8qVmbzFB27cHJ565GAB6YLZOew65yMZZmXpw3TPWrKTEsAccnoBz1oA0gflyDnnsOnIqQdTk459CT1qtEwZPmxkjnjNSrhGzuJyem3gc+goAkQhiRuHUA8dD6YoUhSM8seBwajuJILaJp5NiKQu9yMZycDJ+pA/GpQMsp/pQBCdu9DuZdjBh1HOOD+v+FOtUjgtkht1CRRgRoirgBQOAB6Dpj2okA5x94kduelQxyFOAQRj0oAtsOv6UvcnoAMj9M1GpDEk7MdAMYJ6f4U4Y3kbQTt6baAHBeSQ3XnkHmoblgg3A4A6naePerMYDErsYAMBuI4JPp+eK5L4pa5FofhuaXftllBVQR7jP9KAPBvizq4vfFd0IX+WNvLyPZjXGrJtQckbh3qG6u3vb2WaQAhmyTj3qGSTfg9wKAHf8tE3HP06DrShhlixJ/xqLcU28deadFhvmIP4CgB1tbtPcKkQJJBPH0/+tWx4P06YeKLeUo+yNyCdp6iqti0jTeVEozhvmx7dq9N8CWcUGnTCdVF60h2gr0XaOfzzQB6z4fijVTLH8i4wQM/59K2JmMeGGevPqecHr/niqGlxqtuAuPQYHtU91k5Q844yB19aAKl2we8AG7JPoeav3+EtvLGfugnj3qhZqWu0LfwnJyO2au6owERXuemB/n2oAyiOT7j04IqJlIAI5HfjvU8YInVCvXjp71p3NqGWPywpPcBfY0Acb4u1628N6YLy6G53by4k9SQSCfbj+VfNXiDWrjWdYuL26Ys0hx82T06CvVv2g72KL+zdPV8ykCZh6YLD+teHSOcn0Ht7UAdZ4lfyPAfh62IYO81y7Hb8pG4YH1riZD1rvfisn2HULbSQMLZRqcYx/rEV/wCRFcA3Lf4UANbv/wDXppJz1pW6HpVSS7RXZTnIODxQB7J8BZNnxC01zkYtpwen9019WIC2CeoI7e9fJHwQb/iudPPIIt5+QB/c/wDr19TWV020KTkDGOBQA++BZd+1gFwOVwSPUVFYTm3k3qnBO5gMnn1/+tVwkycMjYIx2wOtUzEVn2kjPUjigDVYBl8yPj8Khv4zPEZYx+8Q8+pGKoWlwYuufLPGOPT/APXV6XMoYRyNExx+8UKSO/cEf/roAwdWtUv7OeCWNJEdSuGA7rivmXx54Wn0nUpcRERs7FcKAAPSvq+/h2SF4/ukY28cVzniPw9ba5avHNEA4RsHAzkigD49kRkYgjkHBpmCRmu+8a+DLjSbl9sZ8vc2MAeo/wAa4iS3ePO5SOfSgDe8C6Gus6lH55CwJIm4YzuyemM19S+F/DWmafp8Xl20G/aoJ8sA4xXyl4X1NtLv42yVXeueB2NfUXhHU11HTYJIZd8ZiQbQBwecn+X5UAdUwhij6KDxgcZFeatqc/h/T9cuZmWYciEnrkk/yzW148vZbe0hit22Ty4HIGQuG/rXmfiq4WLw+sG4gkkufU8E/rQB51e6ncXbtLIclzkr1963vC/izV9InaW2lMkXBaNydp6ehrklUBWYsPpj2qa2mMMm5DlT1zgg0Ae12nxOE5HnWYXnkKD17nk+td1oGsWGpGM27KCcnax5Bz06n1r5uvRH5S3VpuA6MD0B4puk6nPbXMbpI4KsG4780AfXMTkMCQMEc8dDkf571cUblYDaRxxjPGef0rzf4f8AiiHULCCG6kPngYXOOeelehWr8EbT+lAD5oI50VJ4o5FVkfDqGAYMGU89wQCD2IqYg7V2DkAcgdqZkiUKFLLjJbcOORgY98k59venKNpX7xIAwcDJPqccCgAZeCMDIPTHPSs+SOYXUgYxGDaMYB3BufX8K0jgKuO3bNVpeVPB3DpjHpQAwcEkZzUiT4A3Yxznt2qjNLtL9R6cCmGZiSBnpnHpQBpvebYz8uCvBIFeAfHbVJp7iGJlxGWcr/30PevW/EGqDT7I+X805+6CBxjFfOHxJ1efUtZeORs+SzovygY+YUAcgWK9hjPan4YBQQOaWCAu4G3PNPkIZhtHsKAHuN6IdqgqAOlLC+OiqcdjUKjB5PI9KsWyhy42k8dqALticlSqjce5HtXoPhCK4kuo92doyvt0rkdC09pWjwpxk/jxXsngrRWjWOR48Lnvg/w/44oA7jTYBDagEA9f5UPLyRgHPAOM1LINijOOM7V9eKqNuG3CfNz6dfbOP1oAuWlv8mQp74AGD19c5qvqnl+bhUUYPqeufr+FXbI7oQ7xSBiSSmBnr6dKz9RcG6frjjI44oAq+YyuGx09TnHNWFvZAQGX65/Gq0gHQHHvx61C3AwSfyoA8M+OWn3Ca4t9OcxzYC5H3evFeYWFu11exwKMs52ivcPjuhbRrBtrZ81RnHXhq8v+HUEcvjbSxLzEJwW4HA5oAn+MV8t/8Q9WuE2lWW3AwOPlt41P6g1xJ79PyqzqNw1zdSytkl26/pVV+ARj8sUARykhXPcA9qx2O9mY4BJzxV7UHxGq4+9VCgD2P4HP/wAVxpxyBiKfrzn93X04jqmACR06cZr4o8L65d6Nq9re2EuyaNSAexBBBBr37wn8W7S6aODWIVtpD1nDBU/LrQB7JaX8OXRpA8iKGKgru5BwPbOO+KlvWV9jIflK9RjI/wA81g2V9bXsaT2VxBMjKCXTkEYOBn8vX9eNBZDtwSSOORQBJAAy9MMP04qWC5CscjgMVBx/jVYthGUkYbjqOcjmmszLjJz688jigDXd0lBHY9KouRCHMhChQTk4AA7mmJKQeCAwBHXtxVt08yLLgEHqBzmgDJ1bR7TVoDHcxo3+1xwcivGPG/w9ltXkmt0JjGSMfUmvcyrRvjaFUdAO307U6Xy54fKlw6Pxx/OgD4+uNLltpykkZU59K1dCk1S1mH9nSSR7sA8Dn06ivefEXgi1vH3xjueQRzz9KztF8JjTrjdMqnPHYnvx0oA5CZJ4dMFxqUryXcgXBOOBtPBx71xWr37SBoJHYgdOnHFerfEizOm2UUzIPKf5VPrwx/pXil7MpkZssST9e1AFbbwxcYA/wpoYHJBXOM44qSK4Lo0ZwARxnr0qsyFWIOCB60AaFlcGJ2VsMjDleKsrbwrNjzY8ezDjmstCN3WnNkzFgRkEnr70Ad14auJ7S7h2KxjBGCuCOvtX0N4evVmsoGPDP2OBjnHT8hx3r5U0bV5dNlR8o+0ghHGR19K958E+OrLUrCJbhUtZRgEEjacE9qAPUEZQAByOOhBoL4wTntz6Vn2MwFtF5kwmfYAZSAN3vgdM/wBKV71DKq7uBzuBGB7UAW3kyoxlW98ccVRnmXBDHGeD3zx0qG4vWBJjOf8A9VUXmOG5HJyR6nH+AoAnmdWZh0GcE8f5zVea7ito2dm+bGMAd6gmnAfhsEg/KSBgcc4rm/EeorHE/wA3AHqM0AYnjDxAqxyykglRhV7dQK8Yv5/Pu3kcfeYn1yc11Xiq9W4giUPhiWyM/SuXgtZbqQJGAcUAQWrSPMnl+o4ArYsPD91cxiRoWOe//wBat7wp4Ymmu1DLuyQT0OBmvbtJ8NxxWMS7QWCjJ46/lQB82HQrqObb5TAHqeK3dF8K3ExAaJsHAzxXvdx4YtRKrbV3EdRj8R0q5b6bDCVUKBwBwBQBw3hnwiLZUZ4/nBznPtXoVparBFhQAB1GBzU8cQXaq4Hfk1YZDtODjtweelAFEkszKCTnJGf5c1NBCHjySCOeRj19vpU3losnljnK9hnjjvjipiSsYEY55A9uetADNvloxJG0DgYAIrn5GBlbJwD0zgVr6hL5MGF/i4GDWHIxZycnB6mgB7SJhtnXPHNVGZTjPOR27g1Y4Bb5se/Xv+tU3PzqVfAI6e2OtAHnHxukQaJZRBiTuVsnqcZFeZ+BYzG2s3vINnp8lwrf7WVUf+hV3XxunbzLOPzCV2D5OMDBbkce+PwFcfaI9j8L9S1WMgfbbxtJPPUeUkp/kKAOBbqTzimOwGdxAHfNPY8Hnn61Qv5SBsDct1HXigCnK/mSMxGCabRRQBf05syqD/OtpHZD14Pv71hacf3wFbY6YOSPegDf8NeJtS8P3iXOm3DLj7ysAwI+hBFe9+AviDY+JIkiu3itr9FAZHkXEnGSRnHPBOK+ZASjAD8qntrh4JhLBK8Ui9GRiCPp+dAH2grELtZiAO4I9KQttJG4Y6D8v/rivIfh78UoZooNM18Mshwq3LMzbjjA3cEk169G2AHThTypHRsjg0ALGXRtw6/WteGVXtskruUdAwBz/wDrrIkcqSDyMHnPP0qeC5MLbt23156ZNAGhNCGUMxx1yMj2zVKRGjYHpz2Oe9aEVwsijLZ/OllQHqo6jn8aAKcT7h83ABAxn1p+VVSjDOOeeScfh701rdlZWjGDnPU5/CnwybpY0dV2nruJx9Rx/hQBzPxC0h9X8OsI2B8n5iD1wFbp+dfMOq2z21xIrDkMQea+zTGY34BMbj5h615j8Rfh3DqMct9o0Cicne0Qzzx2xn3oA+cI4+c9BSvuYnnK+ua2NW0e6snMbwlPYg49u1ZkisCQVK8YOc0ANiibfgnjHHNLBn7UgVurd/rT4Cyzh+px/SkjcNcAhQFJzgHjrQBLcwJ5vySqT15NaWnTSwFF3YVT2Oe9YV0xExIz1/E1f06ZvNCnJRiPegD13wv4rumtRBNIscalQh3BiRgeo45zxk8Y9cDsrLWpDDuXbK4XKruC844GTXmGlWSxhPmO7YMe/NdTpTlNqlyMAc5OelAHTXOvLAB5rKpPT5hzx0qxpc8t1btcSEeWen5VmweHhqDxyXQdY8ngjnp1+ldNbaXi3WC3iIixtwpbGMY/lQBn3UO9921Sy7ijDr0GfzHH4Vw3iuO4WN5NrsqoWYKNxwBzgAZJx2r1ZNKuW3B4sYJHOeeBz/n0rUtNHjijImCng9Mn+dAHy5caPdX2uC0iAMgPQfzr13wZ8M47aNJdQlIYqchT05+lejz6TYQyrcm0i37lLyMSCu0gqfzA6Vd3vINoVtvPJzzzQBj6R4atbBVVWLL9e2e9adztto1KkYAAA/z9anmkMMXTL4yMt97n/wDVWW4edQ7s2ByFJ6e1AEMp887VXJGD/wDq/SnxwsrKTjGM7s8/lU0cYVVCg9PxpVOWHI5IznNAAqnn04IP4UAlCPmAyf1/zn86Qgrx8xBJbn6dKXO7d1z9DQASEBsBhu9OOn+FKHDKSSM5OSfr9KDypyCdvI5NZWoXWGZIwPMKkHDH/CgCvqk/mzEDnGev1/z+dUHJG/y2BORyx4Az7D+lOdsrntnr61CW75I9T/n/ADxQAm9iW3KQ3TrkHnqKgLN/s445zU0udxO1scfd5/iqhc3MdpBJcXBOxBknnnrj+lAHi3xkvDNrrIG+5ha5vxRdPYeFdJ0BWHlyeXqz8g4eSLb6Z6AUa1enxF4pQpllmmUYJJ4zzWZ44nSTxLeJET5Ns32WMkn7kfyr+goAwJWAViTkAE8H0FZM8hlkLHp29hVm+mOfLU/72P5VToAKKKKALVhzMBW4hGOOcVhWJxMOa2geOM57GgB8yjKkHgimKe/9akjIIwTwRSMu08gkY44oAfHKyMCCQR0Oa9a+GvxMk06SLT9ekaSyP3ZmLEx8ccYJI46e9eQ4B6GpAflzzmgD7PSWORPMhcSxkZDKdwPHoPrTklyXG1lx0LKefpXzR8PPiDe+GJGgnzcae+SY2BO08cjkV9C6Frmm6/bC40q5WWPaSVBw6jp8wB4oA1xIy5wGxngbjVmG7kDEPnsMehBOf5j8qz9xQkFs89gfWpDIMcHv0x70AaiSx7iwUb2OW468d6eQjHKgACsdCM7iw3HA4/GrkEzb1+fr+QoA0I3IKhyMEY5Oex/OpjGFXCjg855NVImYqG6oeBweP881KjsudrAYOOPpQBheKfCOn67bOGhQXIHyt90E4OOgrxzxj8MNStHWWygM8RHIj5wcc9/rX0CJogG3goQScDOBkZPWngmTcULEbiASOaAPkSXw/qNus5mtJAAMbtvTHWsGJNki7lI54H419rTQw3UcsUsQYMpBUg81xup/CvQ7xxJFbm2ZSSdpc559zQB8uGIzOQFIOf61t6VYsbZ5DGf3ZAz0xzXt8/ws0m2USQ73cHnIYnt6GrR8E6eImjZSc7flAY7cfjQBxXha0/tMjAzIqqM5I69MivStH8OQ27KJ18yR1BGenTng0uheFYrKQPDuHAzwa7C2tsKocEsAAGI4H+eKAKtlYJGMlCWICj0ArRgiELDauB2z/iakUYACdR1z6U4YHJOAT1JPp+VADLmVo5AQueCOM8dKFaSZcsAqds85qViC4IZMZ+bOeev9cfrSSSqqkknkdhk0ALt5zz6E5PrmmO6x5y4GSRg59ao3l4y8LuHXseRmsHVL97aIz7wFWRfM/ds21N43HgjGFyc9BigDop5VlyAeCe55NRBgeccFRznP1rDluzAqPI4jV3VEYnAYk/KBnqT2Hep47tvlGSenbrQBqZOcjONvf1pE5IKjrjPBqk2ogPggsu3A2jPPTn07frQL0bV8w5PBbGetAFvALHO76hj6dKWQgDc4AC9/TrWbJqI/hPGf6fWqV9ezSQuiOiAkFiyFwRn5hgEdRkA9jg4IGKANK8vFT5YjnPfkZ6e1YzyEkljljkioXkdmIPHOAeT2/SlySeSc9ckEGgBC5Zu459feoZH98E9BzT3YED2PHJ/nVadgu9pCwQcE4J745/z+lACTfcdpm2xjljkjAz+deLfFHxuLwCx05mEQ5Zgx5PPtWr8TPHCRQzadp0uc8MwznO4+/tXiksjSPkk5NAHVeCJIra+udUuhmCzgkXBPWSSKRY//AB4Z/CuNvrkgtI+WdznOeprpNWI0zwvZ2wJE19turgEHK+WXVB+TE/lXETStK5J6dhQBHRRRQAUUUUAWLH/XitheRyP0rGs/9cK10yR70ASA856cVKH4APPocVB3HrTgeTk8UASkLxjr9OtIWx1/Wmkcj9OKRz8wGKAJFbj5q0tH1e90e7W4sZnjde2TtPIPI9OKyR344pwbA/8ArUAe8+FvjDa3Ajt/EEKwyYw1wgO3/vkAmvTtN1Cx1i38/TLlbiLjJXK9+nODXx1uym4Dj/69W9O1C40+4Sa1kMciEFWHagD7FVQDgqvXJG3ofapFl+cHbgdOleAeHfi7qVoqR6nGt4gP32zu/mK9W8N+MNH1uNfscjwuFUbJFCc4PAwTxxQB21re7eGztBH8PtnrWjGQ6k8EY6Y9qwFboQcjqCB7VZtrlogrIuQR8q9OcdDQBoSwq8YeMqRzyOhphR0GeVz29aSG9OH3KgAYhTnPy9j/APqqwrCVDt+hJAoAdHcnz0LL8w9B7VZnugduCMHPQc9fWoPLDOcKCPSmmHKAkd+MdBQA5nRhtwuM9cVE0atvSIrHJgfN5e4HrgcjB78fSneRtIPcdsdaesfAJBPTHbvQBKu0YAZe3AU+tO8wD7pHrwKjVCCuTnAHvTxHg8ZoAC7twCAM9xzjFRNtSMs52qBuYngAYyc1KBnbtBwOOlIwIVtnDdiRxnHFADjnJBUe3FRXDhVJ/A8VITuLLsyPXHHaqOoThThASMZJ6cUAZ97NH5qo8gVnYqFPVj1+X3+npT7dUJdmO3AyDjAwO9VZIojcJO8aGVAyo+0ZTOMgH0OBn1wKTV7iW30ae4tkLMq/MoHagCpNY2Vq0U0FpbBR8kbxWwDYY4PKjOD37cZPSnlxtXBAGAcbTnBrw6P4mX2malNGseYBLkK69unrXUaV8V9PuJbePU7dk80hSY4uF5/3vpz7mgD0sPz36elMYjJzk4HSsa38T6TM8ey7QoRndtBBPoDu9aq6l430iymEcgZiFBDKARnn39qAN5hJyybCnptO7P1zjtUczFmAVQB1OVz2+teM+Jvidci5xp3yop4GPb681t6J8V7O7tANUtWS7B+9Eg2kY92z1oA9JLYHyICMkfdxxikmcHqq8+3vXEL8RdJZnJWXA5UeWB+Z389fQVz+r/FRYSRZ26kZOdy//ZUAepPtUF3O0AZzj39K8n+JvjdoWlsLJxsHBIGD1Fcp4g+IuoajEIwdi4xgZwP1rgry5e4maSQ5LHvQAXdw08zSSElm5OfrmrfhnTF1rXLWxeVII5SQ8r9EABJJ59qyS2eg/DHvVW6nHlCOJ2+Y/vAOhHGPrQBe8V6x/bGqySxKFtwFSMAY4VQo/QVi0UUAFFFFABRRRQBNaf64cVqr7Gsm14mBrTGMc0ATdQDz0p2MjI61Erc80/IoAlRh0NSMARgjDdqr5zjFSBgy7W9aAFMZXkDj1pvHXnil3GPuD60p2OOOD3oAABjgY/CgA9+tJgjpQGVsg9aAHKe2D9KmhmaJgynaarEd/wBaM4IGcmgDufDXj3VtHkQC5d4RxsZQw/WvX/CvxIsNSWOK6Z0lPUsFAzj0Br5qR8nB6j6fganhmMZDK2CD2oA+zLeZJol8o7o+5DDjj/8AVVpZDG3Q9eD6CvmPwj47vNKlVZJS0YzkED0+le3+GvF9hrUf+tUOPXA9B0oA7cX3ykhckA4GRzVqGeJ3yUKuCyjIGSM8njtx/KsLcMlgcjnHINSo5GNpO4dvxoA6I4I4OMnj86BgluA239OnFYKXJUgb/m9DjP8Aj61Mt6U+XfyMcZH+fWgDZXhSM8jAzxS9MHB6CsVbx9vXcfQADPPp9P8APao/tkvnhkA2tgtublcA9P0/Xk0AbeVBHUAcnoB9TSZRRjnpzz3rHe8c7cHGSP5VAblsE5J5x0FAGzc3SKpGcHpnjmsefEl0ZFZ/uEYz8vUdvXjr9ahMgJ2sOOmMd8fpTNy8nnAJx6/55oAd1YDq4GATjnmnRMNzIQGjfKtx15xUJZQQQwC59R602KU/aFIUFAT824dcnj9BQB8zfFLS49M8Z6jDGuyJ5GdFGBgFj6VyR+4AeRjuBzXd/GWZZPGFwN/mFRgtwMnc3XH1rgCcLjigCVLmRVVQxApJbmVwN7tj19KrFhkZ6/hRnK8UAP3kjHOc0jlsZx+VQk7VJA5x0PfimlvfrQBNvOTk9PWmMx6sf/rUwv8Ae+lMZ/zoAWRuPeoXJOetJI4wckKPXiqU9xuBVOh6k0AOuZ+DGnHZjVWiigAooooAKKKKACiiigCS3OJRWkCcDn9aykbawNXopBIMjPpz1oAsgnj2p6tkkGoFOcU/PNAEobAxkY6U7JPPH51EDkLSljkD1oAnWTrnkUEHrn9agJIz78U5ZDn60ASBjxzg/WiT2NN549acDuyD1zQA6NieCc47596TkHrTWUgjBojkJyOwoAdnp3PFOVjt5601CDjrk0eYcAEdRmgCZXI6H8c1s6Prlzp8weKRh0rDznr1zjIpQ5BPXjrQB794L+ISzqsN63OOpbr0r06zvYrtEaOQMD/CD718d213LbyBkYg9eK9H8GeNLu3eKNgXXOMcevrigD6GjlIADnp6ED8e9CyHBAzjPAyK5vQ/ES38K7onBx7euK2iXZHWEgNkY38gc+31oAsbxtB3dcEc5yfb1pwZtoycHGcZ6Z9ajWRh1Oc8+lIjHCg+vQeuaAJAxH8Qx14PXio/vD/e5II9sdKcclc9vSqzTN5oix8+0MeeMHIxn8DQBMZMDazLknAycZpC7AcYYYxnd2qMu28k4IGeD3wBUSyu8km8YBUlCp5xgdeOuc+tAEyHJUuFyGJHfHOAefbr9apa9qaaTpstzK67wp2gnqc4NO1O7GmwCZwxI+6F7cgd/qK8K+I3i251Cd4ACkYZgBx6j/CgDjPFeptqet3Vw7E73Pf3NYwfp07dO1K5BduufrUZ2r1B6etAAzgYHXjtSFsAEcZpo28YXtTXyMZPGKAEZiQMmmbs8g9fQ00kk496TdjJ/GgB7N8xyevvUUrhBljhe3eoriby+2Sc4qpLK0pyx6dB6UAOnmMhwPuj9aioooAKKKKACiiigAooooAKKKKAP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Small fungus ball due to saprophytic Aspergillus fumigatus. Incidental note is made of an aortic arch aneurysm. A prone CT scan shows the nodule to be mobile: it is located on the ventral aspect of the cavity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8071=[""].join("\n");
var outline_f7_56_8071=null;
var title_f7_56_8072="Withdrawal from and withholding of dialysis";
var content_f7_56_8072=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Withdrawal from and withholding of dialysis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?7/56/8072/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?7/56/8072/contributors\">",
"     Tony Dash, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?7/56/8072/contributors\">",
"     Lionel U Mailloux, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?7/56/8072/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?7/56/8072/contributors\">",
"     Jeffrey S Berns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?7/56/8072/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?7/56/8072/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?7/56/8072/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The withdrawal from or withholding of dialysis are issues that frequently confront practicing nephrologists. These decisions are intertwined with complex ethical, psychosocial, and financial issues that are becoming increasingly important in this era of managed care and possible rationing of resources [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The universal availability of renal replacement therapy in the United States forces the nephrologist to consider its application in every patient in whom it might be indicated. The nephrologist, however, may consider it a \"failure\" if a patient refuses to initiate or continue on dialysis. Foregoing dialysis is assuming more prominence as patients and physicians grapple with the increasing use of advance directives, and the laudable goals of death with dignity and life with quality. However, not all nephrologists are willing to recommend no treatment, especially when dialysis facilities are available with no need to ration therapy. These issues can therefore be a source of conflict between physicians, patients, and their families [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients and nephrologists are more willing than previously to discuss advanced directives and end-of-life decisions; this prompted the establishment of the Renal Physicians",
"    <span class=\"nowrap\">",
"     Association/American",
"    </span>",
"    Society of Nephrology",
"    <span class=\"nowrap\">",
"     (RPA/ASN)",
"    </span>",
"    work group to formulate guidelines concerning initiation and withdrawal of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/5\">",
"     5",
"    </a>",
"    ]. The group involved multiple disciplines, including physicians, ethicists, nurses, social workers, and clergy. They recommended the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Shared decision-making",
"     </li>",
"     <li>",
"      Informed consent or refusal",
"     </li>",
"     <li>",
"      Estimating prognosis",
"     </li>",
"     <li>",
"      Conflict resolution",
"     </li>",
"     <li>",
"      Advance directives",
"     </li>",
"     <li>",
"      Withholding or withdrawing dialysis",
"     </li>",
"     <li>",
"      Special patient groups",
"     </li>",
"     <li>",
"      Time-limited trials",
"     </li>",
"     <li>",
"      Palliative care",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical aspects of foregoing dialysis therapy are discussed here. A review of the general ethical issues involved in the care of patients with end-stage renal disease is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/50/16165?source=see_link\">",
"     \"Ethical issues in the care of the patient with end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon national, Canadian, and regional data, the withdrawal of dialysis is the second most common cause of death in Canada (after cardiovascular disease) among patients with end-stage renal disease (ESRD) and the third most common cause in the United States (after cardiovascular and infectious diseases) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/3,6-8\">",
"     3,6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Withdrawal means the discontinuation of maintenance dialysis, while withholding of dialysis is defined as foregoing dialysis in a patient in whom dialysis has yet to be initiated. The terms may be used interchangeably in patients with acute or chronic renal failure. The expected outcome from choosing either one of these options is death within a variable period of time (usually 7 to 14 days after withdrawal and up to 90 days when not initiating dialysis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     WITHHOLDING DIALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although less well studied, withholding dialysis probably occurs more frequently in the United States than does withdrawal from dialysis, and may be even more common in other countries. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a survey of American nephrologists, nearly 90 percent reported withholding dialysis at least once during the preceding year and over 30 percent reported withholding it at least six times [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A prospective Canadian study reported that about one-quarter of patients referred for initiation of hemodialysis were not offered dialysis after due consideration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/10\">",
"       10",
"      </a>",
"      ]. Patients in this study typically had very poor functional capacity, as determined by the Karnofsky scale, severe cardiovascular disease, diabetes mellitus, or neurologic disease. One-half of these patients had diffuse atherosclerotic vascular disease and renovascular disease as a contributing cause for their renal failure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/10\">",
"       10",
"      </a>",
"      ]. Only two of 23 patients survived for six months, confirming the end-stage level of their renal disease.",
"     </li>",
"     <li>",
"      An observational survey study from Australia showed that, among 721 patients with stage 5 CKD and a mean age of 80 years, 65 percent were offered conservative treatment (ie, no dialysis) as an option; 14 percent chose to withhold dialysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Primary care physicians also withhold dialysis by not referring patients to nephrologists for evaluation for possible dialysis. One study among physicians in West Virginia, for example, found that 20 of 76 primary care providers (26 percent) had effectively withheld dialysis for at least one patient because of nonreferral to a nephrologist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/12\">",
"     12",
"    </a>",
"    ]. The most common reasons cited by the physician were end-stage heart, liver, or lung disease, old age, and patient refusal.",
"   </p>",
"   <p>",
"    We and others feel it may be appropriate to withhold dialysis in the following specific clinical settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/8,10,13-15\">",
"     8,10,13-15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some patients with severe and irreversible dementia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/13,14\">",
"       13,14",
"      </a>",
"      ]. One survey, however, found that 68 percent of nephrologists would continue or start dialysis in patients in whom a clear advance directive was absent and in whom dementia occurred during the course of therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients who are permanently unconscious (such as the persistent vegetative state) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/13,14,16,17\">",
"       13,14,16,17",
"      </a>",
"      ]. In one study, for example, 83 percent of nephrologists surveyed claimed that they would withhold dialysis for such a patient [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/13,14,16\">",
"       13,14,16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with end-stage lung, liver or heart disease, who are therefore confined to bed or chair and need assistance with activities of daily living.",
"     </li>",
"     <li>",
"      Patients with such severe mental disability that they are unable to cooperate with the procedure of dialysis itself, are unable to react to the environment or other people, or are persistently combative with family or staff [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/10,14\">",
"       10,14",
"      </a>",
"      ]. As an example, it is usually appropriate to withhold dialysis from a patient in whom restraints or sedation are required during each dialysis session.",
"     </li>",
"     <li>",
"      Patients with severe, continued and unremediable pain in whom dialysis may prolong life for a short period of time but will also prolong suffering [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/13\">",
"       13",
"      </a>",
"      ]. The physician should attempt to restore decision-making capacity in such patients. These patients, however, are often difficult to work with effectively; consultation with an ethics committee or other support members may therefore be required [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/9,18\">",
"       9,18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hospitalized patients (especially elderly) with multiple organ system failure that persists after three days of intensive therapy. The mortality rate of such patients is very high.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In developing countries with limited resources, the rationing of renal replacement therapy is common, with socioeconomic factors underlying many decisions. In a single center study from South Africa, for example, 53 percent of patients evaluated were ultimately not offered renal replacement therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/19\">",
"     19",
"    </a>",
"    ]. Factors related to poverty were responsible for the denial of such therapy among approximately 60 percent of those in whom dialysis was withheld.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     WITHDRAWAL OF DIALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Withdrawal of long-term dialysis in patients with ESRD occurs frequently, and accounts for approximately 15 to 25 percent of all yearly deaths among the chronic dialysis population in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/3,20-22\">",
"     3,20-22",
"    </a>",
"    ]. As noted above, it is the second or third leading cause of death in such patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/8,22,23\">",
"     8,22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several patient factors are associated with the decision to withdraw from dialysis, including advanced age, diabetes mellitus, extensive atherosclerotic disease, white race, low Karnofsky scores, female gender, higher physical discomfort index, and higher educational level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. Also, elderly patients have a higher mortality rate on dialysis than do younger patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/3,23,24,26-30\">",
"     3,23,24,26-30",
"    </a>",
"    ]. The higher withdrawal rate is a significant part of the overall elevated mortality in this elderly patient dialysis population. In one study, for example, dialysis was discontinued in about six percent of patients under 65 years of age, but in 14 percent of those over 65 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/29\">",
"     29",
"    </a>",
"    ]. In another report, 56 percent of those over the age of 85 died because of withdrawal from chronic dialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The race of the patient with ESRD also significantly affects his or her decision whether to discontinue dialytic therapy. Rates of withdrawal in whites are twice as high as in blacks for all age categories over age 20 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/3\">",
"     3",
"    </a>",
"    ]. The exact reasons are unclear, but this difference could reflect different cultural attitudes or a lesser degree of trust among black patients and their families towards their predominantly white physicians. Interestingly, withdrawal was the cause of death in about 10 percent of patients of Asian descent, but in 20 percent of Native Americans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although suicide is related to dialysis withdrawal, a paucity of data exists concerning the patient factors associated with this act. Using a multivariable model, one study of dialysis patients found that independent predictors of death from suicide included male, white or Asian race, alcohol or drug dependence, age greater than 75 years, and recent hospitalization for a mental illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/32\">",
"     32",
"    </a>",
"    ]. Thus, compared to those who choose to withdraw from dialysis, patients who commit suicide are relatively less likely to have suffered from comorbid conditions, malnutrition, and general debility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MEDICAL CONTEXT OF WITHHOLDING OR WITHDRAWAL FROM DIALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There usually appears to be a proximate reason to consider foregoing dialysis, which can vary based upon the location where the patient is located. As an example, reasons for withdrawal from dialysis noted in the 2008 United States Renal Data System (USRDS) data system were [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Failure to thrive (47 and 36 percent for those at home and in the hospital, respectively)",
"     </li>",
"     <li>",
"      Medical complications (21 and 41 percent for home and hospital, respectively)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Certain comorbid conditions are also frequently present near the time of withdrawal, including diabetic gastropathy, neuropathy, the need for surgery, neoplastic disease, neurologic deterioration, worsening quality of life, and increasing pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/8,23,31,33,34\">",
"     8,23,31,33,34",
"    </a>",
"    ]. In addition, dialysis is sometimes begun as a therapeutic trial in an attempt to improve an extremely poor quality of life; it is subsequently discontinued if no improvement occurs. For some patients, the reason for withdrawal is simply the overall burden that long-term dialysis places on their lives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ETHICS, LAW, AND WITHDRAWAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ethical principles supporting the right of individuals who are competent to withdraw from dialysis or to refuse the initiation of dialysis (many authors feel these are not ethically different actions) include the principle of autonomy and the rights of self-determination and privacy. For example, continued life on dialysis for some patients (such as those in intractable pain) would impose an unfavorable balance between benefit and burden [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/14,35,36\">",
"     14,35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    All patients have the personal and legal right to refuse treatment, since any such informed decision involves the expression of self-determination, independence, and autonomy. Informed consent emanates from the right to privacy and holds that patients may refuse medical care. This right is not absolute, however, since it must be balanced by the government's right to preserve the life of its citizens. Nevertheless, the law generally upholds a patient's right to refuse medical care. This right is based upon the presumption of full and honest informed consent, which includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Full disclosure about the nature of the illness and all aspects of the therapy",
"     </li>",
"     <li>",
"      Complete understanding of all consequences of the decision",
"     </li>",
"     <li>",
"      An open and voluntary decision making process",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These decisions are well-anchored in ethical principles and in the law. The Patient Self-Determination Act (PSDA), approved by Congress to encourage completion of advance directives, is evidence that the decision to withdraw a life-sustaining treatment such as dialysis is legally sanctioned. The responsible physician therefore has little to fear because: \"There has never been a successful criminal prosecution for stopping life-sustaining treatment. So long as a doctor acts reasonably and in good faith to withhold or discontinue treatment with the consent of the patient or family, there is little chance of a criminal charge\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Supreme Court's decision in the Cruzan case also suggests that a competent patient has a constitutional right to make such a choice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/38\">",
"     38",
"    </a>",
"    ]. The decision to accept or refuse therapy legally resides in the patient and not with the physician [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL APPROACH TO WITHHOLDING OR WITHDRAWING DIALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A sequential approach to the possible withholding or withdrawal of dialysis involves:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Assessment of the patient's decision making capacity",
"     </li>",
"     <li>",
"      Identification of the presence of proper advance directives",
"     </li>",
"     <li>",
"      Assessment of possible reversible factors",
"     </li>",
"     <li>",
"      If necessary, the institution of a trial period of dialysis",
"     </li>",
"     <li>",
"      Assessment of patient's motives through in depth dialogue",
"     </li>",
"     <li>",
"      Involvement of the dialysis team",
"     </li>",
"     <li>",
"      Full family involvement",
"     </li>",
"     <li>",
"      Possible appointment of a surrogate",
"     </li>",
"     <li>",
"      Full postwithdrawal or postwithhold support",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Assessment of patient's decision-making capacity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The withdrawal from dialysis may be suggested by the patient, the nephrologist or other members of the health care team, or the patient's family. It must initially be determined that the patient is competent and fully comprehends that the consequences of withdrawing from dialysis include death, usually within one to two weeks. One definition of competence is that the patient is able to understand his condition, to reflect on it in accordance with his or her own values, and to communicate his or her decision to others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/39\">",
"     39",
"    </a>",
"    ]. In those patients who appear to have intact decision-making capacity, the nephrologist should still exclude the subtle presence of factors such as situational depression, mild dementia, and uremic or toxic encephalopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Importance of an advance directive (living wills or health care proxies)",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the capacity for informed consent cannot be restored, then one should look for a previously completed advance directive. Advance directives are documents in which the patient has either detailed his or her desires concerning their future care in the event they become incompetent or has identified a surrogate agent (health care proxy) who knows the patient's desires and directs the patient's medical care accordingly. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/50/16165?source=see_link\">",
"     \"Ethical issues in the care of the patient with end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is usually appropriate to withhold dialysis in incompetent patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Who have previously given a written or documented and explicit oral advance directive indicating that they would not want life-sustaining measures.",
"     </li>",
"     <li>",
"      Who, without an advance directive, have well-documented strongly held beliefs or values that would be inconsistent with dialysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are data suggesting that in patients with ESRD advance directives may contribute to \"good deaths\" and that these patients welcome discussions about advance directives when physicians introduce them [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/18,40-45\">",
"     18,40-45",
"    </a>",
"    ]. Nephrologists have not been aggressive in these areas nor have they developed uniform educational policies in their dialysis units. In two prominent studies, for example, only about 20 percent of patients had advance directives completed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/41,44\">",
"     41,44",
"    </a>",
"    ]. The appointment of a surrogate decision maker may be necessary for some incompetent patients for whom there is consideration of withholding or withdrawing dialysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Assessment of reversible factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with intact decision-making capacity, one should next explore why the patient requests withholding of or withdrawing from dialysis. Some patients may consider withdrawal because of irremediable factors such as chronic debility, repeated dialysis access failures, and loss of limbs and eyesight. Potentially reversible factors in other patients, however, may precipitate contemplation of withdrawal. These might include repeatedly painful needle insertions at the start of dialysis or intradialytic muscle cramps. The nephrologist, in combination with other members of the health care team, should systematically address and modify these factors.",
"   </p>",
"   <p>",
"    The initial question in the patient with uncertain or without intact decision-making capacity for whom withholding dialysis may be appropriate is whether decision-making capacity can be restored. In this setting, one also needs to systematically exclude the presence of remediable factors such as uremic or metabolic encephalopathy and the effects of drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Trial period of dialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A trial period of dialysis may be of use in several different clinical settings, including the patient in whom fear and depression over the dialysis technique must be overcome or in whom multiple debilitating chronic illnesses make the thought of initiating dialysis forbidding. Many such patients often remain on dialysis once their trial period is over.",
"   </p>",
"   <p>",
"    In such setting, a trial period of dialysis of 30 to 60 days should be initiated during which the patient is closely monitored and after which the desire to withdraw from dialysis is reassessed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/24\">",
"     24",
"    </a>",
"    ]. There must, however, be a clear understanding between the physician and patient over the set guidelines. Full communication must therefore be maintained at all times.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Entering into a dialogue with the patient",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nephrologist should not withdraw dialysis upon the initial request for withdrawal but should assess the patient's intent by entering into a full dialogue. As an example, a patient who claims to want to withdraw may actually be \"acting out\" or testing the limits of acceptable behavior. Such a patient may not truly want to discontinue dialysis; repeated attempts at communication may reveal his or her true needs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Interdisciplinary team approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the decisions to withdraw or withhold dialysis are so complex (particularly in the incompetent patient), it is helpful to have other members of the health care team, including the social worker, clergy, and dialysis nurses, complete the assessment. This team should also be involved with patients who have withdrawn and are therefore expected to die in the ensuing weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Involvement of patient's family",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nephrologist needs to insure that the patient has fully informed his or her family or significant others of the decision and its consequences. These supporting members should fully comprehend the decision. Similarly, when a surrogate has been appointed, this individual should be equally involved and aware of the outcomes.",
"   </p>",
"   <p>",
"    The importance of involving family members in this process is underscored by a study examining the preferences of dialysis patients concerning family-based advance care planning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/46\">",
"     46",
"    </a>",
"    ]. More patients preferred to discuss these decisions with family members than with physicians (50 versus 6 percent, P&lt;0.001) and to include family members rather than physicians in future discussions concerning advanced care planning (91 versus 36 percent, P&lt;0.001).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Support the patient's decision",
"    </span>",
"    &nbsp;&mdash;&nbsp;If after repeated discussions with members of the health care team, the competent patient still desires to withdraw from long-term dialysis, he or she should be supported in this decision (even if the nephrologist does not agree) and its sequelae. This is similarly true for the occasional patient who the nephrologist feels is not a good dialysis candidate, but who nevertheless chooses to continue or initiate dialysis treatments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Postwithdrawal period",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients typically have one to two weeks of life remaining after discontinuing long-term dialysis. In one retrospective study, for example, patients died within a mean and median of 8 and 6 days after withdrawal from dialysis, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients express great relief and become very comfortable and are at peace with their decision. At this point, attention should be directed toward the comfort of the patient, such as liberalizing the diet and arranging for hospice care. However, since pulmonary edema is most uncomfortable and may prompt the need for acute therapy, patients should be instructed to carefully limit fluid and sodium intake. As an alternative, some clinicians advocate the continuation of ultrafiltration alone to permit the liberalization of nutrition and fluid intake in the last week or two of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/48\">",
"     48",
"    </a>",
"    ]. Opioids (preferably",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"     hydromorphone",
"    </a>",
"    ) and benzodiazepines should be prescribed for pain, dyspnea and anxiety.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     Morphine",
"    </a>",
"    should be used cautiously in patients with renal failure since its sedative effects are prolonged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/47/36601?source=see_link&amp;anchor=H25#H25\">",
"     \"Medical management of the dialysis patient undergoing surgery\", section on 'Opiates'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The staff can optimally guide the care of the dying patient by capitalizing on the patient's priorities and discussing, in advance, the effects of the dying process on the patient and family. The dialysis care team should insure that patients have addressed major financial and personal affairs, such as wills. This is the time for patients to communicate with loved ones and to come to terms with their life. Withdrawal of dialysis performed in this deliberate manner can contribute to a \"high quality of death\" and a \"reconciled death\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/33,50-52\">",
"     33,50-52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     CONTROVERSIAL AREAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;It may be appropriate to withhold or withdraw dialysis in some patients with a short life expectancy (expected death within 60 days) due to a terminal illness that cannot be reversed by dialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/14,35\">",
"     14,35",
"    </a>",
"    ]. Therefore it may be inappropriate to initiate or continue dialysis in some patients with metastatic cancer. The decision to withhold dialysis from these patients, however, needs to be made on an individual basis, as dialysis may give some patients the time for the resolution of personal and social issues prior to their expected death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     FUTURE DIRECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the future, socioeconomic forces may result in pressure to limit the provision of dialysis. National governing bodies may advance regulations detailing the appropriate use of dialysis in specific settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/16\">",
"     16",
"    </a>",
"    ]. The combination of these social forces and the expected doubling of the ESRD population in the United States within the next decade will make the withdrawal and withholding of dialysis an increasingly common problem for the nephrologist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite this increasing problem, surveys have shown that few nephrologists have participated in formal ethics training [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/42\">",
"     42",
"    </a>",
"    ]; they have also noted that many nephrologists substantially disagree about the provision of dialysis in several important clinical settings. As an example, one study found discord among surveyed nephrologists relating to the management of incompetent patients whose prior wishes about their future medical care are unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nephrologists should therefore pursue and advocate the use of advance directives in all patients. These documents provide excellent guidance for future medical care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/50/16165?source=see_link\">",
"     \"Ethical issues in the care of the patient with end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite their utility, nephrologists have not been as vigorous as possible in promoting the use of advance directives. National forums should therefore be used to discuss this entire issue. Certainly, as in the care of all other chronically ill patients, there is much work yet to be done in this important field [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. If a patient has willingly begun dialysis with a fully open communications policy (atmosphere), then this same patient should be able to withdraw, exercising his or her own best judgment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8072/abstract/8,55,56\">",
"     8,55,56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H568741080\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among patients with end-stage renal disease, the withdrawal of dialysis is the second most common cause of death in Canada and the third most common cause in the United States. The expected outcome is death within a variable period of time (usually 7 to 14 days after withdrawal and up to 90 days when not initiating dialysis). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is appropriate to withhold dialysis among patients with severe and irreversible dementia or a persistent vegetative state; end-stage lung, liver or heart disease; severe mental disability (rendering the patient unable to cooperate with the procedure of dialysis); unremediable pain; and among hospitalized patients, multiple organ system failure that persists after three days of intensive therapy. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Withholding dialysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients have the personal and legal right to refuse treatment, since any such informed decision involves the expression of self-determination, independence, and autonomy. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Ethics, law, and withdrawal'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Withholding or withdrawing dialysis requires an assessment of the patient's decision making capacity or identification of proper advance directives as well as an assessment of possible reversible factors and consideration of patient's motives through in depth dialogue. A trial period of dialysis may be done before making a decision to withhold. Generally the decision to withdraw dialysis involves the dialysis team and family. The appointment of a surrogate may be necessary. Full support is required following withdrawal or the decision to withhold dialysis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical approach to withholding or withdrawing dialysis'",
"      </a>",
"      above.)",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      After withdrawal, attention should be directed toward the comfort of the patient, such as liberalizing the diet and arranging for hospice care. Since pulmonary edema is most uncomfortable and may prompt the need for acute therapy, patients should be instructed to carefully limit fluid and sodium intake. As an alternative, some clinicians advocate the continuation of ultrafiltration alone to permit the liberalization of nutrition and fluid intake in the last week or two of life. Opioids (preferably",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"       hydromorphone",
"      </a>",
"      ) and benzodiazepines should be prescribed for pain, dyspnea and anxiety.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       Morphine",
"      </a>",
"      should be used cautiously in patients with renal failure since its sedative effects are prolonged. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Postwithdrawal period'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nephrologists should pursue and advocate the use of advance directives in all patients. These documents provide excellent guidance for future medical care. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Future directions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/1\">",
"      Levinsky NG. The organization of medical care. Lessons from the Medicare end stage renal disease program. N Engl J Med 1993; 329:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/2\">",
"      Klahr S. Rationing of health care and the end-stage renal disease program. Am J Kidney Dis 1990; 16:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/3\">",
"      United States Renal Data System. USRDS 2009 Annual Data Report. U.S. Department of Health and Human Services. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Am J Kidney Dis 2010; 55(Suppl 1):S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/4\">",
"      Moss AH. 'At least we do not feel guilty': Managing conflict with families over dialysis discontinuation. Am J Kidney Dis 1998; 31:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/5\">",
"      Moss AH. Shared decision-making in dialysis: the new RPA/ASN guideline on appropriate initiation and withdrawal of treatment. Am J Kidney Dis 2001; 37:1081.",
"     </a>",
"    </li>",
"    <li>",
"     Canadian Organ Replacement Register. 1993 Annual Report, Canadian Institute for Health Information, Don Mills, Ontario, Canada, March 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/7\">",
"      Bleyer AJ, Tell GS, Evans GW, et al. Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences. Am J Kidney Dis 1996; 28:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/8\">",
"      Mailloux LU, Bellucci AG, Napolitano B, et al. Death by withdrawal from dialysis: a 20-year clinical experience. J Am Soc Nephrol 1993; 3:1631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/9\">",
"      Singer PA. Nephrologists' experience with and attitudes towards decisions to forego dialysis. The End-Stage Renal Disease Network of New England. J Am Soc Nephrol 1992; 2:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/10\">",
"      Hirsch DJ, West ML, Cohen AD, Jindal KK. Experience with not offering dialysis to patients with a poor prognosis. Am J Kidney Dis 1994; 23:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/11\">",
"      Morton RL, Turner RM, Howard K, et al. Patients who plan for conservative care rather than dialysis: a national observational study in Australia. Am J Kidney Dis 2012; 59:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/12\">",
"      Sekkarie MA, Moss AH. Withholding and withdrawing dialysis: the role of physician specialty and education and patient functional status. Am J Kidney Dis 1998; 31:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/13\">",
"      Lowance DC. Factors and guidelines to be considered in offering treatment to patients with end-stage renal disease: a personal opinion. Am J Kidney Dis 1993; 21:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/14\">",
"      Moss AH. To use dialysis appropriately: the emerging consensus on patient selection guidelines. Adv Ren Replace Ther 1995; 2:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/15\">",
"      Lambie M, Rayner HC, Bragg-Gresham JL, et al. Starting and withdrawing haemodialysis--associations between nephrologists' opinions, patient characteristics and practice patterns (data from the Dialysis Outcomes and Practice Patterns Study). Nephrol Dial Transplant 2006; 21:2814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/16\">",
"      Moss AH, Stocking CB, Sachs GA, Siegler M. Variation in the attitudes of dialysis unit medical directors toward decisions to withhold and withdraw dialysis. J Am Soc Nephrol 1993; 4:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/17\">",
"      Eiser AR, Seiden DJ. Discontinuing dialysis in persistent vegetative state: the roles of autonomy, community, and professional moral agency. Am J Kidney Dis 1997; 30:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/18\">",
"      Singer PA, Thiel EC, Naylor CD, et al. Life-sustaining treatment preferences of hemodialysis patients: implications for advance directives. J Am Soc Nephrol 1995; 6:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/19\">",
"      Moosa MR, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int 2006; 70:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/20\">",
"      Cohen LM, Germain MJ, Poppel DM. Practical considerations in dialysis withdrawal: \"to have that option is a blessing\". JAMA 2003; 289:2113.",
"     </a>",
"    </li>",
"    <li>",
"     ESRD network of New England. 2001 Annual Report to the Centers for Medicare and Medicaid Services. New Haven, Conn: Tyco Printers; July 2002; 60.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/22\">",
"      Murtagh F, Cohen LM, Germain MJ. Dialysis discontinuation: quo vadis? Adv Chronic Kidney Dis 2007; 14:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/23\">",
"      Bajwa K, Szabo E, Kjellstrand CM. A prospective study of risk factors and decision making in discontinuation of dialysis. Arch Intern Med 1996; 156:2571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/24\">",
"      Moss AH. Dialysis decisions and the elderly. Clin Geriatr Med 1994; 10:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/25\">",
"      Leggat JE Jr, Bloembergen WE, Levine G, et al. An analysis of risk factors for withdrawal from dialysis before death. J Am Soc Nephrol 1997; 8:1755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/26\">",
"      Cohen LM, Germain M, Woods A, et al. Patient attitudes and psychological considerations in dialysis discontinuation. Psychosomatics 1993; 34:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/27\">",
"      Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/28\">",
"      Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/29\">",
"      Nelson CB, Port FK, Wolfe RA, Guire KE. The association of diabetic status, age, and race to withdrawal from dialysis. J Am Soc Nephrol 1994; 4:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/30\">",
"      Port FK, Wolfe RA, Hawthorne VM, Ferguson CW. Discontinuation of dialysis therapy as a cause of death. Am J Nephrol 1989; 9:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/31\">",
"      Neu S, Kjellstrand CM. Stopping long-term dialysis. An empirical study of withdrawal of life-supporting treatment. N Engl J Med 1986; 314:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/32\">",
"      Kurella M, Kimmel PL, Young BS, Chertow GM. Suicide in the United States end-stage renal disease program. J Am Soc Nephrol 2005; 16:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/33\">",
"      Cohen LM, McCue JD, Germain M, Kjellstrand CM. Dialysis discontinuation. A 'good' death? Arch Intern Med 1995; 155:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/34\">",
"      Tobe SW, Senn JS. Foregoing renal dialysis: a case study and review of ethical issues. The End-Stage Renal Disease Group. Am J Kidney Dis 1996; 28:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/35\">",
"      Lowance DC. Withdrawal from dialysis: an ethical perspective. Kidney Int 1988; 34:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/36\">",
"      Swartz RD, Perry E, Schneider C, et al. The option to withdraw from chronic dialysis treatment. Adv Ren Replace Ther 1994; 1:264.",
"     </a>",
"    </li>",
"    <li>",
"     Pickering, JH. Death and the law: What is the right to die? Eleventh Annual Leon and Josephine Winkelman Lecture. University of Michigan School of Social Work. Ann Arbor, MI 1989.",
"    </li>",
"    <li>",
"     Cruzan v Director, Missouri Department of Health, 497, US 261, 1990.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/39\">",
"      Kerridge I, Lowe M, Mitchell K. Competent patients, incompetent decisions. Ann Intern Med 1995; 123:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/40\">",
"      Holley JL, Nespor S, Rault R. The effects of providing chronic hemodialysis patients written material on advance directives. Am J Kidney Dis 1993; 22:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/41\">",
"      Holley JL, Nespor S, Rault R. Chronic in-center hemodialysis patients' attitudes, knowledge, and behavior towards advance directives. J Am Soc Nephrol 1993; 3:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/42\">",
"      Holley JL, Foulks CJ, Moss AH. Nephrologists' reported attitudes about factors influencing recommendations to initiate or withdraw dialysis. J Am Soc Nephrol 1991; 1:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/43\">",
"      Mendelssohn DC, Singer PA. Advance directives in dialysis. Adv Ren Replace Ther 1994; 1:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/44\">",
"      Perry E, Buck C, Newsome J, et al. Dialysis staff influence patients in formulating their advance directives. Am J Kidney Dis 1995; 25:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/45\">",
"      Perry LD, Nicholas D, Molzahn AE, Dossetor JB. Attitudes of dialysis patients and caregivers regarding advance directives. ANNA J 1995; 22:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/46\">",
"      Hines SC, Glover JJ, Holley JL, et al. Dialysis patients' preferences for family-based advance care planning. Ann Intern Med 1999; 130:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/47\">",
"      Fissell RB, Bragg-Gresham JL, Lopes AA, et al. Factors associated with \"do not resuscitate\" orders and rates of withdrawal from hemodialysis in the international DOPPS. Kidney Int 2005; 68:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/48\">",
"      Eibach U, Schaefer K. Support after discontinuation of dialysis--medical and ethical considerations. Nephrol Dial Transplant 1998; 13:1154.",
"     </a>",
"    </li>",
"    <li>",
"     Bansal, VK, Vertuno, LL. In: Handbook of Dialysis, 2nd Edition, Daugirdas JR, Ing, TS (Eds), Little Brown and Co 1994. p. 551.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/50\">",
"      Sehgal A, Galbraith A, Chesney M, et al. How strictly do dialysis patients want their advance directives followed? JAMA 1992; 267:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/51\">",
"      Swartz RD, Perry E. Advance directives are associated with \"good deaths\" in chronic dialysis patients. J Am Soc Nephrol 1993; 3:1623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/52\">",
"      Cohen LM, Germain M, Poppel DM, et al. Dialysis discontinuation and palliative care. Am J Kidney Dis 2000; 36:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/53\">",
"      A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995; 274:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/54\">",
"      Lo B. Improving care near the end of life. Why is it so hard? JAMA 1995; 274:1634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/55\">",
"      Kjellstrand CM. Giving life--giving death. Ethical problems of high-technology medicine. Acta Med Scand Suppl 1988; 725:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8072/abstract/56\">",
"      Berman E, Merz JF, Rudnick M, et al. Religiosity in a hemodialysis population and its relationship to satisfaction with medical care, satisfaction with life, and adherence. Am J Kidney Dis 2004; 44:488.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1877 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-202.43.93.2-481E12C6DB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8072=[""].join("\n");
var outline_f7_56_8072=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H568741080\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      WITHHOLDING DIALYSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      WITHDRAWAL OF DIALYSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MEDICAL CONTEXT OF WITHHOLDING OR WITHDRAWAL FROM DIALYSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ETHICS, LAW, AND WITHDRAWAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL APPROACH TO WITHHOLDING OR WITHDRAWING DIALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Assessment of patient's decision-making capacity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Importance of an advance directive (living wills or health care proxies)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Assessment of reversible factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Trial period of dialysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Entering into a dialogue with the patient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Interdisciplinary team approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Involvement of patient's family",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Support the patient's decision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Postwithdrawal period",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      CONTROVERSIAL AREAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      FUTURE DIRECTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H568741080\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/50/16165?source=related_link\">",
"      Ethical issues in the care of the patient with end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/47/36601?source=related_link\">",
"      Medical management of the dialysis patient undergoing surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_56_8073="Pathogenesis and etiology of disseminated intravascular coagulation";
var content_f7_56_8073=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis and etiology of disseminated intravascular coagulation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?7/56/8073/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?7/56/8073/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?7/56/8073/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?7/56/8073/contributors\">",
"     Pier Mannuccio Mannucci, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?7/56/8073/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?7/56/8073/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?7/56/8073/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disseminated intravascular coagulation (DIC, also called consumption coagulopathy and defibrination syndrome) is a systemic process producing both thrombosis and hemorrhage. It is initiated by a number of defined disorders and consists of the following components:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Exposure of blood to procoagulants",
"     </li>",
"     <li>",
"      Formation of fibrin in the circulation",
"     </li>",
"     <li>",
"      Fibrinolysis",
"     </li>",
"     <li>",
"      Depletion of clotting factors",
"     </li>",
"     <li>",
"      End-organ damage",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Disseminated intravascular coagulation is a complication of underlying illness occurring in approximately 1 percent of hospital admissions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/1\">",
"     1",
"    </a>",
"    ]. Treatment of DIC is supportive, with platelet transfusion and clotting factor replacement therapy. In certain selected circumstances, judicious use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    may be beneficial. The prognosis is generally that of the underlying disease.",
"   </p>",
"   <p>",
"    The pathogenesis and etiology of DIC will be reviewed here. The clinical manifestations, diagnosis, and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/20/25929?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF DIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of DIC is primarily due to an uncontrolled and excessive production of thrombin, leading to widespread and systemic intravascular fibrin deposition (",
"    <a class=\"graphic graphic_algorithm graphicRef78959 \" href=\"mobipreview.htm?32/4/32846\">",
"     algorithm 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Activation of hemostasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal activation of hemostasis begins with exposure of blood to procoagulants, primarily mediated by the extrinsic pathway involving tissue factor and activated factor VII (factor VIIa), ultimately leading to the formation of thrombin (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/35/27194?source=see_link\">",
"     \"Overview of hemostasis\"",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/3\">",
"     3",
"    </a>",
"    ]. Thrombin generation is normally localized to the site of injury, inducing platelet aggregation and the deposition of crosslinked fibrin to form the hemostatic plug. The generation of thrombin is tightly regulated by the multiple natural antithrombotic pathways existing in plasma and on the endothelial cell surface, such as antithrombin and tissue factor pathway inhibitor. When these mechanisms are overwhelmed by the markedly increased production of thrombin, thrombin may circulate and lead to disseminated intravascular coagulation. The widespread deposition of fibrin results in tissue ischemia and consumption of platelets, fibrinogen, prothrombin, and factors V and VIII, which in turn may lead to bleeding.",
"   </p>",
"   <p>",
"    DIC results from a massive activation of the clotting cascade. The major initiating factors are the release or expression of tissue factor, usually involving entry of tissue thromboplastins into the circulation, extensive injury to vascular endothelium exposing tissue factor, or enhanced expression of tissue factor by monocytes in response to endotoxin and various cytokines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Intrinsic pathway activation may also occur in some settings, but it appears to contribute more to the development of hypotension than to DIC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Secondary fibrinolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The release of tissue plasminogen activator with subsequent generation of plasmin from plasminogen at the site of vascular injury produces compensatory thrombolysis (secondary fibrinolysis), opening of occluded blood vessels, and the release of fibrin degradation products (FDP). Normally the amount of FDP released is small and these are rapidly cleared from the circulation. However, when there is widespread systemic fibrin deposition, as in DIC, these byproducts may enhance bleeding by interfering with normal fibrin polymerization and by binding to the platelet surface glycoprotein",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    fibrinogen receptor, interfering with platelet aggregation. In addition, since plasmin can cleave proteins other than fibrin, excessive plasmin will lead to proteolytic degradation of fibrinogen and other clotting factors, causing consumption coagulopathy, exacerbating the bleeding diathesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Acute versus chronic DIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;DIC is a dynamic process and its consequences depend on its cause and the rapidity with which the initiating event is propagated. If the activation occurs slowly, an excess of procoagulants is produced, predisposing to thrombosis. At the same time, as long as the liver can compensate for the consumption of clotting factors, and the bone marrow maintains an adequate platelet count, the bleeding diathesis will not be clinically apparent. This is the picture of chronic compensated DIC; its clinical presentation consists of primarily thrombotic manifestations, which can be both venous and arterial (",
"    <a class=\"graphic graphic_table graphicRef63831 \" href=\"mobipreview.htm?34/15/35067\">",
"     table 1",
"    </a>",
"    ). Trousseau syndrome, a hypercoagulable state associated with malignancy, is an example. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/43/35514?source=see_link&amp;anchor=H25#H25\">",
"     \"Hypercoagulable disorders associated with malignancy\", section on 'Chronic DIC'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the reaction is brisk and explosive, the clinical picture (acute decompensated DIC) is dominated by intravascular coagulation; depletion of platelets, fibrinogen, prothrombin, and factors V and VIII; and the production, via the action of plasmin, of fibrin degradation products, which further interfere with hemostasis (",
"    <a class=\"graphic graphic_table graphicRef63831 \" href=\"mobipreview.htm?34/15/35067\">",
"     table 1",
"    </a>",
"    ). The clinical consequence is a profound systemic bleeding diathesis, with blood oozing from wound sites, intravenous lines, and catheters, as well as bleeding into deep tissues. The intravascular fibrin strands cause mechanical shearing of circulating red cells (",
"    <a class=\"graphic graphic_picture graphicRef81610 \" href=\"mobipreview.htm?4/52/4932\">",
"     picture 1",
"    </a>",
"    ), producing the picture of microangiopathic hemolytic anemia (",
"    <a class=\"graphic graphic_picture graphicRef70851 \" href=\"mobipreview.htm?37/50/38694\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/62/9194?source=see_link&amp;anchor=H7#H7\">",
"     \"Extrinsic nonimmune hemolytic anemia due to mechanical damage: Fragmentation hemolysis and hypersplenism\", section on 'Disseminated intravascular coagulation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Thrombotic microangiopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of DIC, a thrombotic microangiopathy resulting from activation of the coagulation system, is different from the pathogenesis of another thrombotic microangiopathy, thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS), which results in part from primary platelet activation due in many cases to a congenital or acquired defect in von Willebrand factor cleaving protease (ADAMTS13)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    primary endothelial injury. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=see_link\">",
"     \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\"",
"    </a>",
"    .) This pathogenetic distinction results in different coagulation abnormalities that usually permit these disorders to be distinguished. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/20/25929?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    That this distinction between DIC and TTP-HUS may be blurred somewhat was raised in a study which included 109 patients with sepsis-induced DIC; 47 and 16 percent of this group had ADAMTS13 levels &lt;20 or &lt;5 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/8\">",
"     8",
"    </a>",
"    ]. Compared with those with ADAMTS13 levels &gt;20 percent, those with levels &lt;20 percent had significantly greater evidence for renal injury. The presence of unusually large VWF multimers along with lower molecular weight forms of ADAMTS13 suggested that the deficiency of ADAMTS13 was partially caused by protease cleavage (eg, thrombin, plasmin, granulocyte elastase), leading to the microangiopathy and renal damage characteristic of both conditions.",
"   </p>",
"   <p>",
"    These observations also challenge the concept that severe reductions in ADAMTS13 levels (ie, &lt;5 percent of normal) are highly specific for the diagnosis of TTP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=see_link&amp;anchor=H11#H11\">",
"     \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\", section on 'ADAMTS13 activity in other conditions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disseminated intravascular coagulation occurs in a variety of serious clinical conditions; the most common are sepsis, trauma and tissue destruction, cancer, and obstetrical complications (",
"    <a class=\"graphic graphic_table graphicRef58104 \" href=\"mobipreview.htm?8/28/8652\">",
"     table 2",
"    </a>",
"    ). In two large series of 346 and 118 patients with DIC, the following distribution of causes was noted: generalized infection (26 and 40 percent, respectively), malignancy (24 and 7 percent), surgery and trauma (19 and 24 percent), liver disease (8 percent), and miscellaneous (23 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Sepsis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both bacterial and nonbacterial infection can be associated with DIC and multiorgan failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/11\">",
"     11",
"    </a>",
"    ]. DIC was classically recognized as a complication of endothelial damage produced by meningococcemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Subsequently, the syndrome has been described with a variety of Gram negative and Gram positive organisms. As an example, overt DIC occurs in 30 to 50 percent of patients with Gram negative sepsis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In animal models of endotoxin-induced DIC, there is evidence that the pathogenesis involves both thrombin generation and suppression of normal antithrombotic mechanisms with downregulation of the protein",
"    <span class=\"nowrap\">",
"     C/thrombomodulin",
"    </span>",
"    system and perhaps impaired fibrinolysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. The balance between thrombin generation, clotting factor depletion, and thrombolysis determines the clinical presentation (ie, bleeding or thrombosis) (",
"    <a class=\"graphic graphic_algorithm graphicRef78959 \" href=\"mobipreview.htm?32/4/32846\">",
"     algorithm 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/4,18\">",
"     4,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several conditions, when present, can accentuate and modify aspects of the hemostatic process.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Shock is associated with reduced blood flow (which diminishes the beneficial effects of hemodilution) and tissue damage (which promotes further thrombin formation).",
"     </li>",
"     <li>",
"      Impaired hepatic perfusion or function causes inadequate hepatic removal of circulating activated procoagulants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In sepsis-induced DIC, activation of the extrinsic pathway appears to be the primary activating pathway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/16,19\">",
"     16,19",
"    </a>",
"    ]. Inhibition of tissue factor suppresses the endotoxin-induced generation of thrombin in experimental models of DIC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/20\">",
"     20",
"    </a>",
"    ] and, in normal humans given a bolus injection of endotoxin, the administration of tissue factor pathway inhibitor produces a dose-dependent inhibition of the activation of coagulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endotoxemia also activates factor XII of the intrinsic pathway. This can lead to conversion of prekallikrein to kallikrein and kininogen into circulating kinins which can mediate increased vascular permeability, vasodilatation, and shock [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/20\">",
"     20",
"    </a>",
"    ]. In experimental models of DIC, inhibition of intrinsic pathway activation ameliorates the hypotension but not the DIC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Activation of coagulation is a consequence of endothelial damage and enhanced expression and release of granulocyte and macrophage procoagulant substances, such as tissue factor. Increased expression and release may be a direct action of endotoxin and other membrane lipopolysaccharides or it may be indirect with mediation via activation of cytokines, such as interleukin-6 and tumor necrosis factor alpha [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/4,22,23\">",
"     4,22,23",
"    </a>",
"    ]. An additional mechanism may be involved in patients with meningococcal sepsis, which is associated with high levels of circulating microparticles, originating from platelets or granulocytes, and having procoagulant activity. In one report, the patients with the most severe manifestations had microparticles which, when added to normal plasma in vitro, generated a substantial amount of thrombin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gram positive bacteremias, including Staphylococcus aureus, Streptococcus pneumoniae, and Clostridia perfringens, also can be associated with DIC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. A variety of other infections, particularly viral infections (eg, varicella, hepatitis) have rarely been associated with DIC.",
"   </p>",
"   <p>",
"    In mice infected with S. pneumoniae, von Willebrand factor and platelets were eliminated from the circulation by the hepatic Ashwell receptor (asialoglycoprotein receptor), following their loss of surface sialic acid through the bacterium's neuraminidase activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/28\">",
"     28",
"    </a>",
"    ]. Such hemostatic adaptation may serve to moderate the onset and severity of DIC during sepsis and improve the probability of host survival.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Trauma and extensive surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute DIC is a common and potentially serious complication of extensive surgery and trauma; release of tissue enzymes and or phospholipids from damaged tissue into the systemic circulation triggers activation of cytokine networks and the hemostatic system. The severity of the coagulopathy in these conditions is a predictor of adverse outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/29-33\">",
"     29-33",
"    </a>",
"    ]. The incidence of DIC among trauma patients who develop the sustained systemic inflammatory response syndrome (SIRS) is greater than 50 percent and the occurrence of DIC and SIRS are strong determinants for post-trauma multiple organ dysfunction syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/15,33\">",
"     15,33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=see_link\">",
"     \"Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Severe head injury is particularly associated with DIC. One study of 159 patients with blunt head injury found a coagulopathy in 41 percent of those with CT evidence of brain injury and 25 percent of those without brain injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/30\">",
"     30",
"    </a>",
"    ]. The syndrome developed within one to four hours after injury and was associated with a higher frequency of death. Another study found direct evidence of procoagulant release and thrombin formation in cerebrovenous blood within six hours after severe isolated head trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/34\">",
"     34",
"    </a>",
"    ]. These changes were associated with increased D-dimer and soluble fibrin concentrations in central venous blood consistent with activation of both coagulation and fibrinolysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignancy is the third most frequent cause of DIC after infection and trauma, accounting for approximately 7 percent of clinically evident cases. Malignancy is a hypercoagulable state and DIC is the most common coagulopathy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/43/35514?source=see_link&amp;anchor=H23#H23\">",
"     \"Hypercoagulable disorders associated with malignancy\", section on 'Disseminated intravascular coagulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    DIC has been reported in as many as 15 percent of patients with advanced disease and in most patients with acute promyelocytic leukemia (APML), in whom it can be reversed by inducing tumor cell differentiation, by downregulating annexin II, the receptor for plasminogen, on the surface of the malignant promyelocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/12/200?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    DIC in malignancy may present acutely with hemorrhage in patients with acute promyelocytic leukemia, or more commonly as a chronic disorder in patients with solid tumors (Trousseau's syndrome) who have variable abnormalities in coagulation tests (",
"    <a class=\"graphic graphic_table graphicRef63831 \" href=\"mobipreview.htm?34/15/35067\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/20/25929?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/12/200?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults\", section on 'Disseminated intravascular coagulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hypercoagulability in this setting is probably due to the interplay of multiple variables [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/36\">",
"     36",
"    </a>",
"    ]. The two most important are the expression by circulating tumor cells of tissue factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/37\">",
"     37",
"    </a>",
"    ] and cancer procoagulant, a calcium-dependent cysteine protease which has been found in malignant and fetal tissue, but not in normally differentiated tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Cancer procoagulant activates factor X directly, independent of the tissue",
"    <span class=\"nowrap\">",
"     factor/factor",
"    </span>",
"    VIIa complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/12/1224?source=see_link\">",
"     \"Pathogenesis of the hypercoagulable state associated with malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Obstetrical complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;DIC occurs in a variety of obstetrical complications (",
"    <a class=\"graphic graphic_table graphicRef58104 \" href=\"mobipreview.htm?8/28/8652\">",
"     table 2",
"    </a>",
"    ). As an example, DIC is seen in more than 50 percent of cases of amniotic fluid embolism and abruptio placentae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. Leakage of thromboplastin-like material into the maternal circulation is the probable cause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The degree of placental separation associated with abruptio placentae correlates with the severity of DIC. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/46/29417?source=see_link\">",
"     \"Placental abruption: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with amniotic fluid embolism typically present with sudden cardiorespiratory collapse during labor and delivery or in the immediate peripartum period. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/42/15016?source=see_link\">",
"     \"Amniotic fluid embolism syndrome\"",
"    </a>",
"    .) Less commonly, there is hemorrhage associated with isolated DIC without antecedent hemodynamic or respiratory instability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/44\">",
"     44",
"    </a>",
"    ]. Although fulminant DIC can occur, it is usually short-lived and self-limiting.",
"   </p>",
"   <p>",
"    DIC is also seen in about 20 percent of all women with HELLP syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/45\">",
"     45",
"    </a>",
"    ], in 84 percent when HELLP is complicated by acute renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/46\">",
"     46",
"    </a>",
"    ], and in up to 7 percent of those with severe preeclampsia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/30/17897?source=see_link\">",
"     \"HELLP syndrome\"",
"    </a>",
"    .) DIC is also a complication of acute fatty liver of pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/38/24166?source=see_link\">",
"     \"Acute fatty liver of pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of DIC in pregnancy include septic abortion and the dead fetus syndrome. In the latter, tissue factor from the retained dead fetus or placenta slowly enters the maternal circulation and initiates DIC and fibrinolysis. In one report, hypofibrinogenemia occurred in 10 percent of cases of intrauterine fetal death within four weeks of fetal demise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/49\">",
"     49",
"    </a>",
"    ]. The presence of DIC is an indication for immediate evacuation of the uterus. When the hypofibrinogenemia is severe, infusion of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    is used to normalize fibrinogen levels prior to delivery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Miscellaneous causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of other disorders have been associated with DIC:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Kaposiform hemangioendothelioma, an aggressive form of giant hemangioma, is frequently complicated by DIC (Kasabach-Merritt syndrome) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/51-54\">",
"       51-54",
"      </a>",
"      ]. The coagulopathy is presumably initiated by prolonged contact of abnormal endothelial surface with blood in areas of vascular stasis. Platelets and fibrinogen are consumed in these hemangiomas, and fibrinolysis appears to be enhanced. The DIC is usually chronic and compensated but can transform into fulminant disease. A similar phenomenon occurs in approximately 50 percent of patients with hereditary hemorrhagic telangiectasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/55\">",
"       55",
"      </a>",
"      ], in as many as 3 to 4 percent of patients with large abdominal aortic aneurysms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/56,57\">",
"       56,57",
"      </a>",
"      ], and in some patients with large venous malformations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/58,59\">",
"       58,59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Insertion of a peritoneovenous shunt is frequently complicated by DIC due to entry into the blood stream of endotoxin or other procoagulant material in the ascitic fluid. The incidence of DIC in this setting can be minimized by intraoperative drainage of the ascites prior to insertion of the shunt [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/60\">",
"       60",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/50/29482?source=see_link&amp;anchor=H18#H18\">",
"       \"Hepatorenal syndrome\", section on 'Peritoneovenous shunt'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute hemolytic transfusion reactions may be complicated by DIC [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/61\">",
"       61",
"      </a>",
"      ]. These reactions reflect destruction of donor erythrocytes by preformed recipient antibodies; they are usually due to ABO incompatibility which is most often the result of clerical error. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/31/11769?source=see_link\">",
"       \"Immunologic blood transfusion reactions\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Paroxysmal nocturnal hemoglobinuria is associated with an increased incidence of venous thrombosis that is infrequently associated with DIC. The proposed mechanism is complement-induced expression of prothrombinase activity on the defective platelets [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/62\">",
"       62",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/50/14121?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical manifestations of paroxysmal nocturnal hemoglobinuria\", section on 'Venous thrombosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bites from rattlesnakes and other vipers cause a coagulopathy similar to DIC. Snake venoms contain a variety of substances that can affect coagulation. As an example, Russell's viper venom contains a protease that directly activates factor X and can produce almost instantaneous defibrination. Supportive care and the use of the appropriate antivenom are effective treatment;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      is of no proven benefit since antithrombin does not block the effects of venom proteases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Many coagulation abnormalities are seen in cirrhosis, complicated and intensified by the decreased synthesis of coagulation proteins. A DIC-like picture can be seen in fulminant hepatic failure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/64\">",
"       64",
"      </a>",
"      ] and in the reperfusion phase of orthotopic liver transplantation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/65,66\">",
"       65,66",
"      </a>",
"      ]. Low-grade, subclinical DIC also appears to be common in patients with cirrhosis, due in part to absorbed endotoxin from the gut [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/67\">",
"       67",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      DIC is a frequent complication of heat stroke, occurring in 45 percent of patients admitted to an intensive care unit with near-fatal heat stroke in Chicago and 31 percent of patients during the Makkah pilgrimage [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/68,69\">",
"       68,69",
"      </a>",
"      ]. The presumed mechanism is nonspecific tissue injury with the release of tissue factor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/69\">",
"       69",
"      </a>",
"      ]. A similar mechanism is presumably responsible for DIC associated with burns [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      DIC may accompany rhabdomyolysis, hyperthermia, acute respiratory distress syndrome, and renal failure in patients with amphetamine overdosage [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/71,72\">",
"       71,72",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Purpura fulminans, characterized by hemorrhagic skin necrosis, can be associated with DIC. It is usually seen in association with homozygous protein C deficiency (neonatal purpura fulminans) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/73,74\">",
"       73,74",
"      </a>",
"      ] or acquired protein C deficiency; an example of the latter occurs in meningococcemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?7/56/8073/abstract/75,76\">",
"       75,76",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/52/841?source=see_link\">",
"       \"Protein C deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An extremely rare cause of DIC is the catastrophic antiphospholipid syndrome. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/31/23034?source=see_link&amp;anchor=H37#H37\">",
"       \"Clinical manifestations of the antiphospholipid syndrome\", section on 'Catastrophic APS'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/62/994?source=see_link\">",
"       \"Patient information: Disseminated intravascular coagulation (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25287803\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disseminated intravascular coagulation (DIC, consumption coagulopathy, defibrination syndrome) is a systemic process producing both thrombosis and hemorrhage, and is a complication of underlying illness occurring in approximately 1 percent of hospital admissions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Pathogenesis",
"      </strong>",
"      &mdash; DIC is primarily due to an uncontrolled and excessive production of thrombin, leading to widespread and systemic intravascular fibrin deposition (",
"      <a class=\"graphic graphic_algorithm graphicRef78959 \" href=\"mobipreview.htm?32/4/32846\">",
"       algorithm 1",
"      </a>",
"      ). Major initiating factors are the release or expression of tissue factor secondary to extensive injury to tissues and vascular endothelium or enhanced expression by monocytes in response to endotoxin and various cytokines. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis of DIC'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <strong>",
"       Chronic DIC",
"      </strong>",
"      : If activation of clotting occurs slowly, an excess of procoagulants is produced, predisposing to both venous and arterial thrombosis (",
"      <a class=\"graphic graphic_table graphicRef63831 \" href=\"mobipreview.htm?34/15/35067\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Acute DIC",
"      </strong>",
"      : If activation is brisk and explosive, the clinical picture is that of intravascular coagulation, consumption coagulopathy, secondary fibrinolysis, a profound systemic bleeding diathesis, and a microangiopathic hemolytic anemia (",
"      <a class=\"graphic graphic_picture graphicRef70851 \" href=\"mobipreview.htm?37/50/38694\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Causes",
"      </strong>",
"      &mdash; The most common causes of DIC are sepsis, trauma and tissue destruction, cancer, and obstetrical complications (",
"      <a class=\"graphic graphic_table graphicRef58104 \" href=\"mobipreview.htm?8/28/8652\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/1\">",
"      Matsuda T. Clinical aspects of DIC--disseminated intravascular coagulation. Pol J Pharmacol 1996; 48:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/2\">",
"      Levi M. Current understanding of disseminated intravascular coagulation. Br J Haematol 2004; 124:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/3\">",
"      Banner DW. The factor VIIa/tissue factor complex. Thromb Haemost 1997; 78:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/4\">",
"      Levi M, van der Poll T, ten Cate H, van Deventer SJ. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest 1997; 27:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/5\">",
"      Franco RF, de Jonge E, Dekkers PE, et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 2000; 96:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/6\">",
"      Sase T, Wada H, Nishioka J, et al. Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases. Thromb Haemost 2003; 89:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/7\">",
"      Pixley RA, De La Cadena R, Page JD, et al. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest 1993; 91:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/8\">",
"      Ono T, Mimuro J, Madoiwa S, et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 2006; 107:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/9\">",
"      Spero JA, Lewis JH, Hasiba U. Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost 1980; 43:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/10\">",
"      Siegal T, Seligsohn U, Aghai E, Modan M. Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases. Thromb Haemost 1978; 39:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/11\">",
"      van Gorp EC, Suharti C, ten Cate H, et al. Review: infectious diseases and coagulation disorders. J Infect Dis 1999; 180:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/12\">",
"      McGehee WG, Rapaport SI, Hjort PF. Intravascular coagulation in fulminant meningococcemia. Ann Intern Med 1967; 67:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/13\">",
"      Winkelstein A, Songster CL, Caras TS, et al. Fulminant meningococcemia and disseminated intravascular coagulation. Arch Intern Med 1969; 124:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/14\">",
"      Thijs LG, de Boer JP, de Groot MC, Hack CE. Coagulation disorders in septic shock. Intensive Care Med 1993; 19 Suppl 1:S8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/15\">",
"      Gando S, Kameue T, Nanzaki S, Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 1996; 75:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/16\">",
"      Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/17\">",
"      Esmon CT, Fukudome K, Mather T, et al. Inflammation, sepsis, and coagulation. Haematologica 1999; 84:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/18\">",
"      Dempfle CE. Coagulopathy of sepsis. Thromb Haemost 2004; 91:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/19\">",
"      Levi M, ten Cate H, Bauer KA, et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/20\">",
"      Colman RW. Contact systems in infectious disease. Rev Infect Dis 1989; 11 Suppl 4:S689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/21\">",
"      de Jonge E, Dekkers PE, Creasey AA, et al. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood 2000; 95:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/22\">",
"      Edwards RL, Rickles FR. Macrophage procoagulants. Prog Hemost Thromb 1984; 7:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/23\">",
"      Jansen PM, Pixley RA, Brouwer M, et al. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. Blood 1996; 87:2337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/24\">",
"      Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/25\">",
"      Murray HW, Tuazon CU, Sheagren JN. Staphylococcal septicemia and disseminated intravascular coagulation. Staphylococcus aureus endocarditis mimicking meningococcemia. Arch Intern Med 1977; 137:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/26\">",
"      Stossel TP, Levy R. Intravascular coagulation associated with pneumococcal bacteremia and symmetrical peripheral gangrene. Arch Intern Med 1970; 125:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/27\">",
"      de Virgilio C, Klein S, Chang L, et al. Clostridial bacteremia: implications for the surgeon. Am Surg 1991; 57:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/28\">",
"      Grewal PK, Uchiyama S, Ditto D, et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 2008; 14:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/29\">",
"      St&eacute;phan F, Hollande J, Richard O, et al. Thrombocytopenia in a surgical ICU. Chest 1999; 115:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/30\">",
"      Hulka F, Mullins RJ, Frank EH. Blunt brain injury activates the coagulation process. Arch Surg 1996; 131:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/31\">",
"      Selladurai BM, Vickneswaran M, Duraisamy S, Atan M. Coagulopathy in acute head injury--a study of its role as a prognostic indicator. Br J Neurosurg 1997; 11:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/32\">",
"      Olson JD, Kaufman HH, Moake J, et al. The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery 1989; 24:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/33\">",
"      Gando S, Nanzaki S, Kemmotsu O. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis. Ann Surg 1999; 229:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/34\">",
"      Scherer RU, Spangenberg P. Procoagulant activity in patients with isolated severe head trauma. Crit Care Med 1998; 26:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/35\">",
"      Barbui T, Finazzi G, Falanga A. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 1998; 91:3093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/36\">",
"      Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992; 11:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/37\">",
"      Rao LV. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992; 11:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/38\">",
"      Gordon SG, Mielicki WP. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue. Blood Coagul Fibrinolysis 1997; 8:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/39\">",
"      Gordon SG, Franks JJ, Lewis B. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res 1975; 6:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/40\">",
"      Gilbert WM, Danielsen B. Amniotic fluid embolism: decreased mortality in a population-based study. Obstet Gynecol 1999; 93:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/41\">",
"      Sutton DM, Hauser R, Kulapongs P, Bachmann F. Intravascular coagulation in abruptio placentae. Am J Obstet Gynecol 1971; 109:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/42\">",
"      Eskes TK. Abruptio placentae. A \"classic\" dedicated to Elizabeth Ramsey. Eur J Obstet Gynecol Reprod Biol 1997; 75:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/43\">",
"      Crane S, Chun B, Acker D. Treatment of obstetrical hemorrhagic emergencies. Curr Opin Obstet Gynecol 1993; 5:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/44\">",
"      Davies S. Amniotic fluid embolism and isolated disseminated intravascular coagulation. Can J Anaesth 1999; 46:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/45\">",
"      Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/46\">",
"      Sibai BM, Ramadan MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168:1682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/47\">",
"      Sibai BM, Spinnato JA, Watson DL, et al. Pregnancy outcome in 303 cases with severe preeclampsia. Obstet Gynecol 1984; 64:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/48\">",
"      Castro MA, Goodwin TM, Shaw KJ, et al. Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol 1996; 174:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/49\">",
"      Parasnis H, Raje B, Hinduja IN. Relevance of plasma fibrinogen estimation in obstetric complications. J Postgrad Med 1992; 38:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/50\">",
"      Strauss JH, Ballard JO, Chamlian D. Consumption coagulopathy associated with intrauterine fetal death: the role of heparin therapy. Int J Gynaecol Obstet 1978-1979; 16:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/51\">",
"      Sarkar M, Mulliken JB, Kozakewich HP, et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997; 100:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/52\">",
"      Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992; 326:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/53\">",
"      Warrell RP Jr, Kempin SJ. Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate. N Engl J Med 1985; 313:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/54\">",
"      Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol 2001; 112:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/55\">",
"      Bick RL. Hereditary hemorrhagic telangiectasia and disseminated intravascular coagulation: a new clinical syndrome. Ann N Y Acad Sci 1981; 370:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/56\">",
"      Fisher DF Jr, Yawn DH, Crawford ES. Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases. Arch Surg 1983; 118:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/57\">",
"      Aboulafia DM, Aboulafia ED. Aortic aneurysm-induced disseminated intravascular coagulation. Ann Vasc Surg 1996; 10:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/58\">",
"      Mazoyer E, Enjolras O, Bisdorff A, et al. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol 2008; 144:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/59\">",
"      Dompmartin A, Acher A, Thibon P, et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol 2008; 144:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/60\">",
"      Smadja C, Franco D. The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients. Ann Surg 1985; 201:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/61\">",
"      Capon SM, Goldfinger D. Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment. Transfusion 1995; 35:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/62\">",
"      Wiedmer T, Hall SE, Ortel TL, et al. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 1993; 82:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/63\">",
"      Tun Pe. Heparin therapy in Russell's viper bite victims with disseminated intravascular coagulation: a controlled trial. Southeast Asian J Trop Med Public Health 1992; 23:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/64\">",
"      Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996; 16:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/65\">",
"      Himmelreich G, Jochum M, Bechstein WO, et al. Mediators of leukocyte activation play a role in disseminated intravascular coagulation during orthotopic liver transplantation. Transplantation 1994; 57:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/66\">",
"      Bakker CM, Metselaar HJ, Gomes MJ, et al. Intravascular coagulation in liver transplantation--is it present or not? A comparison between orthotopic and heterotopic liver transplantation. Thromb Haemost 1993; 69:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/67\">",
"      Violi F, Ferro D, Basili S, et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 1995; 109:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/68\">",
"      Dematte JE, O'Mara K, Buescher J, et al. Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med 1998; 129:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/69\">",
"      Mustafa KY, Omer O, Khogali M, et al. Blood coagulation and fibrinolysis in heat stroke. Br J Haematol 1985; 61:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/70\">",
"      Garc&iacute;a-Avello A, Lorente JA, Cesar-Perez J, et al. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb Res 1998; 89:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/71\">",
"      Walubo A, Seger D. Fatal multi-organ failure after suicidal overdose with MDMA, 'ecstasy': case report and review of the literature. Hum Exp Toxicol 1999; 18:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/72\">",
"      Kendrick WC, Hull AR, Knochel JP. Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med 1977; 86:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/73\">",
"      Branson HE, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 1983; 2:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/74\">",
"      Yuen P, Cheung A, Lin HJ, et al. Purpura fulminans in a Chinese boy with congenital protein C deficiency. Pediatrics 1986; 77:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/75\">",
"      Smith OP, White B, Vaughan D, et al. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet 1997; 350:1590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?7/56/8073/abstract/76\">",
"      Fourrier F, Lestavel P, Chopin C, et al. Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive Care Med 1990; 16:121.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1373 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-D487AFE9F4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8073=[""].join("\n");
var outline_f7_56_8073=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25287803\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS OF DIC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Activation of hemostasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Secondary fibrinolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Acute versus chronic DIC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Thrombotic microangiopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Sepsis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Trauma and extensive surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Obstetrical complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Miscellaneous causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25287803\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/1373\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1373|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?32/4/32846\" title=\"algorithm 1\">",
"      Pathophysiology of DIC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1373|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/52/4932\" title=\"picture 1\">",
"      Genesis of schistocyte",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/50/38694\" title=\"picture 2\">",
"      Schistocytes on peripheral smear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1373|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/15/35067\" title=\"table 1\">",
"      Acute versus chronic DIC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/28/8652\" title=\"table 2\">",
"      Major causes of DIC",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/38/24166?source=related_link\">",
"      Acute fatty liver of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/42/15016?source=related_link\">",
"      Amniotic fluid embolism syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=related_link\">",
"      Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/20/25929?source=related_link\">",
"      Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/50/14121?source=related_link\">",
"      Clinical manifestations of paroxysmal nocturnal hemoglobinuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/31/23034?source=related_link\">",
"      Clinical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/12/200?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/62/9194?source=related_link\">",
"      Extrinsic nonimmune hemolytic anemia due to mechanical damage: Fragmentation hemolysis and hypersplenism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/30/17897?source=related_link\">",
"      HELLP syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/50/29482?source=related_link\">",
"      Hepatorenal syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/43/35514?source=related_link\">",
"      Hypercoagulable disorders associated with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/31/11769?source=related_link\">",
"      Immunologic blood transfusion reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/35/27194?source=related_link\">",
"      Overview of hemostasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/12/1224?source=related_link\">",
"      Pathogenesis of the hypercoagulable state associated with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/62/994?source=related_link\">",
"      Patient information: Disseminated intravascular coagulation (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/46/29417?source=related_link\">",
"      Placental abruption: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/52/841?source=related_link\">",
"      Protein C deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=related_link\">",
"      Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_56_8074="Paraneoplastic pemphigus oral findings";
var content_f7_56_8074=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F59594%7EDERM%2F79518%7EDERM%2F54382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F59594%7EDERM%2F79518%7EDERM%2F54382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Paraneoplastic pemphigus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erosive mucositis in a&nbsp;patient with paraneoplastic pemphigus associated with Castleman's tumor; mucous membrane and cutaneous lesions cleared with tumor removal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Chris Ha, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Paraneoplastic pemphigus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erosions are present on the tongue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Paraneoplastic pemphigus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gingival erosions are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8074=[""].join("\n");
var outline_f7_56_8074=null;
var title_f7_56_8075="Poultry related antigens in HP";
var content_f7_56_8075=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72774&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72774&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hypersensitivity pneumonitides associated with birds and poultry handling",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Environmental source",
"       </td>",
"       <td class=\"subtitle1\">",
"        Major causative antigen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bird fancier's lung (parakeets, budgerigars, pigeons)",
"       </td>",
"       <td>",
"        Droppings, feathers, serum proteins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Poultry worker's lung (feather plucker's disease)",
"       </td>",
"       <td>",
"        Serum proteins (chicken products)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Turkey handling disease",
"       </td>",
"       <td>",
"        Serum proteins (turkey products)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Canary fancier's lung",
"       </td>",
"       <td>",
"        Serum proteins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Duck fever",
"       </td>",
"       <td>",
"        Feathers, serum proteins",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8075=[""].join("\n");
var outline_f7_56_8075=null;
var title_f7_56_8076="Ingredient label terms for egg";
var content_f7_56_8076=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F53488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F53488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    How to read an ingredient label for an egg-free diet",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Avoid foods that contain eggs or any of these ingredients:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Albumin (also spelled albumen)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Egg (dried, powdered, solids, white, yolk)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eggnog",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lysozyme",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mayonnaise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meringue (meringue powder)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ovalbumin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Surimi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Egg is sometimes found in the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Baked goods",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Puddings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ice cream",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Smoothies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Soups",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sauces",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Egg substitutes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lecithin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macaroni",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marzipan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marshmallows",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nougat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pasta",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Keep the following in mind:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Individuals with egg allergy should also avoid eggs from duck, turkey, goose, quail, etc., as these are known to be cross-reactive with chicken egg.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    All FDA-regulated manufactured food products that contain egg as an ingredient are required by US law to list the word \"egg\" on the product label.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; 2010 The Food Allergy &amp; Anaphylaxis Network. Used with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8076=[""].join("\n");
var outline_f7_56_8076=null;
var title_f7_56_8077="Blood pressure algorithm";
var content_f7_56_8077=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74895&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74895&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 519px\">",
"   <div class=\"ttl\">",
"    Blood pressure algorithm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 499px; height: 142px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Arterial blood pressure is the product of cardiac output and systemic vascular resistance. Cardiac output is the volume of blood ejected by the heart each minute; it is the product of heart rate and stroke volume. The stroke volume is the volume of blood ejected by the ventricles with each contraction; it is affected by myocardial contractility, preload, and afterload.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8077=[""].join("\n");
var outline_f7_56_8077=null;
var title_f7_56_8078="Apixaban drug interactions";
var content_f7_56_8078=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F87789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F87789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Apixaban pharmacokinetic interactions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Selected interacting drugs and drug classes",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect",
"       </td>",
"       <td class=\"subtitle1\">",
"        Management suggestions",
"       </td>",
"       <td class=\"subtitle1\">",
"        Recommendations found in licensed product information*",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <strong>",
"         Combined strong inhibitors of CYP3A4 and P-gp",
"        </strong>",
"        (eg, boceprevir",
"        <sup>",
"         &bull;",
"        </sup>",
"        , clarithromycin, cobicistat containing coformulations, conivaptan",
"        <sup>",
"         &bull;",
"        </sup>",
"        , delavirdine",
"        <sup>",
"         &bull;",
"        </sup>",
"        ,",
"        <strong>",
"         all",
"        </strong>",
"        HIV protease inhibitors",
"        <sup>",
"         &Delta;",
"        </sup>",
"        [eg, ritonavir], imatinib",
"        <sup>",
"         &bull;",
"        </sup>",
"        , itraconazole, ketoconazole, nefazodone",
"        <sup>",
"         &bull;",
"        </sup>",
"        , posaconazole",
"        <sup>",
"         &bull;",
"        </sup>",
"        , telaprevir, telithromycin",
"        <sup>",
"         &bull;",
"        </sup>",
"        , voriconazole",
"        <sup>",
"         &bull;",
"        </sup>",
"        )",
"       </td>",
"       <td>",
"        Increased apixaban concentration (significant effect)",
"       </td>",
"       <td>",
"        Avoid co-administration of strong inhibitors of both CYP3A4 and P-gp. Apixaban dose reduction is an option, according to US licensing information, for patients with AF requiring co-administration of strong dual inhibitors, provided not more than one of following factors: age &ge;80 years, weight &le;60 kg, or serum creatinine &ge;1.5 mg/dL. This dose adjustment has not been tested in clinical trials. The efficacy of routine coagulation testing to evaluate the degree of anticoagulation with apixaban is limited and is discussed in the text.",
"       </td>",
"       <td>",
"        <strong>",
"         US:",
"        </strong>",
"        Avoid coadministration or reduce apixaban dose to 2.5 mg twice daily for nonvalvular AF. In patients already taking 2.5 mg twice daily due to any two of the following: SCr &gt;1.5 mg/dL, age &ge;80 years, or weight &le;60 kg, avoid coadministration.",
"        <br/>",
"        <strong>",
"         CAN:",
"        </strong>",
"        Coadministration with strong inhibitors of both CYP3A4 and P-gp is contraindicated.",
"        <br/>",
"        <strong>",
"         EMA, UK:",
"        </strong>",
"        Coadministration with strong inhibitors of both CYP3A4 and P-gp is not recommended.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <strong>",
"         Combined inhibitors of P-gp and/or moderate inhibitors of CYP3A4",
"        </strong>",
"        (eg, amiodarone, azithromycin, chloramphenicol, cimetidine, erythromycin, cyclosporine, diltiazem, dronedarone, felodipine, fluconazole",
"        <sup>",
"         &bull;",
"        </sup>",
"        , grapefruit and grapefruit juice",
"        <sup>",
"         &loz;",
"        </sup>",
"        , lapatinib, lomitapide, mifepristone, naproxen",
"        <sup>",
"         &bull;",
"        </sup>",
"        , nicardipine, quinidine, ranolazine, tamoxifen, verapamil)",
"       </td>",
"       <td>",
"        Increased apixaban concentration (moderate effect in patients with normal renal function; potentially significant effect in patients having severe renal insufficiency)",
"       </td>",
"       <td>",
"        Use with caution; if co-administration is necessary, no specific dose adjustment is recommended. Avoid co-administration in patients with renal insufficiency (CrCl 15 to 50 mL/minute), age &ge;80 years, or low body weight &lt;60 kg.",
"       </td>",
"       <td>",
"        <strong>",
"         US, CAN, EMA, UK:",
"        </strong>",
"        Moderate inhibitors of CYP3A4 and/or P-gp resulted in a &le;1.5-fold increase in apixaban concentrations. No dose adjustment required.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Combined strong inducers of P-gp and CYP3A4",
"        </strong>",
"        (eg, carbamazepine, dexamethasone, rifampin",
"        <sup>",
"         &sect;",
"        </sup>",
"        )",
"        <br/>",
"        <strong>",
"         Inducers of P-gp",
"        </strong>",
"        (eg, doxorubicin, nefazodone, prazosin, St. John's wort, tipranavir, trazodone, vinblastine)",
"        <br/>",
"        <strong>",
"         Strong inducers of CYP3A4",
"        </strong>",
"        (eg, aminoglutethimide, barbiturates, bosentan, efavirenz, etravirine, fosphenytoin, nafcillin, nevirapine, oxcarbazepine, pentobarbital, phenobarbital, phenytoin, primidone, rifabutin, rifapentine)",
"       </td>",
"       <td>",
"        Decreased apixaban concentration (significant effect)",
"       </td>",
"       <td>",
"        Avoid concurrent use with agents known to strongly induce CYP3A4 and/or P-gp. Effect on apixaban concentration may persist for several weeks following discontinuation of a strong inducer of P-gp and/or 3A4.",
"       </td>",
"       <td>",
"        <strong>",
"         US:",
"        </strong>",
"        Avoid co-administration with strong inducers of CYP3A4 and P-gp.",
"        <br/>",
"        <strong>",
"         CAN:",
"        </strong>",
"        Co-administration of strong inducers of CYP3A4 and/or P-gp should generally be avoided. Increased adverse effects (thrombotic and major bleeding) have been noted.",
"        <br/>",
"        <strong>",
"         EMA, UK:",
"        </strong>",
"        Strong inducers of both CYP3A4 and P-gp led to approximately 50 percent decrease in apixaban concentrations. No dose adjustment required. Use caution.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Interaction data and recommendations refer to systemic drug forms. Specific drug interactions and management suggestions may be determined by using Lexi-Interact, the drug interactions program included with UpToDate.",
"    <div class=\"footnotes\">",
"     AF: atrial fibrillation; CYP3A4: cytochrome P-450 3A4; P-gp: P-glycoprotein efflux transporters; VTE: venous thromboembolism; CrCl: creatinine clearance; US: United States Prescribing Information; CAN: Canadian Product Monograph; EMA: European Medicines Agency Summary of Product Characteristics; UK: United Kingdom Summary of Product Characteristics.",
"     <br>",
"      *",
"      <strong>",
"       Drug interactions, management recommendations, and contraindicated drug combinations listed in licensed product information vary by country. Consult official product information for details before using this agent.",
"      </strong>",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       Limited or conflicting data concerning relevance of P-gp inhibition.",
"       <br>",
"        &Delta; Atazanavir, darunavir, fosamprenavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir, and tipranavir.",
"        <br>",
"         <font class=\"lozenge\">",
"          &loz;",
"         </font>",
"         Avoidance of grapefruit and grapefruit juice in large quantities advised due to lack of predictability of its effect.",
"         <br>",
"          &sect; Rifampicin is international nonproprietary (generic) name.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Eliquis (apixaban) US prescribing information (December, 2012). Available at:",
"        <a href=\"file://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf\" target=\"_blank\">",
"         file://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf",
"        </a>",
"        . (Accessed January 7, 2013.)",
"       </li>",
"       <li>",
"        Eliquis Canada Product Monograph (revision November 27, 2012). Available at: file://webprod5.hc-sc.gc.ca/dpd-bdpp/info.do?code=88264&amp;lang=eng. (Accessed January 7, 2013.)",
"       </li>",
"       <li>",
"        Eliquis Summary of Product Characteristics European Medicines Agency version December 20, 2012. Available at:",
"        <a href=\"file://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002148/WC500107728.pdf\" target=\"_blank\">",
"         file://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002148/WC500107728.pdf",
"        </a>",
"        . (Accessed January 7, 2013.)",
"       </li>",
"       <li>",
"        Eliquis film coated tablets United Kingdom Summary of Product Characteristics version December 3, 2012. Available at:",
"        <a href=\"file://www.medicines.org.uk/EMC/medicine/27220/SPC/Eliquis+5+mg+film-coated+tablets/\" target=\"_blank\">",
"         file://www.medicines.org.uk/EMC/medicine/27220/SPC/Eliquis+5+mg+film-coated+tablets/",
"        </a>",
"        . (Accessed January 7, 2013.)",
"       </li>",
"       <li>",
"        Lexicomp online Lexi-Interact Copyright &copy; 1978-2013 by Lexicomp, Inc. All rights reserved.",
"       </li>",
"       <li>",
"        Hansten PD, Horn JR. Top 100 drug interactions: Guide to patient management, 13th ed, H&amp;H Publications 2013.",
"       </li>",
"       <li>",
"        Poulsen BK, Grove EL, Husted SE. New oral anticoagulants. Drugs 2012; 72:1739.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8078=[""].join("\n");
var outline_f7_56_8078=null;
var title_f7_56_8079="Eating attitudes test";
var content_f7_56_8079=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F60963&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F60963&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Eating attitudes test",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"50%\">",
"     </colgroup>",
"     <colgroup span=\"7\" width=\"7%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Always",
"       </td>",
"       <td class=\"subtitle1\">",
"        Usually",
"       </td>",
"       <td class=\"subtitle1\">",
"        Often",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sometimes",
"       </td>",
"       <td class=\"subtitle1\">",
"        Rarely",
"       </td>",
"       <td class=\"subtitle1\">",
"        Never",
"       </td>",
"       <td class=\"subtitle1\">",
"        Score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Am terrified about being overweight",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Avoid eating when I am hungry",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Find myself preoccupied with food",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Have gone on eating binges where I feel that I may not be able to stop",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Cut my food into small pieces",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Aware of the calorie content of foods that I eat",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. Particularly avoid foods with high carbohydrate content (ie, bread, rice, potatoes, etc)",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8. Feel that others would prefer if I ate more",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9. Vomit after I have eaten",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10. Feel extremely guilty after eating",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        11. Am preoccupied with a desire to be thinner",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        12. Think about burning up calories when I exercise",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        13. Other people think that I am too thin",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14. Am preoccupied with the thought of having fat on my body",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        15. Take longer than others to eat my meals",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        16. Avoid foods with sugar in them",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        17. Eat diet foods",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        18. Feel that food controls my life",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        19. Display self-control around food",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        20. Feel that others pressure me to eat",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        21. Give too much time and thought to food",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        22. Feel uncomfortable after eating sweets",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        23. Engage in dieting behavior",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        24. Like my stomach to be empty",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25. Enjoy trying new rich foods",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        26. Have the impulse to vomit after meals",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        ___",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"8\">",
"        For all items except #25, responses receive the following value:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        Always = 3",
"       </td>",
"       <td>",
"        Usually = 2",
"       </td>",
"       <td>",
"        Often = 1",
"       </td>",
"       <td>",
"        Sometimes = 0",
"       </td>",
"       <td>",
"        Rarely = 0",
"       </td>",
"       <td>",
"        Never = 0",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"8\">",
"        For item #25, the responses receive these values:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        Always = 0",
"       </td>",
"       <td>",
"        Usually = 0",
"       </td>",
"       <td>",
"        Often = 0",
"       </td>",
"       <td>",
"        Sometimes = 1",
"       </td>",
"       <td>",
"        Rarely = 2",
"       </td>",
"       <td>",
"        Never = 3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The cutoff score in screening patients for the presence of a DSM-IV eating disorder is 20",
"    <sup>",
"     [1]",
"    </sup>",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Mintz LB, O'Halloran MS. The Eating Attitudes Test: validation with DSM-IV eating disorder criteria. J Pers Assess 2000; 74:489.",
"      </li>",
"     </ol>",
"     <br/>",
"     Reproduced with permission from: Garner DM, Garfinkel PE. Psychol Med 1979; 9:273. Copyright &copy; 1979 Cambridge University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_56_8079=[""].join("\n");
var outline_f7_56_8079=null;
